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INTRODUCTION 
The Intraosseous Transcutaneous Amputation Prosthesis (ITAP) is a titanium alloy 
implant that is anchored to bone (osseointegrated) and penetrates the skin 
(transcutaneous) to provide a means of direct skeletal attachment for artificial limbs. 
This device has the potential to improve the quality of life for amputees by avoiding 
many of the common soft tissue complications associated with conventional socket 
prostheses and by improving comfort, sensory feedback and overall function. The 
main complication associated with ITAP is infection due to a poor soft tissue seal at 
the skin-implant interface. This thesis explores approaches to enhance soft tissue 
integration while simultaneously reducing bacterial colonisation of ITAP. New 
surface modifications and functionalisation with coatings are investigated. 
 
The following literature review evaluates published information relevant to ITAP 
and develops the rationale for further modification of ITAP using the surface 
modifications and coatings that have been investigated in this thesis. 
 
1.1  THE CLINICAL PROBLEM 
1.1.1  Epidemiology of Amputation 
Amputation is a significant clinical problem worldwide. The incidence of extremity 
amputation varies depending on factors such as geography, age and gender (The 
Global Lower Extremity Amputation Study Group, 2000). The global incidence of 
lower extremity amputation has been reported to be between 0.5 and 49.5 per 
100,000 people (The Global Lower Extremity Amputation Study Group, 2000). 
There are estimated to be approximately 1.9 million amputees in the United States 
(Limb Loss Research and Statistics Program, ACA). In the United Kingdom, the 
number of new referrals to prosthetic services made annually has increased from 
4957 in 2006 to 2007 to 5988 in 2010 to 2011 (The Amputee Statistical Database for 
the United Kingdom, 2006/7; Limbless Statistics, United National Institute for 
Prosthetics & Orthotics Development, Annual Report 2010-2011). Data from 
Hospital Episode Statistics (HES) has shown that the total number of lower extremity 
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amputations performed in the National Health Service in England (both major (i.e. 
above ankle) and minor operations combined) was 34,109 between the years 2007 
and 2010 (Holman et al 2012). The commonest indication for amputation in the 
developed world is peripheral vascular disease, whereas in developing countries the 
major indications are trauma and bone tumours (Yinusa et al 2003; Thanni et al 
2007). The incidence of amputation is expected to increase over the next few decades 
due to the ageing population and associated increases in diabetes and peripheral 
vascular disease (Harker 2006; Vamos et al 2010). However, improved diabetic foot 
care and vascular surgical interventions such as bypass and angioplasty procedures 
have the potential to prevent amputations (Larsson et al 2008; Krishnan et al 2008; 
Canavan et al 2008; Gutacker et al 2010). In recent years there have been increases 
in the incidence of amputation due to the returning war wounded (Krueger et al 
2012). Advances in body armour and trauma resuscitation techniques have increased 
survival rates for patients with blast wounds, leading to an increase in severe injuries 
(including amputation) of the unprotected extremities (Manring et al 2009; Kim et al 
2010).  
 
1.1.2  Problems Associated with Conventional Socket Prostheses 
Rehabilitation following amputation is a significant challenge. Traditionally, 
amputees are fitted with socket prostheses that are attached to the stump via suction 
or straps. Socket prostheses may be associated with complications including 
discomfort or pain, excessive perspiration, contact dermatitis, recurrent skin 
infections and the need for repeated fittings due to changing stump shape and poor 
prosthetic fit. Ulceration and pressure sores caused by non-uniform pressure 
distribution over the stump may also occur (Hagberg et al 2001; Koc et al 2008; 
Meulenbelt et al 2011). A survey of non-vascular amputees with socket prostheses 
showed that health related quality of life was significantly lower than age and gender 
matched controls. A quarter of the patients experienced poor or extremely poor 
overall quality of life. This reduction in quality of life was attributed to the fact that 
72% of patients were found to experience excessive heat and perspiration of the 
stump, 62% experienced sores and 59% experienced slow gait (Hagberg et al 2001). 
More recent improvements in the design of the socket have increased the quality of 
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life for some patients; however, a substantial number of patients still experience 
unacceptable function. A 2011 cross-sectional survey of 124 amputees with socket 
prostheses identified skin problems in 36% of patients, which is similar to results 
from earlier studies (Demet et al 2003; Dudek et al 2005; Meulenbelt et al 2011).  
 
1.1.3  Osseointegrated Transcutaneous Amputation Prostheses 
Osseointegrated transcutaneous prostheses such as ITAP have been designed in order 
to avoid the problems described above. These implants are able to avoid these 
problems because the forces that would be encountered by the soft tissues of the 
stump with the use of a socket prosthesis are transferred directly to the skeleton. 
Figure 1.1 is a schematic diagram of an osseointegrated transcutaneous prosthesis. 
Patients with osseointegrated transcutaneous implants experience increased 
proprioception and sensory feedback, which is known as ‘osseoperception’. 
Osseoperception results in improved control of limb function and gait (Marks et al 
2001; Abarca et al 2006). Although the exact mechanism responsible for 
osseoperception is unknown, hypothetically, transfer of tactile stimuli to endosteal 
nerves in the bone via the implant may play a role (Lundborg et al 1996). Other 
advantages include fixing the external prostheses to short residual limbs (where the 
use of conventional prostheses is problematic) and easier donning and doffing of the 
external prosthesis (Sullivan et al 2003; Kang et al 2010). 
Figure 1.1  Schematic diagram of an osseointegrated transcutaneous prosthesis. 
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1.1.3.1  Use of Osseointegrated Implants Outside of Limb Reconstruction 
Osseointegrated titanium implants have been used successfully in dental surgery for 
replacement of prosthetic teeth for over forty years (Adell et al 1981). The twenty-
year survival rate has been reported to be 98.9% (Ekelund et al 2003). 
Osseointegrated implants have also been used in craniofacial and 
otorhinolaryngological surgery e.g. for bone-anchored hearing aids and auricular 
implants. Implant infection/failure rates of up to 10% have been reported  
(Nishimura et al 1995; Granstrom 2007; Hagr et al 2007). Failure rates have been 
found to be higher in older patients potentially due to reduced blood flow and 
osteoporosis (Drinias et al 2007; Granstrom 2007).  Higher failure rates have also 
been reported in specific regions such as the frontal bone and the zygoma, which 
may be related to these regions being irradiated more than other bones (Granstrom 
2007). Osseointegrated digital prostheses have been generally uncomplicated with 
good long-term functional and cosmetic outcomes as well as low infection rates 
(Lundborg et al 1996; Manurangsee et al 2000; Aydin et al 2007; Aydin et al 2008; 
Doppen et al 2009; Sierakowski et al 2011). In contrast, infection is a common 
complication associated with osseointegrated transcutaneous prostheses to treat limb 
amputations with reports of superficial infection rates varying between 
approximately 18 and 55% (Tillander et al 2010; Brånemark et al 2014). However, 
few deep intramedullary infections necessitating implant removal have been reported 
(Aschoff et al 2010; Brånemark et al 2014). 
 
The reduced success rate associated with osseointegrated limb amputation prostheses 
compared with dental, craniofacial, otorhinolaryngological and digital implants may 
be related to the greater soft tissue mass and coverage around limb implants, which 
increases interfacial movement of the soft tissue relative to the stiffer less mobile 
bone-anchored implant. The particularly high success rates associated with dental 
osseointegrated implants is potentially partly due to the fact that oral mucosal 
fibroblasts exhibit more rapid proliferation, greater extracellular matrix 
reorganisational ability as well as increased matrix metalloproteinase expression and 
growth factor secretion compared with dermal fibroblasts (Stephens et al 2001; Gron 
et al 2002; Rodemann et al 2011). Furthermore, Pendegrass et al (2015) have shown 
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that oral gingival epithelial cells up-regulate focal adhesion and hemidesmosome 
expression at earlier time points compared with epidermal keratinocytes. 
Hemidesmosome expression in oral gingival cells was found to be three times greater 
compared with that of epidermal keratinocytes at four hours after seeding onto 
titanium alloy surfaces (Pendegrass et al 2015). It is postulated that this contributes 
to the formation of a more robust epithelial seal around dental implants compared 
with extra-oral transcutaneous implants. 
 
1.1.3.2  Osseointegration, Bone Structure and Bone Biology 
Osseointegration was first described by Brånemark in the 1950s. It was initially 
defined as a direct structural and functional connection between living bone and the 
surface of a load-carrying implant (Brånemark et al 2001). The definition nowadays 
considers osseointegration to have occurred if there is no progressive movement 
between the implant and the bone with which it has direct contact (Brånemark et al 
2001; Nebergall et al 2012). Osseointegration is not the focus of this thesis as it has 
been studied extensively and is not the main factor limiting the success of 
osseointegrated transcutaneous prostheses. However, as osseointegration is a key 
component of osseointegrated transcutaneous prostheses, the following description 
of bone structure, biology and factors affecting the success of osseointegration has 
been included. 
 
Bone Structure  
Bone is a specialised form of connective tissue. Its basic functions include protection 
of internal organs, locomotion and mineral homeostasis (Buckwalter 1995; Downey 
and Siegel 2006). Macroscopically, the two main morphological types of bone are 
cortical (compact) or cancellous (spongy/trabecular) (Downey and Siegel 2006; 
Buck and Dumanian 2012). Cortical bone forms approximately 80% of the mature 
skeleton and surrounds the marrow and cancellous bone plates. Cortical bone forms 
the diaphysis of long bones. The metaphysis and epiphysis of long bones have 
thinner cortical walls. Cortical and cancellous bone have a similar matrix structure 
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and composition but the mass of cortical bone per unit volume is greater. Cortical 
bone has approximately 5 to 10% porosity and cancellous bone has 50 to 90% 
porosity. The modulus of elasticity and the ultimate compressive strength of cortical 
bone is up to ten times greater than cancellous bone. Cancellous bone has a higher 
rate of metabolic activity and remodelling than cortical bone (Buckwalter 1995; 
Downey and Siegel 2006; Buck and Dumanian 2012). 
 
Histologically, bone consists of woven (primary) or lamellar (secondary) bone (Buck 
and Dumanian 2012). Woven bone is an immature form of bone that occurs in the 
embryonic skeleton and is later resorbed and replaced by lamellar bone (Buckwalter 
1995; Burkitt et al 1997). Woven bone has a disorganised irregular appearance and a 
greater rate of metabolic activity compared with lamellar bone. Lamellar bone has a 
highly organised appearance consisting of layers appearing in parallel units or sheets 
with densely packed collagen fibrils. Concentric rings of lamellae form osteons 
(haversian systems). Osteons surround central canals (haversian canals), which are 
lined by endosteal cells and contain blood vessels, lymphatics and occasionally 
nerves (Buckwalter 1995; Buck and Dumanian 2012). Tunnel-like structures known 
as cannaliculi extend from the central canals and contain the cell processes of 
osteocytes. Obliquely orientated Volkmann canals allow the neurovascular bundles 
to interconnect with one another and with the endosteum and periosteum 
(Buckwalter 1995; Burkitt et al 1997). 
 
Periosteum covers the external surface of long bones and consists of an outer fibrous 
layer and inner cellular cambial layers. The periosteum supplies nerves, blood 
vessels and lymphatics to bone and contains numerous osteoprogenitor cells (Burkitt 
et al 1997; Buck and Dumanian 2012). 
 
Cellular Composition of Bone 
The four cellular elements of bone are osteoblasts, osteocytes, bone lining cells and 
osteoclasts. Osteoblasts, osteocytes and bone lining cells originate from 
mesenchymal stem cells. Osteoclasts originate from haematopoeitic stem cells 
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(Buckwalter 1995). Osteoblasts are responsible for production and mineralisation of 
the organic matrix of bone (Freemont 1993). Osteoblasts play a role in regulating 
osteoclastic activity. They produce receptor activator of nuclear factor-κβ ligand 
(RANKL), which activates osteoclasts, as well as osteoprotegerin, which inhibits 
osteoclasts (Simonet et al 1997; Gori et al 2000). Osteoblasts may become 
surrounded by matrix and differentiate into osteocytes or they may become relatively 
inactive and form bone lining cells (Downey and Siegel 2006). Osteocytes have 
connecting cytoplasmic processes that project through the cannaliculi and are 
important in cellular communication and nutrition (Downey and Siegel 2006). 
Osteocytes also appear to be responsible for translating mechanical loading into 
biochemical signals that affect bone formation and resorption (Bonewald and 
Johnson 2008). The fourth cell type is the osteoclast. Osteoclasts are giant 
multinucleated cells responsible for resorption of bone (Freemont 1993; Väänänen et 
al 2000). 
 
Extracellular Composition 
The extracellular composition of bone comprises approximately 90% of its volume 
and is composed of both an organic component and an inorganic component. The 
organic matrix accounts for approximately 35% of the total weight of bone tissue and 
the inorganic part accounts for approximately 65%. The organic makeup of bone 
consists primarily of Type I collagen that is synthesised by osteoblasts, secreted and 
then assembled extracellularly. Small amounts of Type V, VI, VIII and XII are also 
present (Downey and Siegel 2006). Non-collagenous proteins and non-protein 
components that are involved in the structural integrity and/or control of bone cell 
function are also present. These include osteocalcin and osteonectin and 
transforming growth factor-β (Freemont 1993). The inorganic matrix of bone 
provides a major portion of the tensile yield strength. The mineral salts of bone 
contain 99% of the calcium, 85% of the phosphorus and 40 to 60% of the sodium 
and magnesium found in the body. The inorganic matrix of bone contains a salt of 
calcium and phosphate, which has a crystal structure that closely resembles 
hydroxyapatite (Freemont 1993). Bone mineral crystals are classified as apatite, 
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rather than pure hydroxyapatite as they contain both carbonate ions and acid 
phosphate groups (Buckwalter 1995). 
 
Factors Affecting the Success of Osseointegration 
Osseointegration is influenced by a number of factors. Firstly, the material of the 
implant is important. Titanium is a popular choice due to its excellent 
biocompatibility. It is bioinert. It has been proposed that the absence of negative 
tissue responses associated with titanium is responsible for its enhanced 
osseointegration (Stanford and Keller 1991). When titanium is exposed to air, a thin 
titanium oxide layer forms on the surface. A thickness of approximately 2-5 nm is 
often formed in a few seconds (Guo et al 2012). The oxide layer is known to increase 
corrosion resistance and may improve ingrowth of bone cells (depending on the 
surface preparation and thickness of the oxide layer formed) (Cunha et al 2014). It 
has been postulated that the interface between titanium and the living bone is a 
titanium peroxy matrix and that a chemical bond forms between the tightly adherent 
oxide layer and the tissue (Adell et al 1981, Brånemark et al 2001).  
 
Intraoperatively, tissues should be handled carefully in order to minimise tissue 
damage, which could be detrimental to osseointegration (Adell et al 1981). Drilling 
temperatures should be kept as low as possible and irrigation may be used while 
drilling (Adell et al 1981). Handling the implant with only titanium instruments is 
more favourable for osseointegration (Granstrom 2007). The design of the implant is 
also relevant. A screw-shaped implant may show better primary stability than a cone-
shaped implant. Roughened and microgrooved surfaces have been found to promote 
osseointegration (Adell et al 1981; Granstrom 2007, Mavrogenis et al 2009). Surface 
nanotopography has also been shown to influence osseointegration by promoting 
osteoblast adhesion and migration and by influencing cell differentiation (de Oliviera 
et al 2007; Feller et al 2015). For example, nanotextured surfaces produced by 
chemical treatment of titanium with a mixture of sulphuric acid and hydrogen 
peroxide have been found to upregulate the early expression of bone sialoprotein and 
osteopontin in osteogenic cell cultures, which leads to an increase in bone-like 
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nodule formation (de Oliviera and Nanci 2003; de Oliviera et al 2007). It has been 
shown that nanoscale features on titanium implants may direct the differentiation of 
mesenchymal stem cells towards an osteogenic lineage and stimulate osteoprogenitor 
cell differentiation towards an osteoblastic phenotype (Dalby et al 2006; Mendonca 
et al 2009; Tan et al 2014; Tsimbouri et al 2014). Nanotopography may lead to 
alterations in cell shape, which may affect cell differentiation by influencing cellular 
interaction with surface features via filopodia (McBeath et al 2004; de Oliviera et al 
2007; Feller et al 2015). Furthermore, nanotopography may affect cell differentiation 
by influencing gene expression, e.g. higher gene expression of α1β1 integrins in 
cells grown on nanotextured surfaces has been observed (Rosa et al 2014; Curtis and 
Tsimbouri 2014). Poor bone quality e.g. due to irradiation or primary osteoporosis is 
detrimental to osseointegration (Granstrom 2007).  
 
1.1.3.3 Failure Mechanisms of Osseointegrated Transcutaneous Prostheses 
Mechanisms that prevent the formation of a robust seal between the soft tissues and 
the implant result in failure of transcutaneous implants. Epithelial downgrowth is the 
main mechanism that prevents this seal forming. Epithelial downgrowth is the 
migration of epithelial cells downwards and parallel to the side of the implant 
(Figure 1.2 (a)). The presence of a transcutaneous implant prevents the wound 
margins from meeting. The epithelial cells are unable to form cell-cell adhesions as 
they would during normal wound healing. As a result, prevention of epithelial cell 
migration via contact inhibition does not occur (Zegers et al 2003; Pendegrass et al 
2012a). This leads to epithelial downgrowth.  The failure of the epithelium to unite 
with the surface of the implant and the subsequent space at the skin-implant interface 
provides a direct route for microorganisms to enter the underlying soft tissues (Von 
Recum et al 1984; Pendegrass et al 2006a). Marsupialisation is the formation of 
pockets between the implant and the surrounding epithelium that occurs as a result of 
epithelial downgrowth (Figure 1.2 (b)). The pockets are filled with cell detritus and 
exudate, which creates a favourable environment for bacterial colonisation (von 
Recum et al 1984).  In some cases further epithelial downgrowth may lead to the 
cells re-establishing continuity beneath the implant resulting in the implant becoming 
extra-cutaneous. This rarely occurs with osseointegrated medical devices. Avulsion 
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is a mechanically induced failure mechanism in which the soft tissue-implant 
interface is disrupted. Small forces may cause avulsion when the prosthesis is poorly 
supported by the attachment of soft tissues. Avulsion has been shown to lead to 
haematoma formation, focal inflammatory areas and tissue necrosis, which 
predispose to infection (von Recum et al 1984). 
 
 
 
 
Figure 1.2  Diagram illustrating the process of (a) epithelial downgrowth and  
(b) marsupialisation. 
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1.2  CONSIDERATION OF SKIN HISTOLOGY AND WOUND HEALING 
In order to increase the skin-implant seal and to improve the success of 
transcutaneous implants it is necessary to consider the histological features of skin 
and the process of wound healing. 
 
1.2.1  Histological Features of Skin 
The skin consists of three layers, namely the epidermis, dermis and hypodermis. The 
epidermis is a stratified squamous keratinising epithelium composed of 90 to 95% 
keratinocytes (Kanitakis 2002). Small numbers of other cells are also present, e.g. 
melanocytes, Langerhan’s cells and Merkel cells. Mitotically active cells within the 
stratum basale (the deepest layer of the epidermis) give rise to other keratinocytes. 
There is progressive movement of cells from the stratum basale up through to the 
more superficial layers of the epidermis. These layers are the stratum spinosum, the 
stratum granulosum, the stratum lucidum (which is only present in very thick skin) 
and finally the stratum corneum. Cells are continuously shed from the outer stratum 
corneum and replaced by the progressive movement and maturation of cells from the 
deeper layers (Burkitt 1997). The epidermal appendages (sweat glands and 
pilosebaceous follicles) are specialised epithelial structures connected to the surface 
epidermis but located mainly within the dermis and hypodermis (Kanitakis 2002).  
The cells of the stratum basale attach to the basement membrane that separates the 
epidermis from the underlying dermis by hemidesmosomes. The basement 
membrane is synthesised by the basal keratinocytes and dermal fibroblasts. It 
regulates the exchange of metabolic products between the dermis and epidermis and 
serves as a support for keratinocyte migration during wound healing (Kanitakis 
2002; Woolf 1998). The basement membrane consists of four zones. The plasma 
membrane of keratinocytes contains the hemidesmosomes. The lamina lucida 
contains the bullous pemphigoid antigen and various isoforms of the protein laminin 
(laminin 5, 6 and 10). The lamina densa consists of type IV collagen. The sub-basal 
lamina filamentous zone mainly contains anchoring fibres (Kanitakis 2002). 
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The dermis is the supportive connective tissue underlying the epidermis that 
incorporates a generous vascular system to provide metabolic support for the 
avascular epidermis and for thermoregulation (Burkitt 1997). The thickness of 
dermis varies considerably depending on the anatomic location (Kanitakis 2002). 
The majority of dermal fibres consist of type I and type III collagen. Fibroblasts are 
the predominant cells of the dermis and all connective tissues. They produce and 
organise the extracellular matrix and play a crucial role in wound repair (Sorrell and 
Caplan 2004). The extracellular matrix of the dermis consists of fibrous proteins and 
proteoglycans. The fibrous proteins include structural proteins such as collagen and 
elastin as well as adhesive proteins such as fibronectin and laminin (Alberts 2002; 
Schultz et al 2005). The dermis consists of two zones. The upper papillary zone 
forms upright projections known as dermal papillae. These papillae are separated 
from each other by rete ridges (prolongations of the epidermis). This increases the 
surface of contact between the dermis and the epidermis, which allows better 
adhesion between these layers. The papillary dermis consists of collagen fibres 
arranged in loose bundles. It contains loops of blood vessels and nerve fibres. The 
deeper reticular dermis consists of coarser collagen bundles orientated approximately 
parallel to the overlying skin surface. It contains thick elastic fibres, vascular and 
nerve plexuses and the deep part of cutaneous appendages such as sweat glands, 
sebaceous glands and hair follicles (Burkitt 1997).  
The deepest layer of the skin, the hypodermis, consists mainly of mature adipose 
tissue cells, which are arranged in lobules (Woolf 1998). Lobules are separated by 
connective septa containing fibroblasts and other cells e.g. dendrocytes and mast 
cells. Sweat glands, vessels and nerves are also present in the hypodermis (Woolf 
1998; Kanitakis 2002).  Figure 1.3 is a histological section of the skin. 
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Figure 1.3  Histological section of the skin (Adapted from Slomianka 2009).  
 
1.2.2  Wound Healing 
Wound healing consists of four overlapping stages, which are haemostasis, 
inflammation, proliferation and maturation. Haemostasis starts immediately after the 
injury or incision. Platelets accumulate within the tissue defect (Reinke and Sorg 
2012). Clotting mechanisms are activated leading to conversion of fibrinogen to 
polymerised fibrin. This is stabilised by fibronectin binding by means of a 
glutaminase bridge (Woolf 1998). The blood clot that forms is composed of 
cytokines, growth factors, fibrin molecules, fibronectin, vitronectin and 
thrombospondins (Reinke and Sorg 2012). In the case of incised wounds without a 
large tissue defect, the gel formed by fibrin and fibrinogen acts as a ‘glue’ to help       
 
This image has been removed by the author for copyright reasons. 
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keep the wound edges apposed. The provisional wound matrix formed during the 
haemostasis stage acts as a scaffold for the migration of leucocytes, keratinocytes 
and endothelial cells as a reservoir of growth factors (Woolf 1998; Reinke and Sorg 
2012). 
The inflammatory phase of wound healing is activated by the haemostasis stage. The 
clot and surrounding wound tissue release pro-inflammatory cytokines and growth 
factors such as transforming growth factor-β, platelet-derived growth factor, 
fibroblast growth factor, and epidermal growth factor (Guo and DiPietro 2010). 
Within the first few hours after wounding neutrophils are recruited (Woolf 1998). 
Neutrophils release inflammatory mediators such as tumour necrosis factor α, 
interleukin-1β and interleukin-6 to amplify the inflammatory response and stimulate 
vascular endothelial growth factor and interleukin-8 to promote the repair response 
(Reinke and Sorg 2012). Another important function of neutrophils is to release 
proteolytic enzymes such as the broad specificity serine proteases (e.g. elastase) and 
metalloproteinase that specifically digests collagen. As a result, neutrophils digest 
bacteria and non-viable tissue (Broughton et al 2006). Macrophages migrate into the 
area approximately one to three days after injury (Woolf 1998; Reinke and Sorg 
2012). Initially, they release cytokines and promote the inflammatory response. 
Macrophages phagocytose pathogens and cell debris. Additionally, they are 
responsible for inducing and clearing apoptotic cells including neutrophils, thus 
promoting the resolution of inflammation (Guo and DiPietro 2010). 
The proliferation phase occurs approximately three to ten days after wounding. 
Fibroblasts migrate into the wound and lay down collagen type I and III. Collagen 
type III predominates initially but is later replaced by collagen type I (Reinke and 
Sorg 2012). Fibroblasts also produce fibronectin, glucosaminoglycans and 
proteoglycans, which are components of the extracellular matrix  (Guo and DiPietro 
2010). Angiogenesis is initiated when growth factors bind to their receptors on the 
endothelial cells of existing vessels. This activates intracellular signalling cascades. 
The activated endothelial cells secrete proteolytic enzymes, which degrade the 
basement membrane. The endothelial cells proliferate and migrate into the wound. 
New ‘sprouts’ form a vessel loop and differentiate into arteries and venules and 
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mature. Local keratinocytes at the wound edges and epithelial stem cells from hair 
follicles or sweat glands re-epithelialise the wound. The formation of granulation 
tissue is the last step in the proliferation phase. Granulation tissue is highly vascular 
and contains a high density of capillaries as well as fibroblasts, granulocytes, 
macrophages and loosely organised collagen bundles (Reinke and Sorg 2012). 
The final stage of wound healing is maturation and involves the process of tissue 
remodelling and increasing wound strength (Gosain and DiPietro 2004). This stage 
can last for years after the initial wounding occurred. The formation of granulation 
tissue stops through apoptosis of the cells. The mature wound is acellular and 
avascular. Collagen type III is replaced by the stronger Collagen type I. 
Myofibroblasts result in wound contraction, which helps reduce the surface of the 
developing scar (Guo and DiPietro 2010; Reinke and Sorg 2012). Figure 1.4 
summarises the process of wound healing. 
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1.4 The four overlapping stages of wound healing (Adapted from Gendaszewska-
Darmach and Kucharska 2011 and Akhundov et al 2012). 
 
The soft tissue seal around transcutaneous implants could potentially be improved by 
modifying the surface of the implant to promote wound healing and increase 
fibroblast and/or keratinocyte adhesion. 
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1.3  BACTERIAL COLONISATION VERSUS TISSUE INTEGRATION 
1.3.1  ‘Race for the surface’ 
In order to achieve tissue integration and prevent biomaterial-associated infections it 
is necessary for tissue cells to win the ‘race for the surface’ against bacteria. The 
term ‘race for the surface’ refers to the competition between eukaryotic cells and 
bacterial adhesion on the biomaterial surface (Gristina 1987). In the case of ITAP, 
ideally fibroblasts and keratinocytes need to adhere to the surface before bacteria do. 
If the fibroblasts win the ‘race’, the implant surface would be covered by a cellular 
layer, making the surface less available for bacterial attachment. This would lead to 
successful tissue integration. However, bacteria may win the ‘race’ establishing 
biofilm formation, which may be very difficult to eradicate. Furthermore, bacteria 
may be able to start the ‘race’ before tissue cells, because at the time of surgery, 
bacteria are frequently introduced despite aseptic technique (Gristina et al 1988; 
Subbiahdoss et al 2010a; Subbiahdoss et al 2010b). Approximately 270 bacteria/cm2 
are known to fall into wounds in theatre during a one-hour surgical procedure 
(Fitzgerald 1979; Busscher et al 2012). However, a number of factors may reduce 
bacterial colonisation. Adequate skin preparation is necessary, particularly as hair 
follicles and sebaceous glands, which may be disrupted during the skin incision, are 
a source of bacteria. Modern, better-ventilated operation theatres with conventional 
ventilation systems with 20 air-changes per hour and laminar air flow systems with 
up to 600 air-changes per hour, may also reduce the numbers of bacteria entering a 
wound (Ahl et al 1995; Verkkala et al 1998; Busscher et al 2012). 
 
1.3.2  Biofilm Formation 
If bacteria win the ‘race for the surface’ against tissue cells, they adhere to the 
surface and colonise it. This results in impairment of tissue cell functions by bacterial 
virulence factors and toxins (Gristina et al 1988; Subbiahdoss et al 2010a; 
Subbiahdoss et al 2010b). The bacteria produce a hydrated matrix consisting of 
polyssacharide, nucleic acids and protein known as extracellular polymeric substance 
(EPS) or the glycocalyx layer. They become encased in EPS and the implant 
becomes covered by a biofilm. The bacteria within biofilms act as a group rather 
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than autonomous individuals (Davies 2003). They communicate and respond to local 
cell density through a cell-to-cell signalling process known as quorum sensing.  
Quorum sensing is mediated by bacterial secretion and detection of low molecular 
weight highly diffusible signalling molecules known as autoinducers. When the 
concentration of autoinducers reaches a threshold level, it indicates that a sufficient 
level or ‘quorum’ of bacteria is present. This leads to regulation of gene expression. 
Bacteria may use quorum sensing to regulate the secretion of EPS and to control 
biofilm formation (Smith et al 2004; Nadell et al 2008). Quorum sensing has also 
been shown to be responsible for the release of degradative extracellular enzymes 
and cytotoxins in a number of bacterial species (Davies 2003).  
 
It is generally accepted that biofilm formation proceeds in five stages, which are 
illustrated in Figure 1.5. Stage one is the process of initial attachment, which 
involves loose or transient bacterial adhesion to the surface. During stage two, 
robust, irreversible adhesion occurs and EPS is secreted. Stages three and four 
involve cell replication and aggregation of cells into microcolonies followed by 
growth and maturation. Stage five consists of detachment or dispersal of cells from 
the biofilm, which allows propagation and self-renewal of the biofilm (Hall-Stoodley 
et al 2004; Renner and Weibel 2011). 
 
Figure 1.5  The stages of biofilm formation (Adapted from Park et al 2011). 
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1.3.3  Antibiotic Resistance in Biofilms 
Bacteria within biofilms are known to be considerably less susceptible to 
antimicrobials than the same bacterium grown in planktonic culture (Davies 2003). 
In vitro biofilm models have shown the survival of bacterial biofilms after treatment 
with antibiotics at concentrations hundreds of times above the minimum inhibitory 
concentration of the bacteria (Ceri et al 1999). Antibiotics have also been shown to 
fail to eradicate bacteria within biofilms in vivo (Stewart and Costerton 2001). 
Several theories to explain mechanisms of resistance to antibiotics in bacterial 
biofilms exist. 
It has been hypothesised that the inability of antibiotics to penetrate all areas of the 
biofilm may play a role in resistance. It has been suggested that the glycocalyx may 
act as a barrier to antibiotic diffusion (Donlan and Costerton 2002). However, as the 
biofilm matrix is predominantly water, it is unlikely that diffusion of solutes the size 
of antibiotics would be blocked (Stewart and Costerton 2001). In theory, the 
antibiotics may react with biofilm matrix components and be deactivated leading to a 
delay in the rate of penetration. Reduced penetration of some antibiotics through 
biofilms has been demonstrated in vitro, but other antibiotics have been shown to 
readily penetrate through biofilms.  For example, Singh et al (2010) found that 
penetration of the glycopeptide vancomycin and the β-lactam antibiotics oxacillin 
and cefotaxim was significantly reduced through Staphylococcus (S) aureus and S 
epidermidis biofilms. Penetration of the aminoglycoside amikacin and the 
fluoroquinolone ciprofloxacin was unaffected (Singh et al 2010). There have been 
some conflicting results between studies. For example, a Fourier transform infrared 
spectrometry study showed delayed penetration of ciprofloxacin through 
Pseudomonas (P) aeruginosa biofilms (Suci et al 1994). In contrast, a diffusion cell 
bioassay showed that ciprofloxacin was able to penetrate P aeruginosa biofilms but 
failed to kill the bacteria effectively (Walters et al 2003). It is likely that differences 
in experimental conditions between studies and the heterogeneity of biofilms may 
explain the conflicting results (Mah 2012). 
Another theory to explain antibiotic resistance of biofilms is that the chemical 
microenvironment is altered (Stewart and Costerton 2001; Stewart 2002). Bacteria 
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within biofilms are expected to experience some form of nutrient limitation. This 
results in slow growth of bacteria, which could account for the increase in resistance 
to antibiotics. It is known that the antibiotic sensitivity of both planktonic bacteria 
and bacteria within biofilms is dependent on the growth rate of the bacteria and 
decreases with reduced growth rate (Evans et al 1990; Duguid et al 1992; Costerton 
et al 1999; Donlan and Costerton 2002). Additionally, non-growing bacteria have 
been shown to be phenotypically tolerant to the killing activity of β-lactam 
antibiotics (Tuomanen et al 1986). Reduced oxygen availability within the deep 
layers of biofilms may affect antibiotic sensitivity. For example, minimum inhibitory 
concentrations of aminoglycosides are known to be increased under anaerobic 
conditions (Tack and Sabath 1985). Differences in pH within biofilms may also 
occur due to local accumulation of acidic waste products. This may affect the action 
of antibiotics (Stewart and Costerton 2001). Furthermore, the osmotic environment 
within a biofilm may be altered leading to a stress response. The stress response 
could change the relative proportion of porins (transmembrane proteins that 
selectively transport molecules through the outer cell membrane) and reduce 
permeability to antibiotics (Prigent-Combaret et al 1999; Stewart and Costerton 
2001). 
The presence of persister cells and small colony variants (SCVs) is also associated 
with the enhanced antibiotic resistance of many bacteria within biofilms (Singh et al 
2009). Persister cells are a subpopulation of dormant, non-dividing cells. Cell 
metabolism is slowed or shut down and antibiotics cannot act because their targets 
are not active (Lewis 2007). SCVs are small slow-growing bacteria, which often 
show increased resistance to antibiotics. One SCV mutant was shown have a 
multifactorial resistance including overexpression of efflux mechanisms and 
alterations in genes affecting the outer membrane composition (Wei et al 2011; Mah 
2012). 
Another factor that may contribute to biofilm resistance is differences in gene 
expression profiles of biofilm cells compared with planktonic cells. A number of 
genes have been identified that exhibit a higher level of gene expression in biofilms 
than planktonic cultures and protect biofilm cells from antibiotics (Zhang et al 2013). 
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For example, the ndvB gene product of P aeruginosa sequesters antibiotic molecules 
before they reach their cellular target and affects the expression of several P 
aeruginosa genes (Beaudoin et al 2012). PA1875-1877 is thought to function as an 
efflux pump (Mah 2012). The function of other genes such as tSSC1, PA0756-0757, 
PA2070 and PA5033 is under investigation (Zhang et al 2011; Mah 2012; Zhang et 
al 2013). 
The inherent resistance of bacteria within biofilms means that in clinical practice, 
once biofilms have formed they are very difficult to eradicate. As a result, biofilm 
formation may lead to chronic infection or the need for the implant to be surgically 
removed (Subbiahdoss et al 2010a; Subbiahdoss et al 2010b). The use of topical 
antimicrobial agents on implants may have the potential to be more effective than 
parenteral antibiotics by preventing initial bacterial adhesion. 
 
1.4 BACKGROUND ON THE CLINICAL USE OF OSSEOINTEGRATED 
TRANSCUTANEOUS PROSTHESES 
1.4.1  Early Direct Skeletal Attachment in Humans 
The earliest published report of clinical application of transcutaneous prostheses in 
humans described use in above-knee and above-elbow amputees in 1977 (Mooney et 
al 1977). Three patients were fitted with a stainless steel implant cemented to the 
intramedullary canal with a carbon collar. Postoperatively the patients developed 
superficial wound infections that delayed fitting of the external prostheses. All three 
patients developed chronic infection aggravated by mechanical irritation leading to 
removal of the implants within six months postimplantation. Movement at the skin-
implant interface was found to prevent maintenance of a good seal (Mooney et al 
1977).  
 
1.4.2  Modern Osseointegrated Transcutaneous Amputation Prostheses 
A small number of osseointegrated transcutaneous amputation prosthesis systems are 
currently in clinical use worldwide. The specific design features of the ITAP model 
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will be discussed in Section 1.5. This section describes other systems that have been 
used in humans to date and have published clinical outcomes. 
 
1.4.2.1  Osseointegrated Prostheses for Rehabilitation of Amputees (OPRA) 
Brånemark’s group have been carrying out treatment with osseointegrated 
transfemoral prostheses at the Centre for Orthopaedic Osseointegration, Gothenburg, 
Sweden since 1990. They have now treated over 100 patients. Initially, their 
rehabilitation protocol for osseointegrated transcutaneous implants was not 
standardised, but the OPRA protocol was introduced in 1999. The OPRA implant is 
made of commercially pure titanium and implantation involves a two-stage 
procedure. The procedure consists of screwing a threaded fixture into the 
intramedullary canal of the residual femur. The skin is closed and once the wound 
has healed, the use of a conventional socket prosthesis is an option until the second 
surgical procedure is performed. The second stage procedure is performed six 
months later once osseointegration has occurred. This procedure consists of inserting 
a skin-penetrating abutment into the distal end of the fixture onto which the external 
prosthetic limb is attached. Once the soft tissues have healed the rehabilitation 
process is commenced. This consists of using a short training prosthesis for the first 
three months and gradually increasing loading on the implant (Hagberg and 
Brånemark 2009). 
 
The clinical outcomes of the 100 patients showed that 20 of the implants required 
explantation. Thirteen were revised, of which nine revisions were successful. They 
reported that proportionately more implants were removed from patients who had not 
been rehabilitated with the OPRA protocol. Fifty-one of the patients from this series 
(55 implants) were included in a prospective clinical investigation. At two years 
follow-up, promising results in terms of quality of life were reported. However, 
several complications occurred. The patients developed an average of one superficial 
infection every two years that required treatment with oral antibiotics. There were six 
deep infections in four patients necessitating removal of one implant. Additionally, 
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three implants were removed due to loosening (Berlin et al 2012; Brånemark et al 
2014). 
 
1.4.2.2  Endo-Exo-Femur Prosthesis 
The Endo-Exo-Femur Prosthesis (EEFP) is a cobalt-chrome implant with a 
spongiosa metal surface (Pitkin 2013). The procedure consists of two stages. The 
first stage employs a press-fit technique to implant the stem into the bone followed 
by closing the soft tissue and skin. After six to eight weeks, a stoma is cut out and a 
transdermal coupler is connected for fixation of the external prosthesis (Aschoff et al 
2011; Aschoff et al 2012). This system has been used to treat more than 50 patients 
in Lübeck, Germany over a period of ten years. In the earlier years, this implant was 
associated with a high rate of complications. In 2010, it was reported that 20 out of 
37 patients who had undergone this procedure required one or more revisions. Four 
patients underwent removal of the implant due to failure. Two patients underwent 
successful reimplantation at a later date (Aschoff et al 2010). Design modifications 
such as the use of a smoothly polished coupler and a larger circular incision have 
lead to substantially improved results. Of 24 implants (in 23 patients) inserted 
between January 2009 and December 2011, no revisions were required (Aschoff et al 
2012).  However, long-term follow-up data including information about cases of 
infection that did not require revision are needed.  
 
1.5  DEVELOPMENT OF ITAP 
1.5.1  Basic Principles of ITAP  
ITAP is different from other osseointegrated transcutaneous implants. Research on 
previous implant designs for direct skeletal attachment has focused on 
osseointegration and this has been achieved with excellent success rates (Brånemark 
et al 2014). In contrast to other osseointegrated transcutaneous implants, research 
into developing the ITAP design focuses on promoting the soft tissue seal. 
Additionally, the surgery is a single-stage procedure, which allows faster 
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rehabilitation. A failsafe device is included in the design to protect the bone from 
fracture if excessive loading occurs (Newcombe et al 2013). 
 
1.5.2  Biomimickry and Specifics of the ITAP Design 
ITAP is a biomimetic implant that is modelled on the deer antler. The deer antler is 
considered to be a natural analogue of ITAP because it is a bony skin-penetrating 
appendage that maintains an intact infection-free interface despite undergoing 
extreme loading during the rutting season (Pendegrass et al 2006a; Pendegrass et al 
2006b). Histomorphological analysis has shown that deer antlers possess a highly 
porous pedicle structure beneath the skin. The pedicle contains pores with a 
significantly larger size and has a greater number of pores than the antler proper. 
Additionally, numerous thick Sharpey’s fibres were seen to be spanning the dermal 
soft tissue-pedicle interface creating a seal between the dermal tissues and the 
pedicle bone. These fibres were found to emanate from the pores and were orientated 
perpendicular to the pedicle surface (Pendegrass et al 2006b). The dermal seal is 
considered to be the key to the success of ITAP. It is believed that this seal presents a 
physical barrier to epithelial cell migration, which prevents invasion by 
microorganisms and ultimately infection (Pendegrass et al 2006a; Pendegrass et al 
2006b).  
 
As a result of the study findings described above, ITAP has a flange incorporated 
into the design in order to promote soft tissue integration. The flange has 0.7 mm 
drilled holes which mimics the porous nature of the pedicle. Figure 1.6 is a schematic 
diagram of the ITAP model. In addition to this, the flange is coated with a plasma 
sprayed layer of hydroxyapatite. A goat model of ITAP demonstrated that epithelial 
downgrowth was reduced significantly around flanged implants. It was also found 
that if dermal attachment is achieved even without epithelial attachment, epithelial 
downgrowth is inhibited (Pendegrass et al 2006a; Pendegrass et al 2006b). It is 
postulated that once epithelial downgrowth is prevented and keratinocytes in the 
epithelium come into contact with the implant surface, they may attach via 
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hemidesmosomes and allow an epithelial seal to from in addition to the dermal seal 
(Pendegrass et al 2006a; Pendegrass et al 2006b; Gordon et al 2010). 
 
Figure 1.6  Schematic diagram of the ITAP design. 
 
1.5.3  Choice of Titanium Alloy as a Biomaterial 
In addition to the features of titanium that enhance osseointegration discussed above 
in Section 1.1.3.2 (i.e. biocompatibility, bioinertness and corrosion resistance due to 
the formation of an adhesive titanium oxide layer on the surface), titanium and its 
alloys possess favourable mechanical properties such as high strength and low 
density (Geetha et al 2009). Commercially pure titanium alloy is used most 
commonly for dental implants, but titanium alloys are used commonly for 
orthopaedic implants including ITAP due to enhanced mechanical properties 
necessary for load-bearing (Navarro et al 2008). Ti6Al4V is the most commonly 
used titanium alloy in orthopaedics. Aluminium and vanadium stabilise the 
microstructure and improve the mechanical structure in relation to commercially 
pure titanium. The elastic modulus of titanium alloys varies from 55 to 110 GPa 
which is closer to the elastic modulus of bone than some other metals including 
stainless steel and cobalt-chrome alloys which have elastic moduli of greater than 
200 GPa (Geetha et al 2009). This has the potential to reduce the risk of stress 
shielding i.e. a reduction in mechanical stress in cortical bone adjacent to an 
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orthopaedic implant, due to the elastic modulus mismatch, leading to periprosthetic 
loss of bone stock (Sumner et al 1998). A less desirable feature of titanium and its 
alloys is its susceptibility to wear. It undergoes significant wear when it is rubbed 
with itself or most other metals (Miller and Holladay 1958).  Titanium alloy wear 
may lead to the liberation of potentially toxic metal debris into the surrounding 
tissues (Agins et al 1988). Another disadvantage is the high cost of refining, 
processing and fabricating titanium (Seong et al 2009). The cost of titanium alloys 
varies according to the alloying elements used (Yoshimura et al 2009). 
 
1.5.4  Clinical Application of ITAP  
The ITAP model has been translated clinically in a relatively small number of 
patients to date. ITAP was first used clinically to treat veterinary cases. Favourable 
functional outcomes as well as robust dermal and osseous integration have been 
reported in the radius or tibia of four dogs (Fitzpatrick et al 2011). ITAP has been 
used to treat human transhumeral and transfemoral amputees. A patient who 
sustained a transhumeral amputation in the ‘7/7’ London Underground Bombings 
was fitted with an ITAP device. At two years postoperatively, she was reported to 
have near-normal shoulder range of motion, without infection or pain (Figure 1.7) 
(Kang et al 2010). Ongoing Phase 1 clinical trials of transfemoral ITAPs at the Royal 
National Orthopaedic Hospital have yielded some promising results with patients 
anecdotally reporting improved function (O’Leary n.d.). However, the problem of 
infection has not been solved (Chimutengwende-Gordon et al 2010 unpublished 
audit).  
 
 
    
 
 
 
 51 
 
Figure 1.7 (a-c) Near-normal motion with a transhumeral ITAP. This patient was 
unable to use conventional prostheses due to restricted motion. (d) The skin-implant 
interface at 740 days. (e) A radiograph of the ITAP (Kang et al 2010). 
 
1.6  APPLICATION OF THE ‘RACE FOR THE SURFACE’ TO RESEARCH ON 
PREVENTING INFECTION OF ITAP 
To date, research on preventing infection of ITAP has focused on enhancing the soft 
tissue-implant seal. This thesis proposes that it may be beneficial to use a surface that 
possesses both soft tissue enhancing properties and antimicrobial activity. The 
antibacterial activity would need to be present during the early postoperative period 
until soft tissue attaches. This would mean that adhesion of any bacteria present 
before soft tissue integration has occurred would be prevented. Additionally an 
antimicrobial that is released from the implant surface into the surrounding tissues 
would be needed to kill bacteria present within the soft tissues. This would enable 
fibroblasts to win the ‘race for surface’ against bacteria. 
 
1.6.1  Potential Strategies to Increase Soft Tissue Attachment to ITAP  
1.6.1.1  Porous Titanium  
A fully porous titanium alloy ITAP flange with interconnected pores is a design 
modification that has the potential to improve the soft tissue seal to a greater degree 
than the current drilled-hole flange.   This may emulate the deer antler more closely 
than drilled holes, due to the larger number of pores and the interconnected porosity. 
A flange is necessary rather than a porous section of the implant shaft, as the porous 
section would not have adequate mechanical strength to be used for the implant 
 
This image has been removed by the author for copyright reasons. 
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shaft. Pores allow migration and proliferation of cells as well as ingrowth of blood 
vessels and consequently tissue formation within the porous structure (Hulbert et al 
1970; Kuboki et al 1998).  
 
Additive layer manufacturing techniques such as Electron Beam Melting (EBM) and 
Direct Metal Laser Sintering (DMLS) processes allow fabrication of porous custom-
designed titanium implants with a controlled porosity (Parthasarathy et al 2010). A 
laser or an electron beam melts a metal powder and portions rapidly solidify to 
produce a fully dense body according to a computer-aided design model. A layer-by-
layer process is used to produce complex three-dimensional structures (as shown in 
Figure 1.8) that cannot be fabricated by traditional methods, such as metal casting or 
net-shape powder metallurgy (Parthasarathy et al 2010; Koike et al 2011a; Koike et 
al 2011b; Gong et al 2014).   
 
Studies investigating the ability of porous biomaterials to induce tissue ingrowth 
have predominantly focused on bone tissue ingrowth with a view to using porous 
metals as a substrate for joint replacement prostheses. Bone ingrowth into porous 
materials results in mechanical interlocking between the implant and the surrounding 
bone (Story et al 1998). Open porous metallic structures with greater porosity, pore 
size and interconnectivity have been shown to result in increased bone ingrowth in 
vivo (Karageorgiou and Kaplan 2005). It is generally accepted that the minimum 
pore size required to allow ingrowth of cells, vascularisation, nutrient delivery and 
regeneration of mineralised bone, is approximately 100 μm and the optimum pore 
size is in the range of 100 to 400 μm (Hulbert et al 1970; Kuboki et al 1998; 
Karageorgiou and Kaplan 2005; Ryan et al 2006; Wang and Jain 2010).  
 
The effect of porous titanium on promoting soft tissue attachment has been studied to 
a lesser degree. In vivo soft tissue ingrowth into transcutaneous porous titanium alloy 
implants ranging from 40 to 160 μm in size has shown incomplete soft tissue 
ingrowth (up to approximately 50% at four to six weeks) (Farrell et al 2014). There 
is a lack of quantitative data in the literature showing whether fully porous titanium 
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alloy structures with larger pore sizes (in the range of the drilled holes used in the 
current ITAP flange) increase soft tissue ingrowth and vascularisation. Studying the 
effect of functionalising porous titanium alloy structures with bioactive coatings to 
determine if this enhances soft tissue ingrowth further may also be of value. 
Bioactive materials are defined as ‘materials that elicit a specific biological response 
at the interface of the materials which results in the formation of a bond between the 
tissues and the materials’ (Cao and Hench 1996). 
 
 
Figure 1.8  Photograph and scanning electron micrograph of porous titanium alloy. 
 
1.6.1.2  Hydroxyapatite 
Hydroxyapatite is a naturally occurring calcium phosphate mineral with the chemical 
formula Ca10(PO4)6(OH)2 (Kay et al 1964). It is one of the main constituents of bone 
comprising approximately 60 to 70% of bone (Piatelli et al 1993). Pure 
stoichiometric hydroxyapatite has a calcium/phosphorus (Ca/P) molar ratio of 1.67 
(40 weight % Ca2+ and 18.5 weight % PO43-) (Murugan and Ramakrishna 2005). 
Hydroxyapatite shows excellent biocompatibility and is primarily osseoconductive 
(promotes bone growth on its surface) rather than osseoinductive (promotes 
differentiation of stem cells into osteoblasts) (Albrektsson and Johansson 2001; 
Kalfas 2001; Hu and Miao 2004; Larsson et al 2012). It is also considered bioactive 
 5mm!
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as it forms a strong chemical bond with host bone tissue. Hydroxyapatite coatings 
may be derived from natural or synthetic sources and are commonly used to increase 
the bioactivity and promote osseointegration of biomaterials for dental implants, hip 
and knee arthroplasties and fracture fixation devices (Manley et al 1998; D’Antonio 
et al 2001, Murugan and Ramakrishna 2005). A disadvantage of hydroxyapatite is 
that it possesses poor mechanical strength, making it unsuitable for use on its own 
for load bearing applications. The fracture toughness of hydroxyapatite is 
approximately 1.0 MPa m1/2, which is low compared with the fracture toughness of 
bone, which is approximately 2-12 MPa m1/2 (Kitsugi et al 1993; Murugan and 
Ramakrishna 2005). Therefore, its use is restricted to non-loadbearing applications 
such as coatings for implants or to fill bone defects (Calori et al 2011).  
 
The ITAP flange is coated with hydroxyapatite because hydroxyapatite has also been 
shown to enhance soft tissue integration (Piza et al 2004; Pendegrass et al 2006a; 
Larsson et al 2012). Larsson et al (2012) conducted a histological assessment of soft 
tissue integration of abutments for bone anchored hearing implants in an ovine 
model. The use of hydroxyapatite-coated titanium abutments resulted in greater 
dermal adherence and less epithelial downgrowth than non-coated abutments 
(Larsson et al 2012). Smith et al (2006) assessed soft tissue integration of external 
fixator pins. They found that dermal contact on fully coated external fixator pins was 
greater than on pins that were not coated with hydroxyapatite or on pins where only 
the threaded intraosseous portion was coated with hydroxyapatite. However, they 
also studied bacterial colonisation and showed that fully coated hydroxyapatite pins 
were associated with increased bacterial colonisation despite the increased soft tissue 
integration (Smith et al 2006). This indicates that although hydroxyapatite increases 
soft tissue integration, if the implant is exposed to bacteria before the seal has 
formed, hydroxyapatite may increase bacterial colonisation leading to an increased 
risk of infection. The increased bacterial colonisation associated with hydroxyapatite 
may be related to the chemical composition and the positive surface charge of the 
coatings (Laure et al 2008). Eukaryotic cells (such as human tissue cells) and 
prokaryotic cells (such as bacteria) are likely to be descended from a common 
primordial ancestor (Cooper 2000). The endosymbiotic theory hypothesises that 
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eukaryotes evolved from symbiotic association of prokaryotes (Cooper 2000). As a 
result, surfaces such as hydroxyapatite that promote human tissue cell adhesion and 
growth may also promote bacterial colonisation. It is necessary to achieve the correct 
balance between promoting eukaryotic cell and bacterial adhesion. The use of other 
coatings in combination with hydroxyapatite that further enhance soft tissue 
integration and/or coatings with antibacterial activity may have the potential to 
overcome any detrimental effects of hydroxyapatite on bacterial colonisation.  
 
1.6.1.3  Fibronectin-Functionalised Coatings 
Adsorption of fibronectin onto hydroxyapatite has the potential to enhance soft tissue 
integration further. Fibronectin is a glycoprotein that is present in the extracellular 
matrix and plasma that is produced by most mesenchymal cells (Mosher 1984; Sousa 
et al 2005). Fibronectin has multiple functions. Its main functions include promotion 
of cellular migration during wound healing, regulation of cell growth and 
differentiation, promotion of cell-to-cell adhesion, cell-to-basement membrane 
attachment and clot stabilisation (Sousa et al 2005; Proctor 1987). 
 
Fibronectin usually exists as a dimer composed of two nearly identical subunits of 
approximately 250 kDa. The subunits are linked covalently by disulphide bonds near 
one end (Pankov and Yamada 2002). Each monomer consists of three types of 
repeating units, I, II and III. Types I and II consist of disulfide-bonded loops %of 
approximately 50 amino acids long. Type III is approximately 90 amino acids long 
without any disulfide bonds. Fibronectin contains binding sites for heparin, collagen 
and fibrin (Odermatt et al 1985; Pankov and Yamada 2002). Fibronectin attaches 
fibroblasts and other cells via the tripeptide Arginine-Glycine-Aspartic acid (RGD) 
amino acid sequence. The RGD sequence is the cellular recognition site of a number 
of other extracellular and platelet adhesion proteins e.g. type I collagen, vitronectin, 
fibrinogen, von Willebrand factor and osteopontin (Ruoslahti and Perschbacher 
1987). The RGD sequence binds integrins, which are a family of heterodimeric 
transmembrane glycoproteins that mediate cell-cell and cell-extracellular matrix 
interactions. Cellular attachment to extracellular matrix results in clustering of 
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integrins, which associate with a variety of cytoplasmic proteins to from focal 
complexes with the actin cytoskeleton (Hotchin and Hall 1995). Integrins are 
composed of two non-covalently associated subunits, denoted α and β. The 
combinations of α and β subunits determine the specificity for extracellular ligands. 
Fibronectin is recognised by at least ten cell surface receptors of the integrin family 
including α5β1, αIIbβ3 and α4β1 (Johansson et al 1997; Alberts 2002). 
 
Several in vitro studies have demonstrated that fibronectin can enhance fibroblast 
adhesion and/or spreading on biomaterials (Grinell 1984; Cannas et al 1988; Dean et 
al 1995; Middleton et al 2007). Adsorption of fibronectin onto hydroxyapatite has 
been shown to result in greater increases in fibroblast focal adhesion formation and 
soft tissue attachment compared with fibronectin and hydroxyapatite individually 
(Pendegrass et al 2010a).  The exact nature of the bonding between hydroxyapatite 
and proteins is not entirely clear (Dong et al 2007). However, it has been reported 
that strong adsorption of some proteins with hydroxyapatite is mediated by the acidic 
N-terminal (Shaw et al 2000; Stayton et al 2003). Electrostatic energy is reported to 
play a dominant role in the interaction between hydroxyapatite and proteins (Shen et 
al 2008). Proteins can interact with hydroxyapatite through functional groups such as 
-OH, -NH2 and COO-. Hydrogen bonding results in the adsorption of many 
interactive groups with no net charge (Dong et al 2007). 
 
1.6.1.4  Approaches to Increase Epithelial Cell Attachment 
Research into increasing keratinocyte attachment to ITAP has also been carried out. 
Covalent bonding of the basement membrane protein laminin to titanium alloy 
results in a 20-fold increase in the number of keratinocyte adhesion plaques 
compared with uncoated titanium alloy (Gordon et al 2010). Additionally, the 
formation of cell-cell adherens junction on titanium alloy by adsorbing E-cadherin 
has been shown to result in a four-fold increase in keratinocyte attachment 
(Pendegrass et al 2012a). Approaches such as these may be useful as an adjunct to 
increasing dermal attachment. However, as it has been shown that epithelial 
attachment by hemidesmosomes occurs if dermal attachment is achieved (Pendegrass 
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et al 2006a; Gordon et al 2010). This thesis has taken the approach of enhancing 
dermal attachment with the aim of achieving epithelial attachment secondary to this. 
 
1.6.2  Antibacterial Coatings 
In theory, using the strategies discussed above to promote soft tissue attachment 
should enable fibroblasts to win the ‘race for the surface’ and block bacterial 
attachment. However, bacteria often adhere to surfaces that promote tissue 
integration. Consequently, these strategies for promoting soft tissue integration could 
also potentially increase bacterial colonisation in the period before a robust seal has 
formed. Therefore, the addition of an antimicrobial agent may be valuable and is 
another approach that may help fibroblasts win the ‘race for the surface’ against 
bacteria. Antimicrobial agents may also be cytotoxic to eukaryotic cells. For 
example, dose-dependent impairment of osteoblast and fibroblast viability, 
proliferation and/or morphology has been demonstrated following exposure to a 
range of antibiotics including rifampicin, doxycycline, penicillin, gentamicin, 
ciprofloxacin, clindamycin and metronidazole (Isefuku et al 2001; Isefuku et al 2003; 
Antoci et al 2007a; Ferreira et al 2009; Rathbone et al 2011). Therefore, it is 
important to ensure that the toxicity to eukaryotic cells associated with antimicrobial 
agents is limited. 
 
1.6.2.1  Antibiotic coatings 
Antibiotic coatings have been applied to titanium and other orthopaedic implant 
materials and assessed both in vitro and in vivo. For example, the aminoglycoside 
gentamicin has been used to coat implants in several studies. Neut et al (2012) 
developed a gentamicin-releasing coating for cementless titanium hip prostheses that 
demonstrated a wide-spectrum of antibacterial efficacy (Neut et al 2012). Titanium 
implants coated with polyelectrolyte multilayers incorporating gentamicin have been 
shown to reduce S aureus bone infection (Moskowitz et al 2010). Gentamicin and 
gentamicin-RGD coatings with 99% release of gentamicin within 24 hours have been 
found to be biocompatible and associated with good bony integration (Alt et al 
2011). A clinical prospective case series of 21 patients treated with a gentamicin-
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coated tibial nail showed good clinical, laboratory and radiological outcomes after 
six months. These patients included complex tibial fractures and revision cases. No 
patients developed infections. However, this study was non-randomised and did not 
have a control group (Fuchs et al 2011). Covalent bonding of antibiotics to implant 
surfaces has been studied in order to confer long-term antibacterial activity. Antoci et 
al (2007) covalently bound antibiotics to titanium and showed that antibiotic activity 
against S aureus was maintained for at least six weeks (Antoci et al 2007b; Antoci et 
al 2007c). Vancomycin-modified titanium rods implanted into S aureus infected rat 
femora decreased clinical signs of infection and bacterial load and prevented 
osteolysis (Antoci et al 2007c). Other antibiotics that have had promising results 
include tobramycin, ciprofloxacin, cationic steroidal antimicrobial-13 (CSA-13), 
doxycycline, minocycline and rifampicin (Darouiche et al 2007; Moojen et al 2009; 
De Giglio et al 2011; Hickok et al 2012; Sinclair et al 2013). A potential drawback 
associated with the use of antibiotics is the emergence of antibiotic-resistant strains. 
As a result, alternatives to antibiotics such as antiseptics and inorganic antimicrobial 
agents (including metals with antimicrobial properties) are of interest (Darouiche et 
al 1998; Campbell et al 2000; Kalicke et al 2006; Zhao et al 2009). 
 
1.6.2.3  Silver Coatings 
Silver has been used to treat infections for centuries (Politano et al 2013). It has been 
considered attractive as an antimicrobial agent because it has a broad spectrum of 
antimicrobial activity against both bacteria and fungi (Guggenbichler et al 1999; 
Agarwal et al 2010). Importantly, silver resistance is considered rare and numerous 
antimicrobial resistant strains have been found to be susceptible to silver-based 
compounds (Wright et al 1998; Silver 2003; Alt et al 2004; Percival et al 2011; 
Jaiswal et al 2012). Metallic silver is inert, but when silver compounds come into 
contact with moisture or body fluids, biologically active silver cations are released 
(Lansdown 2010). The silver ion binds strongly to electron donor groups in 
biological molecules containing sulphur, oxygen or nitrogen (Schierholz et al 1998). 
This results in interference with bacterial DNA function, thus preventing bacterial 
replication (Modak and Fox 1973; Darouiche 1999; Feng et al 2000). Silver also 
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interacts with the sulphydryl groups of the metabolic enzymes of the electron 
transport chain and inactivates them (Petering 1976; Darouiche1999). 
It is essential that the silver concentration used for medical applications is carefully 
selected because silver is known to have cytotoxic effects on eukaryotic cells. 
However, this cytotoxicity is dose-dependent. Studies have shown that when used at 
low concentrations, silver has antibacterial activity without being cytotoxic to 
eukaryotic cells (Bosetti et al 2002; Alt et al 2004; Chen et al 2006; Chen et al 2008; 
Agarwal et al 2010). A number of other metals also possess this property, which was 
termed the ‘oligodynamic effect’ by von Nägeli in 1893 (Clement and Jarrett 1994). 
Silver has received a great deal of interest and has been said to be the element with 
the highest toxicity for microorganisms and the least toxicity for animal cells 
(Guggenbichler et al 1999). 
Silver has been used in medicine with varying results for applications such as wound 
dressings and coating of medical devices including urinary, vascular, central venous 
and peritoneal catheters, vascular grafts, prosthetic heart valves and sutures 
(Darouiche 1999; Ewald et al 2006). In orthopaedic research, as well as coating 
implants, silver has been used to confer antimicrobial activity to bone cement (Alt et 
al 2004; Oei et al 2012; Propokovich et al 2013; Prokopovich et al 2015).  
Several in vivo studies of silver-coated orthopaedic implants have failed to show 
significant antimicrobial effectiveness of silver. Sheehan et al (2004) concluded that 
silver-coated wires inoculated with bacteria and inserted into rabbit femoral canals 
did not reduce biofilm formation compared with controls (Sheehan et al 2004). A 
trial of 106 silver-coated external fixation pins compared with 56 uncoated control 
pins in 24 patients showed a non-statistically significant reduced rate of positive 
microbiological cultures compared with uncoated screws (Masse et al 2000). In this 
study, silver coated pins were associated with a significant increase in silver serum 
levels, which resulted in the study being terminated prematurely for ethical reasons. 
Conversely, a number of other in vivo studies have shown promising results with 
silver-coated implants. Rodent models assessing silver-coated tibial intramedullary 
rods (Akiyama et al 2013) and implants inserted into back subcutaneous tissue 
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(Shimazaki et al 2010) have shown significant reductions in bacterial numbers with 
silver coated implants. Collinge et al (1994) inserted external fixation pins into the 
iliac crest of sheep and found that silver-coated pins were less frequently infected 
than stainless steel pins (Collinge et al 1994). In humans, silver-coated 
megaprostheses in patients with bone sarcomas reduced the infection rate from 
17.6% to 5.9% (Hardes et al 2010). 
The results of these studies on silver-coated orthopaedic implants indicate that silver 
has the potential to be an effective antimicrobial agent, but that the method of 
application and the concentration used must be optimised. In the case of ITAP, 
silver’s antimicrobial properties could be investigated by combining it with soft 
tissue seal-enhancing coatings to prevent bacterial growth. 
 
1.7  AIMS AND HYPOTHESES 
The overall goal of this research is to develop a surface and coatings for the ITAP 
flange that reduces the infection risk by enabling fibroblasts to win the ‘race for the 
surface’ against bacteria. In order to meet this aim, I investigated the use of a fully 
porous titanium alloy flange coated with fibronectin-functionalised hydroxyapatite 
and silver (HAAgFn).  
 
The specific aims of this research were: 
1. To identify a porous titanium alloy structure that promotes soft tissue 
ingrowth. 
 
2. To develop an antibacterial cytocompatible HAAgFn coating that can be 
applied to porous titanium alloy to reduce bacterial colonisation without 
being detrimental to soft tissue cell adhesion in vitro. 
 
3. To assess the effect of using a porous titanium alloy flange for ITAP with and 
without HAAgFn coatings on soft tissue integration and bacterial 
colonisation in a transcutaneous pin model in vivo. 
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It was hypothesised that: 
1. More open porous titanium alloy structures with larger pore sizes would 
increase soft tissue ingrowth more than less open porous structures. 
 
2. HAAgFn would reduce bacterial colonisation while enabling viable fibroblast 
growth. 
 
3. The use of a fully porous titanium alloy ITAP flange would increase soft 
tissue integration and reduce bacterial colonisation compared with the 
standard ITAP flange. 
 
4. Coating the porous titanium alloy flange with HAAgFn would increase soft 
tissue integration and reduce bacterial colonisation further. 
 
1.8  CHAPTER OVERVIEW 
Chapter Two presents a study investigating the effect of altering pore and strut size 
combinations on soft tissue ingrowth into porous titanium alloy structures in vivo. 
This chapter aimed to explore the hypothesis that more open porous titanium alloy 
structures with larger pore sizes would increase soft tissue ingrowth more than less 
open porous structures. Porous titanium alloy cylinders were inserted into sheep 
paraspinal muscles and left in situ for four weeks. A histological assessment of soft 
tissue ingrowth was performed. The outcome of this chapter was that the porous 
structure that promoted soft tissue ingrowth to the greatest degree was identified and 
this was selected for further study in Chapters Six and Seven. 
 
The aims of Chapters Three and Four were to investigate the hypothesis that 
HAAgFn would reduce bacterial colonisation while enabling viable fibroblast 
growth. In Chapter Three an in vitro assessment of dermal fibroblast viability, 
proliferation and morphology on HAAgFn was performed. In Chapter Four an in 
vitro assessment of the antibacterial activity of the cytocompatible surface identified 
from Chapter Three was carried out.  The bactericidal activity of these surfaces was 
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investigated by challenging the surfaces with two bacterial species that have caused 
infection in clinical trials of ITAP. 
 
Chapter Five presents the coating of porous titanium alloy ITAP flanges with the 
porous structure identified from Chapter Two with the HAAgFn coatings selected 
from Chapter Three and Four.  The flange design, the surface characteristics of the 
coating and the release kinetics of silver are presented.  
 
Chapters Six and Seven investigated the hypotheses that firstly, the use of a fully 
porous titanium alloy ITAP flange would increase soft tissue integration and reduce 
bacterial colonisation compared with the standard ITAP flange; and secondly, 
coating the porous titanium alloy flange with HAAgFn would increase soft tissue 
integration and reduce bacterial colonisation further. In these two chapters I assessed 
the in vivo performance of HAAgFn-coated porous titanium alloy. A histological 
assessment of in vivo soft tissue integration in an ovine transcutaneous pin model is 
presented in Chapter Six. Chapter Seven assessed in vivo bacterial colonisation on 
the same implant designs and coatings tested in Chapter Six. 
 
Chapter Eight discusses the key findings of this thesis. It discusses the benefits and 
drawbacks of the research carried out. It highlights how the knowledge contributed 
from this thesis may be used to direct future clinical applications. Further areas of 
research are discussed.  
 
It is hoped that the findings presented in this thesis will contribute to the further 
development of ITAP for clinical translation. 
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CHAPTER TWO 
Soft Tissue Integration of Porous Titanium Alloy Cylinders: 
In Vivo Investigation of the Effect of Pore and Strut Size 
Combinations on Soft Tissue Ingrowth 
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2.1  INTRODUCTION 
The current ITAP model employs a flange with drilled holes, which has been shown 
to reduce epithelial downgrowth and increase dermal attachment significantly 
compared with a solid pin without a flange (Pendegrass et al 2006a). Despite this, in 
clinical practice infection remains an issue with the use of this flange. A fully porous 
titanium alloy flange may be an alternative to the drilled-hole model and it is 
postulated that this may enhance soft tissue attachment to a greater degree. It is 
essential that pores of a sufficient size to promote successful soft tissue ingrowth are 
selected for the fully porous flange design. If pores are not of a sufficient size, poor 
vascularity leading to a lack of nutrients may inhibit fibroblast survival resulting in 
reduced tissue ingrowth (Pendegrass et al 2006a). 
 
The effects of porous metals on soft tissue ingrowth have been investigated by 
several groups (although to a lesser extent than bone tissue ingrowth as discussed in 
Chapter One). The use of porous-coated metal implants has been studied. Bobyn et al 
(1982) used peel tests to study fibrous tissue attachment in a canine model. Stainless 
steel plates that were porous-coated with cobalt-based alloy powder were implanted 
into the dorsal subcutaneous tissues of mongrel dogs. They studied a range of pore 
sizes and found that the largest pore sizes tested (50 to 200 μm) were associated with 
the greatest tissue attachment strength (Bobyn et al 1982). LaBerge et al (1990) also 
used a canine model to study soft tissue bonding to porous-coated cobalt-chrome 
alloy implants with larger average pore sizes of 300 or 900 μm at two, four and six 
months after implantation. A non-vascularised fibrous membrane surrounded the 
implants with smaller pore sizes, without ingrowth or mechanical bonding. The 
implants with larger pore sizes resulted in the development of a vascularised 
membrane and increasing attachment strength and vascularity over time (LaBerge et 
al 1990). Hacking et al (2000) reported vascularised paraspinal fibrous tissue 
ingrowth into fully porous tantalum blocks inserted into the dorsal subcutaneous 
tissues of dogs with pore sizes of approximately 400 μm. They did not assess the 
effect of altering pore size or quantify the degree of vascularisation or tissue maturity 
(Hacking et al 2000). Reattachment of canine supraspinatus tendons to the greater 
tuberosity between porous tantalum washers resulted in tendon ingrowth into the 
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porous tantalum. Collagen density and tendon-implant strength increased with time 
(Reach et al 2007). These studies focused on applications to attach muscles and 
tendons to implants (LaBerge et al 1990; Hacking et al 2000; Reach et al 2007) and 
subcutaneous tissue attachment to implants (Bobyn et al 1982) rather than on soft 
tissue integration to enhance dermal attachment to transcutaneous implants. 
 
Osseointegrated transcutaneous pin models to assess soft tissue ingrowth into porous 
titanium have been conducted. However, so far the effect of large pore sizes in the 
range of the size of the drilled holes used in the ITAP flange have not been 
investigated. Farrell et al (2014) inserted transcutaneous porous titanium pins with 
pore sizes of 40 to 100 μm and 100 to 160 μm into the subcutaneous tissue of the 
backs of rats. Histological analysis demonstrated incomplete soft tissue ingrowth of 
approximately 30% after three weeks and 50% at four to six weeks (Farrell et al 
2014). Jeyapalina et al (2012) assessed the effect of transcutaneous pins with a 
subdermal barrier coated with a porous titanium coating. The pins were inserted into 
sheep metacarpals. After nine months, the porous-coated implants reduced infection 
and proximal skin migration compared with smooth titanium controls (Jeyapalina et 
al 2012). 
 
This chapter aims to examine the effect of a range of porous titanium alloy 
structures, with pore sizes up to 1000 μm in diameter, on soft tissue ingrowth and 
revascularisation. The effect of different strut sizes will also be studied. The overall 
aim of this chapter is to select a pore and strut size combination that results in 
successful soft tissue ingrowth and can be used in future in vivo transcutaneous pin 
models of the ITAP. 
 
It was hypothesised that more open structures with larger pore sizes would result in 
the most successful soft tissue ingrowth and revascularisation. 
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2.2  MATERIALS AND METHODS 
The study was performed under a Project License and a Personal License according 
to the UK Home Office Scientific Procedures Act 1986. 
 
2.2.1  Implants 
10 mm x 20 mm porous titanium alloy cylinders with spherical pores and 
interconnecting struts of a constant diameter were implanted into the paraspinal 
muscles of skeletally mature female sheep (Mules) weighing between 60 and 80 kg. 
The implants were manufactured using Electron Beam Manufacturing (EOS, 
Germany). Nine groups (i.e. pore and strut size combinations) were studied (Table 
2.1). Six machine finished implants for each pore and strut size combination were 
implanted (n=6).  
 
 
Group Pore size 
(μm) 
Strut size 
(μm) 
Abbreviation 
1 1000 400 P1000 S400 
2 1000 200 P1000 S200 
3 700 400 P700 S400 
4 700 300 P700 S300 
5 700 200 P700 S200 
6 500 400 P500 S400 
7 500 300 P500 S300 
8 500 200 P500 S200 
9 250 300 P250 S300 
Table 2.1  Pore and strut size combinations. 
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2.2.2  Surgical Procedure 
2.2.2.1  Premedication and Anaesthesia 
0.2 mg/kg of 2% xylazine (Bayer HealthCare, Berkshire, UK) was administered as 
premedication. Induction of anaesthesia was achieved with 2 mg/kg of intravenous 
ketamine hydrochloride (Fort Dodge Animal Health Ltd, Southampton UK) and 2.5 
mg of intravenous midazolam (Roche Products Ltd, Hertfordshire, UK). Subjects 
underwent endotracheal intubation and 5 mL cephalexin (Schering-Plough Animal 
Health, Welwyn Garden City, UK) was administered as prophylactic antibiotic cover 
on induction. Anaesthesia was maintained with inhaled 2% isoflurane. 
 
2.2.2.2  Operative Details 
Animals were positioned lying prone. The spinal region was shaved approximately 
from the level of the twelfth thoracic (T12) vertebra to the sacrum. The width of the 
shaved area was approximately 15 cm positioned centrally over the spine. The 
shaved area was prepared with povidone iodine solution and then with antiseptic 
chlorhexidine solution. 2 cm longitudinal incisions were made through the skin, 
subcutaneous fat and fascia paraspinally and the cylinders were implanted within the 
paraspinal muscles. 3-0 vicryl sutures were used to close the fascia and subcutaneous 
tissues and a continuous subcuticular 3-0 vicryl suture was used to close the skin. 
Four implants were implanted through separate incisions on both sides of the spine. 
 
2.2.2.3  Postoperative Course 
Cefalexin was administered for three days postoperatively as further prophylactic 
antibiotic cover. Postoperative analgesia consisted of 2 mL buprenorphine (Alstoe 
Animal Health, Meton Mowbray, UK) administered intramuscularly twice daily. 
Animals were allowed to mobilise freely. 
 
2.2.3  Removal of Implants 
Four weeks postoperatively, euthanasia was performed with 0.7 mL/kg intravenous 
pentobarbitone (JM Loveridge Ltd, Southampton, UK). The implants were removed 
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en bloc with the surrounding soft tissues. Care was taken not to disrupt the 
attachment of the soft tissues to the implants.  
 
2.2.4  Histological Procedure 
Specimens were analysed with hard grade resin histology. 
 
2.2.4.1  Histological Processing 
The specimens were fixed in 10% formal saline. Following this, they underwent 
ascending graded alcohol dehydration in LR White Resin (London Resin Company 
Ltd, Reading UK). The histological processing protocol used is detailed in Appendix 
1.1. 
 
2.2.4.2  Preparation of Histological Sections 
The resin-embedded samples were cut transversely through the middle of each 
implant. The resulting blocks were glued onto slides with cyanoacrylate glue. The 
upper surface (the middle section of each implant) was ground flat using an Exakt-
Micro-Grinding System (Mederex, Frome, UK). This flat surface was then glued 
onto a second glass slide using Technovit glue (Kulzer, Exakt, Germany) under an 
ultraviolet light source. After allowing the specimen to cool, a 300 μm section was 
cut away from the Technovit glue surface using an Exakt E310 diamond-edged band 
saw (Mederex, Frome, UK). The resulting sections were ground to thickness of 70 
μm using the Exakt-Micro-Grinding System with 400, 1200, 2500 and 4000 grit 
paper and polished with alpha-alumina suspension (Struers, Denmark). A micrometer 
was used to measure the thickness of specimens (Mitutoyo Ltd, UK). 
 
Once a smooth surface was achieved, the sections were stained with toluidine blue 
for 25 minutes before proceeding onto analysis under a Zeiss microscope. Toluidine 
blue stains nucleic acids blue as it has a high affinity for acidic tissue components 
(Sridharan and Shankar 2012). Further analysis was carried out after secondary 
staining with paragon for 25 minutes. Paragon is a polychromatic stain that stains 
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cellular components dark blue and connective tissue such as collagen pink 
(Vydyanath et al 2012). 
 
2.2.4.3  Histological Analysis 
The resulting cross-sections were divided into three zones: Zones 1 and 2 being the 
outer sections and Zone 3 being the central section of the implant (Figure 2.1). The 
following outcomes were assessed for each pore in each zone: 
 
1. Percentage soft tissue fill - A semi-quantitative assessment of soft tissue fill 
within pores was carried out. This was scored by two independent assessors. 
A percentage for soft tissue fill was assigned based on the percentage of the 
pore that was filled with soft tissue as well as taking into account the density 
of the tissue within the pore compared with the tissue outside the implant. 
Figure 2.2 shows examples of percentage soft tissue fill scores. 
 
2. Cell nuclei density - The numbers of nuclei per mm2 were quantified to assess 
recellularisation. 
 
3. Blood vessel density - The numbers of blood vessels per mm2 were quantified 
to assess revascularisation.  
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Figure 2.1  The three zones analysed for each histological section. 
 
   
   
Figure 2.2  Semi-quantitative assessment of percentage soft tissue fill within pores 
(a) 25% (b) 50% (c) 75% (d) 100%. 
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2.2.5  Statistical Analysis 
The data were analysed using SPSS, version 21.0 for Windows (Chicago, US). Non- 
parametric tests were performed. The Kruskall Wallis test was used to determine if 
differences existed between the groups. Pair-wise Mann-Whitney tests were used to 
determine differences between two porous structures. A p value of less than 0.05 was 
considered to be a statistically significant result. The Spearman’s rho analysis was 
used to assess the correlation between variables. The intraclass correlation 
coefficient for agreement between the two assessors of the percentage soft tissue 
semi-quantitative score was calculated. 
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2.3  RESULTS 
Soft tissue ingrowth was not seen in samples from group 9 (P250 S350); therefore, 
data were not collected for this group. Soft tissue was seen to penetrate through to 
the innermost pores in all other groups. The results from Zone 3, the innermost zone, 
are highlighted, as the quality of tissue that penetrates through to the centre of the 
implant is likely to be the best indicator of the overall success of soft tissue ingrowth. 
 
2.3.1  Percentage Soft Tissue Fill 
The intraclass correlation coefficient for agreement between the two independent 
assessors for the percentage soft tissue fill semi-quantitative score was 0.870 (95% 
confidence interval 0.822 to 0.906) (Appendix 2.4). The highest overall percentage 
fill scores were observed in the following pore/strut size combinations: P1000 S400, 
P1000 S200 and P700 S300. Soft tissue was present throughout all three zones of all 
implants from these groups. The ingrown tissue was dense and well organised 
displaying extensive collagen deposition with little open space and a well-ordered 
arrangement of collagen fibres. Intimate contact was observed both between the 
surrounding soft tissue and the implant surface and tissue within the pores and the 
struts. Increased collagen deposition was observed at the periphery of the pores and 
the struts. Very few gaps within the soft tissue were seen. Less densely organised 
tissue with more gaps within the tissue was present within the remaining pore and 
strut size combinations (i.e. P700 S400, P700 S200 and all three P500 groups) 
(Figure 2.3). 
 
P1000 S400 was associated with significantly greater percentage fill than P700 S400 
in all three zones (p=0.010). There were no significant differences between P1000 
S200 and P700 S200 (Zone 1 p=0.101, Zone 2 p=0.138, Zone 3 p=0.445). There 
were no significant differences between P700 S300 and P700 S200 (Zone 1 p=0.177, 
Zone 2 p=0.792, Zone 3 p=0.329). Within Zone 3, P700 S300 was associated with 
greater percentage soft tissue fill than P500 S300 (p=0.003). No differences were 
observed between P700 S400 and P500 S400 (p=0.484) or between P700 S200 and 
P500 S200 (p=0.101) (Figures 2.4 to 2.6).  
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Figure 2.3  (a) and (b) P1000 S400 Zone 3 - densely ordered tissue filling pore. (c) 
P700 S300 Zone 3 - dense tissue with intimate contact between pore edges and soft 
tissue (blue arrows) and increased tissue density at the pore periphery (white arrows). 
(d) P700 S200 Zone 1 - gap in soft tissue (red arrow). (e) P500 S300 Zone 3 - less 
dense soft tissue infiltration with gap in soft tissue at pore periphery (red arrow). (f) 
P500 S200 Zone 1 - sparse soft tissue infiltration and lack of contact between soft 
tissue and periphery of implant (red arrows). 
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Figure 2.3 (a) and (b) P1000 S400 zone 3 - densely ordered tissue filling pore (c) 
P700 S300 zone 3 - dense tissue with intimate contact between pore edges and soft 
tissue (blue arrows) and increased collagen deposition at the pore periphery indicated 
(white arrows) (d) P700 S200 zone 1 - gap in soft tissue (red arrow) (e) P500 S300 
zone 3 - less dense soft tissue infiltration with gap in soft tissue at pore periphery 
(red arrow) (f) P500 S200 zone 1 – sparse soft tissue infiltration and lack of contact 
between soft tissue and periphery of implant (red arrow). 
b! a!
c! d!
e! f!
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Figure 2.4  Box-and-whisker plot showing percentage fill in Zone 1. 
 
 
Figure 2.5  Box-and-whisker plot showing percentage fill in Zone 2. 
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Figure 2.6  Box-and-whisker plot showing percentage fill in Zone 3. 
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2.3.2  Cell Nuclei Density 
In keeping with the findings for percentage soft tissue fill, cell nuclei density was 
greatest for P1000 S400, P1000 S200 and P700 S300. Within Zone 3, although 
P1000 S200 had the highest cell nuclei numbers, there was no significant difference 
when compared with P1000 S400 (p=0.073). P1000 S200 was associated with 
greater cell nuclei density within Zone 3 than P700 S200 and P500 S200 (p=0.006 
and 0.001 respectively). Cell nuclei density within Zone 3 was greater for P700 S300 
than P700 S400 and P700 S200 (p=0.016 and 0.03 respectively) (Figures 2.7 to 
2.10). 
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Figure 2.7  Histological sections demonstrating cell density in Zone 3 of the 
following implants: (a) P1000 S400 (b) P1000 S200 (c) P700 S300 (d) P700 400 (e) 
P500 S400 (f) P500 S300. Cell nuclei density is greatest in (a) to (c). 
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Figure 2.7 Histological sections demonstrating cell density in zone 3 of the 
following implants :(a) P1000 S400 (b) P1000 S200 (c) P700 S300 (d) P700 400 (e) 
P500 S400 (f) P500 S300. Cell nuclei density is greatest in (a) to (c). 
a! b!
c! d!
e! f!
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Figure 2.8  Box-and-whisker plot showing cell nuclei density in Zone 1. 
 
 
Figure 2.9  Box-and-whisker plot showing cell nuclei density in Zone 2. 
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Figure 2.10  Box-and-whisker plot showing cell nuclei density in Zone 3. 
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2.3.3  Blood Vessel Density 
The greatest blood vessel density was observed within P1000 S400, P1000 S200 and 
P700 S300 implants. This was the case within all three zones. Within Zone 3, P700 
S300 was associated with the highest blood vessel density and was associated with a 
significantly greater blood vessel density than both P700 S200 and P500 S300 
(p=0.004 and 0.005 respectively). P1000 S200 was associated with greater blood 
vessel density than P700 S200 (p=0.001), but there was no statistically significant 
difference between P1000 S200 and P500 S200 (p=0.456). There was no significant 
difference between P1000 400 and P700 S400 and P500 S400 (p=0.914 and 0.352 
respectively). Very sparse blood vessel ingrowth was observed within Zone 3 for 
P700 200, P500 400 and P500 200. (Figures 2.11 to 2.14). 
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Figure 2.11  Histological sections demonstrating blood vessel ingrowth in Zone 3 of 
the following implants: (a) P1000 S400 (b) P1000 S200 (c) P700 S300 (d) P700 200 
(e) P700 S400 (f) P500 S200. The arrows indicate blood vessels. In (a) to (c) higher 
numbers of blood vessels are present than in (d) to (f). 
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Figure 2.11 Histological sections demonstrating blood vessel in zone 3 of the 
following implants :(a) P1000 S400 (b) P1000 S200 (c) P700 S300 (d) P700 200 (e) 
P700 S400 (f) P500 S200. The arrows indicate blood vessels. In (a) to (c) higher 
numbers of blood vessels are present than in (d) to (f). 
 
a! b!
c! d!
e! f!
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 Figure 2.12  Box-and-whisker plot showing blood vessel density in Zone 1. 
 
 
Figure 2.13  Box-and-whisker plot showing blood vessel density in Zone 2. 
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Figure 2.14  Box-and-whisker plot showing blood vessel density in Zone 3. 
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2.3.4  Correlation Analysis 
The Spearman’s rho analysis showed positive correlations between percentage soft 
tissue fill of pores and cell nuclei density, which were significant at the 0.01 level 
(Zone 3: p=0.000, Correlation coefficient=0.621). Weaker positive correlations were 
identified between percentage soft tissue fill and blood vessel density. These were 
significant at the 0.01 level (Zone 3: p=0.003, Correlation coefficient=0.432). 
Positive correlations were also identified between cell nuclei and blood vessel 
density. These were significant at the 0.01 level (Zone 3: p=0.000, Correlation 
coefficient=0.503). Strong positive correlations were observed between the three 
zones for percentage soft tissue fill, cell nuclei density and blood vessel density 
(Appendix 2.3). Figures 2.15 to 2.18 are graphs illustrating correlations between 
variables. 
 
 
 
Figure 2.15  Graph showing the relationship between cell nuclei density and 
percentage soft tissue fill. There is an increase in cell nuclei density with increasing 
percentage soft tissue fill. 
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Figure 2.16  Graph showing positive correlation between percentage soft tissue fill 
and blood vessel density. 
 
 
Figure 2.17  Graph showing the positive correlation between blood vessel and cell 
nuclei density. 
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Figure 2.18  Graph showing the strong positive correlation between Zone 1 and 
Zone 3 for percentage soft tissue fill (p=0.000, Correlation coefficient= 0.941). 
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2.4  DISCUSSION 
This study has contributed to the current literature by quantifying soft tissue 
ingrowth and by assessing the effects of a range of pore and strut size combinations. 
Three combinations resulted in the greatest soft tissue ingrowth and vascularisation: 
P1000 S400, P1000 S200 and P700 S300. In general, results for P500 were less 
favourable than results for the larger pore sizes. Furthermore, there was no soft tissue 
ingrowth into P250 implants. These findings support the hypothesis that open 
structures with larger pore sizes facilitate soft tissue ingrowth. 
 
Reasons for Increased Soft Tissue Ingrowth into Larger Pore Sizes 
The increased vascularisation associated with larger pore sizes is expected to play a 
role in increasing soft tissue ingrowth. Vascularisation promotes healthy tissue 
ingrowth as it results in oxygenation and provision of nutrients to tissues as well as 
removal of waste products (Jain et al 2005). Therefore, increased vascularisation is 
beneficial when aiming to enhance tissue attachment strength. It is also intuitive that 
the larger pores provide more space for healthy tissue to fill, which in turn may allow 
greater blood vessel ingrowth. However, the findings of Feng et al (2011) do not 
support this. They implanted β-tricalcium phosphate cylinders with pore sizes 
ranging from 300 to 700 μm into the lumbodorsal fascia in rabbits and found that 
pore sizes less than 400 μm limited blood vessel growth, which is in keeping with the 
results from this chapter. However, in contrast to this chapter they found that pore 
sizes above 400 μm did not produce further increases in vascularisation. 
Furthermore, in contrast to this chapter they found that the reduced vascularisation 
observed with pore sizes less than 400 μm was not associated with reduced tissue 
ingrowth. They demonstrated increases in percentage fibrous tissue ingrowth with 
decreasing pore size (Feng et al 2011). These results indicate that factors other than 
vascularisation are likely to contribute to increased tissue ingrowth. The strut sizes 
used may contribute to the differences in findings between this chapter and those of 
Feng et al. Feng et al used a constant interconnection size of 120 μm which is 
smaller than the sizes used in this chapter. However, despite this, the findings of this 
chapter do not completely contradict those of Feng et al. Although this chapter has 
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shown positive correlations between blood vessel density and percentage soft tissue 
fill, the fact that these correlations were not of high strength also suggests that other 
factors contribute to the increased tissue ingrowth. 
 
Larger pore sizes promote cell migration. It is known that if pores are too small, cells 
are unable to migrate through scaffolds. Additionally a cellular capsule forms around 
the edges of the scaffold, which can limit diffusion of nutrients and removal of waste 
products (Yannas et al 1992; O’Brien et al 2007; Murphy et al 2010). Murphy et al 
(2010) studied in vitro adhesion and early proliferation of a pre-osteoblastic cell line 
on collagen-glycosaminoglycan scaffolds up to seven days post-seeding. Although, 
they studied a different cell type and scaffold type and a smaller range of pore sizes 
(85 to 325 μm), the findings are relevant to explaining some of the results of this 
chapter. They showed that larger pore sizes improve cellular infiltration into 
scaffolds with even cell distribution. They found that with larger pore sizes cells 
migrated from the edges into the centre of the scaffolds whereas with smaller pore 
sizes cell aggregation was seen along the edges of the scaffolds limiting the number 
of cells infiltrating the scaffolds. The aggregations found with smaller pore sizes at 
this early time-point formed a ‘skin’ around the outer surface of the scaffolds, which 
restricts the diffusion of nutrients and removal of waste from the cells colonising the 
centre of the scaffold. The authors did however identify an early additional peak in 
cell number in scaffolds with a mean pore size of 120 μm at time points up to 48 
hours post-seeding. They showed that specific surface area is greater for smaller pore 
sizes. This explains this peak, as specific surface area increases cell infiltration and 
tissue ingrowth. However, they concluded that the effect of specific surface area is 
overcome by larger pores due to the importance of increased cell migration and 
proliferation and the reduced cell aggregations along the edges of the scaffold 
(Murphy et al 2010).  
 
Selection of a Porous Structure for the ITAP Flange 
Overall, there were few differences or clear advantages between the three structures 
found to promote the soft tissue ingrowth to the greatest degree in this chapter. 
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P1000 S200 resulted in the greatest cell nuclei density. Increased cell nuclei density 
is important as fibroblasts secrete collagen. P700 S300 produced the greatest 
vascularisation. These results provide three options for porous flange structures that 
would be suitable for use in further studies of ITAP. It was decided that P700 S300 
would be used in further studies due to its effects on promoting vascularisation. 
Additionally, as overall P1000 S400 and P1000 S200 structures did not have a clear 
advantage over P700 S300, P700 S300 would be preferable as structurally it is likely 
to result in less risk of flange breakage. This is because the larger the pore size, the 
greater the void volume, which may compromise the mechanical properties of the 
scaffold (Karageorgiou and Kaplan 2005). 
 
Differences in Minimum Pore Size for Soft Tissue Ingrowth with Other Studies 
Although, it was hypothesised that smaller pore sizes would be associated with less 
favourable results, it is interesting that there was a complete absence of soft tissue 
ingrowth into the P250 S300 structure. Other studies have shown soft tissue ingrowth 
into pores of this size and smaller. For example, Farrell et al (2014) used small pore 
sizes (40 to 160 μm) but demonstrated soft tissue ingrowth. However, the degree of 
soft tissue fill of pores was 30 to 50% which is considerably less than that observed 
in the implants with pore sizes of 500 to 1000 μm studied in this chapter (Farrell et al 
2014). Differences in tissue morphology may have contributed to the observation of 
soft tissue ingrowth into smaller pore sizes as Farrell et al’s study was conducted in 
rodents. Furthermore, as mentioned earlier, the effect of strut size may also have 
contributed to differences in results between this chapter and other studies. It is 
possible that if smaller strut sizes were used in combination with pores sizes of 250 
μm the results may have been different. 
 
It is also interesting to note that the mean pore size of the deer antler pedicle is 217 
μm, which is considerably smaller than the pore sizes that resulted in favourable 
results in this study (Pendegrass et al 2006b). Other factors such as the surface 
chemistry and the presence of proteins such as fibronectin may play a role in the fact 
that smaller pore sizes promote soft tissue ingrowth into the deer antler pedicle. The 
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use of biological coatings may have the potential to enhance soft tissue ingrowth into 
porous titanium alloy structures in general (including those with smaller pore sizes). 
Additionally, the deer antler pedicle protrudes from the frontal bones of the skull of 
the animal and is thus immobilised, resulting in less motion at the interface, which 
may promote better soft tissue infiltration. Similarly, a transcutaneous pin model 
with the implants fixed to bone would result in less motion at the soft tissue-implant 
interface and potentially better soft tissue ingrowth results in general, including for 
smaller pore sizes. In clinical practice, soft tissue infiltration results could potentially 
also be improved in general (i.e. for all pore sizes) due to the surgical technique. The 
surgical technique for implantation of ITAP (in humans) includes thinning of the soft 
tissues and suturing of the thinned skin flap to the drilled-hole flange providing 
further immobilisation of the tissues (Kang et al 2010). It would, however, be 
technically more difficult to suture through a fully porous implant due to the needle 
being obstructed by adjacent layers of pores. Therefore, separate dedicated pores for 
suture fixation (not obstructed by adjacent layers) could be added to the side of the 
implant to solve this problem. The theory that suturing the soft tissue could result in 
better soft tissue infiltration is supported by Bobyn et al’s study (1982). Porous 
implants were implanted into dorsal flank subcutaneous tissue in a canine model. 
Soft tissue ingrowth was demonstrated with small pore sizes ranging from 5 to 200 
μm. They had secured the implants in place with suture fixation at the time of 
implantation (Bobyn et al 1982).  
 
Upper Limit for the Degree of Openness of Porous Structures for Promoting Soft 
Tissue Ingrowth 
In keeping with the principle that open structures are beneficial, P700 S400 did not 
promote soft tissue ingrowth as much as P700 S300. It is expected that this is due to 
the fact that the larger strut size reduces the volumetric porosity and takes up free 
space. However, it is important to note that porosity does not explain all the results 
of this study. Firstly, when pore size was decreased but strut size also decreased 
proportionally there were differences and soft tissue ingrowth was impaired e.g. 
P1000 S400 was associated with significantly better soft tissue ingrowth than P500 
S200. This suggests that pore size itself (separate to porosity) was a key factor 
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affecting soft tissue ingrowth. However, results for P700 S200 did not fit in with the 
principle that open structures were better or that pore size is the main factor. P700 
S200 did not perform as well as P700 S300. This means that the relationship between 
pore size and soft tissue ingrowth is not linear. Open structures are needed for soft 
tissue ingrowth, but for a given pore reducing the strut size and hence increasing the 
degree of openness increases soft tissue ingrowth only up to a point. If a larger range 
of strut sizes had been studied for a given pore size it would have provided more 
information about what this point is. The results of this study suggest that the point at 
which reducing strut size for P700 structures reduces soft tissue ingrowth is when the 
strut size is between 300 and 200 μm. 
 
The finding that there is an upper limit for a beneficial effect for openness of porous 
structures is in keeping with the findings of Pendegrass et al (2010) (Pendegrass et a 
2010a). They studied pore sizes of 500, 700 and 1000 μm, but did not alter strut size. 
The implants had drilled holes and were not fully porous structures as used in this 
study; however, the findings are relevant. The implants were subcutaneous plates 
implanted onto the medial aspect of sheep tibiae. The implants were removed after 
four weeks and soft tissue attachment was examined histologically. Similarly to the 
findings of this chapter, it was found that a pore size of 700 μm resulted in better soft 
tissue ingrowth than 500 μm. Pores of 500 μm diameter resulted in a contracted band 
of dermis with a clear gap between the soft tissue and the internal pore margins. 
Often the tissue did not fully traverse the complete pore. Pores of 700 μm diameter 
resulted in greater contact and significantly more perpendicular cell nuclei indicating 
better soft tissue attachment. In contrast to the findings of this chapter, 1000 μm 
pores had a detrimental effect. Pores of 1000 μm diameter demonstrated pegs of 
dermis not completely traversing the pores with one-sided dermal attachment often 
noted. It is possible that a reason this chapter did not find this detrimental effect with 
1000 μm pores is that the advantage of an interconnecting fully porous structure 
meant that any negative effect of a pore size of 1000 μm was overcome. However, if 
this is the case, it is unknown if in the long term the disadvantageous effects of 1000 
μm pores will occur. This supports the choice of P700 S300 for future study rather 
than P1000 S400 or P1000 S200. It is expected that the reason Pendegrass et al found 
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that pores of 1000 μm produced less favourable results is because if pores are too 
large, the decrease in surface area limits cell adhesion as discussed earlier (Murphy 
et al 2010). 
 
Pore Size and Bacterial Colonisation 
This study has resulted in the selection of an open porous structure with a larger pore 
size (P700 S300) for further in vivo testing with the ultimate aim of encouraging 
fibroblasts to win the ‘race for surface’ and prevent bacterial colonisation. This study 
has not assessed bacterial colonisation but this will be studied in subsequent chapters 
of this thesis. Braem et al (2013) conducted quantitative analyses of in vitro bacterial 
colonisation on porous titanium and showed that increasing pore size is associated 
with an increase in roughness parameters leading to an increase in bacterial 
attachment (Braem et al 2013). Therefore, it will be interesting to determine if the 
soft tissue ingrowth promoted by the porous structure selected by this chapter will 
overcome the possible detrimental effects of large pore sizes on bacterial 
colonisation. Chemical modification of titanium surfaces to increase hydrophilicity 
reduces bacterial numbers suggesting that functionalisation to reduce the infection 
risk of porous coatings may be of value (Braem et al 2014). These previous studies 
have not assessed the bacterial colonisation in an in vivo model, when soft tissue 
attachment is also occurring. Further in vivo transcutaneous pin studies (Chapter Six 
and Seven) will study this gap in the current knowledge by assessing the in vivo 
effect of P700 S300 titanium alloy flanges with and without bioactive and 
antimicrobial coatings on both soft tissue attachment and bacterial colonisation. 
 
Limitations of This Study 
As discussed earlier a transcutaneous pin model would be more representative and 
would limit the mobility of the soft tissues at the interface, which is likely to affect 
the results. Additionally, the model used in this chapter did not specifically assess 
dermal tissue integration as the implants were inserted into the paraspinal muscles. A 
transcutaneous pin model will be used for further in vivo studies that will be 
presented in this thesis.  
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It could be argued that the use of a semiquantitative assessment of percentage soft 
tissue fill is another limitation as different assessors could potentially interpret 
findings differently.  In order to estimate the likelihood of this, the assessment was 
carried out by two independent observers. The intraclass correlation coefficient of 
0.870 for agreement between the two assessors indicated that the semi-quantitative 
score had a high level of interobserver reliability. Furthermore, quantitative 
assessments of cell nuclei density and blood vessel density were carried out. 
However, a limitation of the quantitative assessment is that the number of blood 
vessels was quantified, however, the size of blood vessels was not taken into 
account. The size of blood vessels may affect vascularisation. 
 
This study did not perform mechanical testing. It is noted that other studies that have 
performed mechanical testing have shown that the histological findings support 
strength of attachment results (La Berge et al 1990; Hacking et al 2000). Mechanical 
testing by other researchers has shown that increased pore size is associated with 
increased soft tissue attachment strength (Bobyn et al 1982; La Berge et al 1990).  
 
Finally, the time period of four weeks for this study was short. It is known that as 
time increases soft tissue attachment increases (Bobyn et al 1982; La Berge et al 
1990). A study with a longer time period may have provided useful information. For 
example, it would have been possible to determine if the detrimental effects of pore 
sizes of 1000 μm identified by the study of drilled holes by Pendegrass et al (2010) 
become apparent with a fully porous structure over time. However, if significantly 
longer time periods were studied it would mean obtaining meaningful results for cell 
nuclei density would be unlikely. This is because it is likely that there would be too 
many cells present to see distinctly as separate nuclei that are quantifiable. 
Additionally, an assessment of early attachment is essential as early soft tissue 
attachment is the key factor affecting the outcome of the ‘race for the surface.’ 
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2.5  CONCLUSION 
This chapter has quantified percentage soft tissue fill, cell nuclei and blood vessel 
density associated with a range of porous titanium alloy structures. The results show 
that larger pores sizes are supportive of soft tissue ingrowth. P1000 S400, P1000 
S200 and P700 S300 resulted in the greatest soft tissue ingrowth. P700 S300 
supported blood vessel ingrowth to the greatest degree and therefore a fully porous 
ITAP flange with this structure will be designed (Chapter Five). This flange will be 
assessed in future in vivo studies of ITAP (Chapters Six and Seven). The following 
chapters (Chapters Three and Four) will develop a fibronectin-functionalised 
hydroxyapatite coating with silver incorporated into it that will be used to coat the 
porous flange to determine if this has additional effects on soft tissue integration and 
bacterial colonisation. 
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CHAPTER THREE 
In Vitro Assessment of the Effects of Hydroxyapatite, Silver 
and Fibronectin on Fibroblast Viability 
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3.1  INTRODUCTION 
Bioactive coatings such as hydroxyapatite and fibronectin may be applied to porous 
titanium to further enhance soft tissue integration. Fibronectin-functionalised 
hydroxyapatite coatings have been found to improve in vitro fibroblast attachment 
compared with hydroxyapatite, uncoated titanium or titanium with adsorbed 
fibronectin (Pendegrass et al 2010a). Studies on other cell types including 
mesenchymal stem cells and osteoblasts have also shown that hydroxyapatite with 
fibronectin or the RGD sequence improves cellular responses such as cell spreading, 
proliferation and attachment (Sawyer et al 2005; Deligianni et al 2006; Sogo et al 
2007; Dolatshahi-Pirouz et al 2011). A histological assessment of in vivo soft tissue 
attachment to subcutaneous plates with drilled holes and hydroxyapatite coatings has 
shown an improvement in dermal contact and ingrowth with fibronectin adsorption 
(Pendegrass et al 2010a). Another in vivo assessment has shown significantly more 
perpendicular dermal fibroblast alignment relative to the implant when fibronectin is 
adsorbed onto hydroxyapatite-coated solid subcutaneous plates compared with 
hydroxyapatite alone, indicating an improvement in ingrowth (Chimutengwende-
Gordon et al 2011). 
 
As discussed in Chapter One, a potential disadvantage of the use of fibronectin-
functionalised hydroxyapatite coatings is that they could increase bacterial 
colonisation and the risk of peri-implant infection (Smith et al 2006; Laure et al 
2008; Henderson et al 2010). Therefore, during the early postoperative period before 
the soft tissue seal has formed, the addition of an antimicrobial agent may be useful 
to prevent bacterial colonisation. This study explores the incorporation of silver into 
fibronectin-functionalised hydroxyapatite coatings. Silver was selected over other 
antimicrobials due to its broad spectrum of activity against both gram-positive and 
gram-negative bacteria as well as fungi. Additionally, silver’s known action against 
numerous antibiotic-resistant strains e.g. methicillin resistant Staphylococcus 
epidermidis, methicillin resistant Staphylococcus aureus and antibiotic resistant 
Pseudomonas, Acinetobacter and Enteroccoccus species, could be beneficial 
clinically (Wright et al 1998; Alt et al 2004; Agarwal et al 2010; Percival et al 2011). 
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Electrochemical deposition is a technique that may be used to incorporate silver into 
hydroxyapatite coatings. The technique involves precipitation from an aqueous 
electrolyte solution containing calcium phosphate and silver nitrate. An electric 
current passed through the solution results in positively charged ions from the 
solution being attracted to the implant, which acts as a cathode and is consequently 
coated. Advantages of electrochemical deposition include that it takes place at low 
temperatures, allows control of coating composition and is economical. It is a non-
line-of-sight technique that is capable of coating complex structures (Garcia-Gareta 
et al 2013). This is important because it would enable coating of the inner pores of an 
ITAP flange fabricated from porous titanium. Other more commonly commercially 
available methods such as plasma spraying are not able to do this (Garcia-Gareta et 
al 2014). Ghani et al (2012) modified Redepenning et al’s technique of 
electrochemical deposition by impregnating hydroxyapatite with silver ions 
(Redepenning et al 1996; Ghani et al 2012). The silver-containing hydroxyapatite 
coating produced was uniform, crystalline, antibacterial and resulted in a sustained 
release of silver over 22 days (Ghani et al 2012). 
 
It is essential that preliminary experiments are conducted in vitro to assess the effects 
of these silver-containing coatings on dermal fibroblast viability before use in an in 
vivo model. Silver is known to have dose-dependent cytotoxic effects (Agarwal et al 
2010). If the concentration of silver used is too high, fibroblast viability will be 
impaired which would prevent or delay the formation of a soft tissue seal. However, 
when used at lower concentrations, silver has been shown to maintain its 
antibacterial activity without being cytotoxic (Bosetti et al 2002; Alt et al 2004; Chen 
et al 2006; Agarwal et al 2010). For example, Agarwal et al (2010) developed 
polymeric thin films with silver contents as low as 0.4 µg/cm2. They found that these 
low silver content films were able to achieve a 99.9999% reduction in 
Staphylococcus epidermidis colonisation in suspensions incubated in contact with the 
films without being toxic to fibroblasts (Agarwal et al 2010).  
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The in vitro biocompatibility of antibacterial silver-containing hydroxyapatite 
coatings produced by a range of methods including magnetron co-sputtering (Chen et 
al 2006), ion-beam assisted deposition (Feng et al 1999; Bai et al 2011), the sol-gel 
technique (Jadalannagari et al 2014) and electrodeposition (Lu et al 2011) has shown 
a lack of cytotoxicity to cell types such as osteoblasts, osteoblast precursors and 
macrophages. Fibroblast viability has been assessed on plasma-sprayed silver-
containing hydroxyapatite coatings and was found to be cytocompatible (Chen et al 
2008). However, fibroblast viability on electrochemically deposited silver-containing 
hydroxyapatite coatings specifically needs to be determined. The effect of this 
coating in combination with fibronectin has also not been studied. Furthermore, the 
cytotoxic effects of the specific silver/HA electrochemical deposition method used in 
this study have not been studied for eukaryotic cells in general.  
 
Preconditioning the surface with serum or simulated body fluids is a method that 
could be applied to reduce the cytotoxic effects of silver-containing hydroxyapatite 
coatings (Coathup et al 2012). This simulates the in vivo environment and removes 
some ionisable metals from biomaterials (Sandrucci et al 2005). In the case of serum-
preconditioning, the proteinaceous layer that forms may provide attachment sites for 
cells (Ducheyne and Qui 1999). Furthermore, preconditioning has been shown to 
have effects on the pH and the crystallinity of the apatites formed (Foppiano et al 
2007). It has also been postulated that the cytoprotective action of serum may be due 
to its trophic properties, which promote cell growth (Hidalgo and Dominguez 1998). 
It has been shown that detrimental effects of silver nitrate on human dermal 
fibroblast proliferation are reduced by increasing the concentration of fetal calf 
serum in the culture medium (Hidalgo and Dominguez 1998). 
 
This study aimed to assess human dermal fibroblast viability on fibronectin-
functionalised silver-containing hydroxyapatite (HAAgFn) with varying silver 
contents. The study also aimed to determine whether the cytotoxicity of these 
coatings can be reduced by serum-preconditioning. It was hoped that a 
cytocompatible HAAgFn coating would be identified that could then be assessed for 
antibacterial activity before applying it to porous titanium and implanting it in vivo. 
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It was hypothesised that firstly, HAAgFn coatings would support viable fibroblast 
growth. Secondly, reducing the silver content of coatings would increase the 
cytocompatibility. Thirdly, serum-preconditioning would increase the 
cytocompatibility. 
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3.2  MATERIALS AND METHODS 
3.2.1  Surface Preparation 
10 mm x 3 mm titanium alloy (Ti6Al4V) discs were used. The discs were ground 
with grinding paper in ascending order of grit sizes, (400, 1200, 2500 and 4000) 
(Struers Ltd, Solihull, UK). A Metopol 2000 grinder (Buehler, Coventry, UK) was 
used to polish the discs with MD polishing cloth (Struers Ltd, Solihull, UK), OP-S 
colloidal silica suspension (Struers, Denmark) and 30% hydrogen peroxide (H2O2) 
(BVD, VWR International Ltd, Poole, UK). The discs were washed with tap water, 
rinsed with distilled water and then ultrasonically cleaned in a 10% Decon 90 
solution for 10 minutes (Decon Laboratories Ltd, East Sussex, UK). The discs were 
washed in distilled water prior to ultrasonic cleaning in acetone. 
 
The following surface coatings were tested: Polished (uncoated) titanium alloy (Pol), 
hydroxyapatite (HA), hydroxyapatite with fibronectin (HAFn), hydroxyapatite with 
silver (HAAg) and hydroxyapatite with silver and fibronectin (HAAgFn). HA was 
electrochemically deposited onto the surface of the discs.  
 
3.2.1.1  Electrochemical Deposition 
The discs were immersed into a 0.13 M solution of calcium phosphate monobasic 
(Ca(H2P4)2). The disc to be coated acted as a cathode and was attached to the 
negative terminal of a DC Dual Power Supply 6010D. A platinum (Pt) ring was used 
as the anode. An electrical current of 200 mA (current density 80 mA/cm2) was 
applied for 10 minutes. The current was controlled using a FLUKE 867B Graphical 
Multimeter (Fluke Corporation, USA). To produce HAAg coatings, 100 mg of silver 
nitrate (AgNO3) was added per litre of the Ca(H2P4)2 solution as described by Ghani 
et al (2012). This coating was named HAAg100. Modifications of this coating named 
HAAg10 and HAAg50 were developed. These coatings were produced by adding 10 
or 50 mg of AgNO3 per litre of the Ca(H2P4)2 solution respectively. An electrical 
current of 70 mA (current density 28 mA/cm2) was applied for four minutes. The 
equipment used for electrochemical deposition is shown in Figure 3.1. 
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Electrochemical deposition of HAAg coatings was carried out in the dark to prevent 
precipitation of silver. The initial layer of brushite (Ca(HPO4).2(H2O)) that formed 
(with or without silver incorporated) was converted to HA by immersion in 0.1 M 
sodium hydroxide for 72 hours (Ghani et al 2012; Garcia-Gareta et al 2013). 
 
 
Figure 3.1 Photograph and schematic diagram of the equipment used for 
electrochemical deposition. 
!
   Power Supply 
           Anode 
          (Pt ring) 
    Multimeter 
     Electrolyte Solution 
     (Ca(H2P4)2 and AgNO3) 
     Cathode 
(Ti6Al4V disc) 
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3.2.1.2  Sterilisation, Addition of Fibronectin and Preconditioning 
Discs were sterilised with dry heat for one hour at 160°C. Filter sterilised fibronectin 
was added to surfaces as a 20 μL droplet containing 500 ng of human plasma 
fibronectin (F2006 Sigma-Aldrich, Dorset, UK). Additional sets of discs were 
preconditioned by immersing discs in fetal calf serum (First Link Ltd, UK). For 
surface characterisation experiments, all groups were preconditioned for 24 hours 
(P24). For experiments with fibroblasts, HAAg10 and HAAg50 groups were 
preconditioned for 4 hours (P4), 8 hours (P8) or 24 hours. HAAg100 surfaces were 
preconditioned or 24 hours or 48 hours (P48). (The longer preconditioning periods 
were chosen for HAAg100 surfaces because a scanning electron microscopy (SEM) 
pilot study of cell morphology on HAAg100 had shown poor results on these 
surfaces). 
 
3.2.2  Surface Characterisation 
Surface characterisation was carried out to determine if there were any differences in 
the morphology, the composition and roughness of the coatings as these factors may 
affect cell attachment and subsequently cytocompatibility. Six areas on three discs 
per group (P0 and P24) were analysed. SEM was used to visualise samples and 
assess the morphology of the coatings (JSM 5500LV, JOEL, UK). Energy Dispersive 
X-ray Analysis (EDX) Analysis (EDAX Genesis V5216 AMETEK, NJ, USA) was 
used to measure the percentage weight and atomic percentage of silver within 
coatings. Surface Roughness (Ra) was measured using a non-contact surface optical 
profilometer (Bruker Contour GT).  
 
3.2.3  Cell Culture 
Human dermal fibroblasts (1BR3G, ECACC) were cultured in 225cm2 vented flasks 
(Corning Incorporated, New York, USA). The cells were cultured in Dulbecco’s 
modified Eagle’s Medium (DMEM) (Sigma-Aldrich, Dorset, UK) containing 4500 
mg/L glucose, 1% penicillin/streptomycin (Invitrogen Corporation, Paisley, UK) and 
10% fetal calf serum (First Link Ltd, UK). The cells were cultured at 37°C with 5% 
humidified carbon dioxide (CO2). 
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3.2.4  Fibroblast Viability 
Cells were seeded onto the disc surface at a density of 5000 cells per disc and 
cultured for 24 hours. The surfaces were rinsed with phosphate buffered saline 
(Sigma-Aldrich, Dorset, UK) for five minutes to remove weakly adherent cells from 
the surface. The cells remaining on the disc surface were incubated in a solution 
containing 2 μM calcein AM and 4 μM Ethidium homodimer-1 (Invitrogen 
Molecular Probes Live/Dead viability/cytotoxicity Kit L-3224) for 45 minutes in the 
dark. A Zeiss microscope was used to visualise cells using the FITC filter to view 
both live (green staining) and dead (red staining) cells and the DAPI filter to view 
any additional dead cells. Six areas on each disc were visualised. The experiment 
was repeated three times. The numbers of live cells and dead cells were counted and 
the percentage of live cells in each area was calculated. 
 
3.2.5  Fibroblast Metabolism 
Cells were seeded onto the disc surface at a density of 15,000 cells per disc. After 24 
hours, the surfaces were rinsed with 1 mL of phenol red free DMEM (Sigma-
Aldrich, Dorset, UK) for five minutes. 1 mL of 10% Alamar blue in phenol red free 
DMEM was then added. The cells were incubated at 37°C with 5% CO2 for four 
hours. Six discs per coating were used and two 100μL aliquots from each sample 
were added to a white 96 well plate (FluoroNuncTM). Absorbance was measured 
using an Ascent fluoroscan plate reader (Thermo Electron Corporation, MA). 
 
3.2.6  Fibroblast Morphology 
SEM was used to assess cell morphology. Fibroblasts were seeded at a density of 
5000 cells per disc onto two discs from each group. After 24 hours the discs were 
washed with phosphate buffered saline to remove weakly adherent cells. The discs 
were fixed with 1.5% glutaraldehyde in 0.1 M sodium cacodylate buffer and serially 
dehydrated with ascending concentrations of industrial methylated spirits and 
ethanol. They were immersed in hexamethyldisilazane and then air-dried for 24 
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hours (Appendix 1.2). Following this, they were gold sputter coated using an 
Emitech K5500 (Emitech Ltd, Ashford, Kent) prior to imaging with the SEM (JSM 
5500LV, JOEL, UK).  
 
3.2.7  Statistical Analysis 
The data were analysed using SPSS, version 21.0 for Windows (Chicago, US). The 
Kolmogorov-Smirnov test indicated that the data did not fit the assumptions for 
parametric testing (p<0.05). Therefore, non-parametric tests were performed. The 
Kruskall Wallis test was used to determine if differences existed between the groups. 
Mann-Whitney tests were used to perform pair-wise comparisons. A post hoc 
Benjamini-Hochberg test was carried out because a large number of comparisons 
were made. This was carried out because as the number of comparisons increases, 
the likelihood of a false-positive result increases. The Benjamini-Hochberg test 
controls the false discovery rate by adjusting the threshold for significance. A false 
discovery rate of 0.05 was used and the threshold for significance was reduced for 
each pair-wise comparison according to the rank of the p value and the number of 
comparisons. The p values and adjusted thresholds for significance are detailed in 
Appendix 3. The Benjamini-Hochberg test reduces the chance of a Type 1 error but 
increases the chance of a Type 2 error to a lesser extent than more simple tests such 
as Bonferroni or Sidak corrections (Benjamini and Hochberg 1995). 
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3.3  RESULTS 
3.3.1  Surface Characterisation 
3.3.3.1  Surface Topography 
SEM of the electrochemically deposited coatings showed the presence of a 
combination of needle shaped, plate shaped and globular microcrystals on HA and 
HAAg surfaces. HAAg100 coatings appeared to have a greater proportion of larger 
plate shaped crystals and a more disorganised morphology than HAAg50 and 
HAAg10 coatings. The presence of a protein film was visible on surfaces that had 
been preconditioned. As it was necessary to dry the samples prior to performing 
SEM, cracks were visible within the protein film. Few needle shaped and plate 
shaped crystals were visible on preconditioned surfaces and the crystals appeared to 
be predominantly aggregated together as globules beneath the film (Figure 3.2). 
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Figure 3.2  Scanning electron micrographs showing the surface topography of (a) 
Pol (b) HA (c) HAFn (d) HAAg10 (e) HAAg50 (f) HAAg100 (g) Pol (P24) (h) HA 
(P24) (i) HAAg50 (P24) (j) HAAg100 (P24).  
 
 
 a! Pol$ b!
 c!  d!
 e!  f!
 g!    h!
 i!  j!
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3.3.3.2  EDX Analysis 
EDX analysis detected the presence of silver in all HAAg coatings and confirmed the 
absence of silver in the control coatings. The silver-containing coatings were from 
different population distributions (p=0.000) with HAAg100 coatings having the 
highest percentage silver content (median atomic silver percentage 0.665 and weight 
percentage 2.985) and HAAg10 having the lowest percentage silver content (median 
atomic percentage 0.205 and weight percentage 0.885) (Table 3.1). The addition of 
fibronectin and preconditioning resulted in the appearance of other elements not 
detected in HA and HAAg coatings such as Cl, K, Mg and N (Figure 3.3). In some 
cases HAAg surfaces that had been preconditioned had a lower silver content than 
non-preconditioned HAAg surfaces (Table 3.1). However, these reductions were not 
statistically significant (p>0.05. Exact p values for individual comparisons are shown 
in Appendix 3.1.1). 
Surface Ag Atomic % Weight % Ag   
Pol (P0/P24) 0.000 0.000  
HA (P0/P24) 0.000 0.000  
HAFn (P0/P24) 0.000 0.000  
HAAg10 0.205 (0.190 to 0.230) 0.885 (0.840 to 0.990)  
HAAgFn10 0.145 (0.090 to 0.240) 0.635 (0.390 to 1.030)  
HAAg50 0.280 (0.270 to 0.330) 1.220 (1.200 to 1.430)  
HAAgFn50 0.290 (0.230 to 0.370) 1.195 (1.010 to 1.560)  
HAAg100 0.665 (0.440 to 0.820) 2.985 (1.980 to 3.620)  
HAAgFn100 
HAAg10 (P24) 
HAAgFn10 (P24) 
HAAg50 (P24) 
HAAgFn50 (P24) 
HAAg100 (P24) 
HAAgFn100 (P24) 
0.595 (0.440 to 0.760) 
0.200 (0.150 to 0.230) 
0.150 (0.130 to 0.180) 
0.270 (0.230 to 0.390) 
0.290 (0.200 to 0.400) 
0.460 (0.310 to 0.620) 
0.535 (0.440 to 0.690) 
2.350 (1.960 to 3.240) 
1.040 (0.760 to 1.130) 
0.860 (0.710 to 0.980) 
1.165 (1.020 to 1.380) 
1.145 (0.880 to 1.610) 
2.340 (1.580 to 3.160) 
2.620 (2.150 to 3.460) 
 
Table 3.1 Atomic and weight percentage of silver for each surface presented as 
median values and (95% confidence intervals).  
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Figure 3.3  EDX spectra (a) Pol (b) HA (c) HAAg100 (d) HAAgFn100 (P24). 
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3.3.3.3  Surface Roughness 
Profilometry showed that Pol was smoother than HA (p=0.000). There was no 
difference in the roughness (Ra) of HA, HAAg10 and 50 surfaces (p=0.302). 
However, HAAg100 and HAAgFn100 surfaces were significantly rougher than all 
other surfaces (p<0.05. Exact p values for individual comparisons are shown in 
Appendix 3.2.1). Preconditioning of HA and HAAg surfaces resulted in reduced Ra 
values. This reduction was statistically significant for HAFn, HAAgFn10, HAAg50 
and HAAgFn100 (p=0.000, 0.000, 0.002 and 0.019 respectively) but was 
insignificant for all other surfaces. The adsorption of fibronectin onto surfaces did 
not affect the Ra values of any surfaces (p>0.05. Exact p values for individual 
comparisons are shown in Appendix 3.2.1) (Table 3.2). 
 
Surface Ra (μm) 
Pol 0.031 (0.028 to 0.033) 
HA 2.952 (2.828 to 3.451) 
HAFn 3.317 (2.802 to 3.444) 
HAAg10 2.804 (2.345 to 3.504) 
HAAgFn10 3.261 (2.602 to 3.683) 
HAAg50 3.022 (2.735 to 3.678) 
HAAgFn50 3.301 (2.411 to 3.635) 
HAAg100 4.774 (4.663 to 5.327) 
HAAgFn100 
Pol (P24) 
HA (P24) 
HAFn (P24) 
HAAg10 (P24) 
HAAgFn10 (P24) 
HAAg50 (P24) 
HAAgFn50 (P24) 
HAAg100 (P24) 
HAAgFn100 (P24) 
4.550 (4.302 to 4.715) 
0.030 (0.025 to 0.041) 
2.800 (2.488 to 3.482) 
2.394 (2.086 to 2.696) 
2.597 (2.334 to 3.802) 
2.255 (2.087 to 2.605) 
2.333 (2.250 to 3.028) 
2.540 (1.947 to 4.059) 
4.358 (3.296 to 5.579) 
4.184 (3.477 to 4.638) 
Table 3.2 Surface roughness results presented as median values and (95% 
confidence intervals). 
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3.3.2  Fibroblast Viability 
Non-preconditioned HAAg10 surfaces were cytotoxic to fibroblasts compared with 
HA, HAFn and Pol controls. HAAg50 had a greater cytotoxic effect than HAAg10 
(p=0.000). HAAg100 exhibited the greatest cytotoxicity and there was a further 
reduction in the percentage of live cells on this surface compared with HAAg50 
(p=0.002). Preconditioning of HAAg surfaces significantly reduced the cytotoxic 
effects. After 24 hours preconditioning all surfaces were cytocompatible with more 
than 90% cell viability. There was no reduction in viability on HAAg (P24) surfaces 
compared with Pol, HA and HAFn controls (p>0.05. Exact p values for individual 
comparisons are shown in Appendix 3.3.2). On HAAg10 and 50 surfaces, which 
were preconditioned for 4, 8 and 24 hours, it was observed that increasing the length 
of the time period of preconditioning increased the percentage of live cells on these 
surfaces.  Increasing the time period of preconditioning from 24 hours to 48 hours 
(for HAAg100+/-Fn) did not significantly further increase the cytocompatibility. 
Preconditioning did not affect the cytocompatibility of the control surfaces. 
Adsorption of fibronectin onto surfaces did not significantly improve the 
cytocompatibility of surfaces (Figures 3.4 and 3.5). 
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Figure 3.4  Live (green): dead (red) staining images of fibroblasts (a) Pol (b) HA (c) 
HAFn (d) HAAg10 (e) HAAg50 (f) HAAg100 (g) HAAgFn100 (h) HAAg50 (P4)  
(i) HAAg10 (P8) (j) HAAgFn50 (P8) (k) HAAg10 (P24) (l) HAAg50 (P24) (m) 
HAAg100 (P24) (n) HAAg100 (P48) (o) HAAgFn100 (P48). 
 
 a!  b!  c!
 d!  e!  f!
 g!  h!  i!
 j!   k!  l!
 m!  n!  o!
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Figure 3.5  Box-and-whisker plot showing the percentage of live fibroblasts on each 
surface.  
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3.3.3  Fibroblast Metabolism 
The greatest cell metabolism was observed on HAFn controls, which was 
significantly greater than Pol (p=0.008) but was not significantly different when 
compared with HA (p=0.143). There was less cell metabolism on non-
preconditioned HAAg surfaces compared with controls (p=0.000). Increasing the 
silver content of coatings was associated with a reduction in cell metabolism. 
Decreased cell metabolism was observed on HAAg100 surfaces compared with 
HAAg50 and HAAg10 surfaces (p=0.000). The cell metabolism on HAAg surfaces 
increased after preconditioning, compared with HAAg surfaces that had not been 
preconditioned. Increasing the time period for preconditioning up to 24 hours 
resulted in increased cell metabolism (HAAg10 and 50 groups). Increasing the length 
of the time period from 24 hours to 48 hours did not result in any further increase in 
cell metabolism (HAAg100 groups). There was no difference in cell metabolism 
between HAAg10, HAAg50 and HAAg100 surfaces after 24 hours preconditioning 
(p=0.574) and no difference between these surfaces and Pol and HA controls 
(p>0.05. Exact p values for individual comparisons are shown in Appendix 3.4.2). 
However, greater cell metabolism was observed on HAFn controls than on HAAg 
(P24) surfaces (p<0.05). Adsorption of fibronectin onto HAAg10 and HAAg100 did 
not significantly increase cell metabolism (p=0.799 and p=0.977 respectively). 
However, adsorption of fibronectin onto HAAg50 resulted in an increase in cell 
metabolism (p=0.003). Increased cell metabolism was observed on HAAgFn50 (P4) 
compared with HAAg50 (P4) (p=0.000). Fibronectin did not have any other 
statistically significant effects on HAAg surfaces that had been preconditioned 
(p=000) (Figure 3.6). 
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Figure 3.6  Box-and-whisker plot showing the Alamar blue absorbance results for 
each surface. 
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3.3.4  Fibroblast Morphology 
Fibroblasts cultured on HA surfaces appeared larger and flatter than fibroblasts on 
Pol surfaces, which were smaller and rounder. Greater cell spreading was observed 
on HAFn surfaces than HA surfaces. Cells were seen to grow on HAAg10 and 50 
surfaces that had not been preconditioned but the morphology was poor with 
minimal cell spreading and pseudopodia. Few cells were seen on HAAg100 and 
HAAgFn100. Predominantly cell remnants were seen on these surfaces. 
Preconditioning of HAAg surfaces resulted in greater cell spreading and improved 
cell morphology for all silver content coatings. The presence of pseudopodia was 
often obscured by the HA crystals; however, some pseudopodia were visible on HA 
and HAFn controls and HAAg and HAAgFn surfaces that had been preconditioned. 
In most cases, pseudopodia were not visible on non-preconditioned HAAg surfaces  
(Figures 3.7 and 3.8). 
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Figure 3.7 Scanning electron micrographs of fibroblasts on non-preconditioned 
surfaces (a) Pol (b) HA (c) HAFn (d) HAAg10 (e) HAAgFn10 (f) HAAg50 (g) 
HAAgFn50 and (h) HAAg100. 
 a!  b!
 c!  d!
 e!  f!
 g!  h!
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Figure 3.8  Scanning electron micrographs of fibroblasts on preconditioned surfaces 
(a) Pol (P24) (b) HA (P24) (c) HAAg10 (P4)  (d) HAAg50 (P4) (e) HAAg10 (P24) 
(f) HAAgFn50 (P24) (g) HAAg100 (P24) and (h) HAAg100 (P48). 
  
 a!    b!
 c!  d!
 e!  f!
 g!  h!
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3.4  DISCUSSION 
This study has shown that incorporation of silver into hydroxyapatite (with and 
without fibronectin) produces a coating that is cytotoxic. The cytotoxic effects of the 
coating are reversed after serum preconditioning for 24 hours. Cell metabolism is 
also increased after preconditioning, which may be due to increased cell 
proliferation.  
 
Reasons for Increased Cytocompatibility after Preconditioning 
Previous studies using inductively coupled plasma mass spectrometry (ICP MS) by 
Ghani et al (2012) have demonstrated a sustained release of silver from HAAg 
produced using this method of electrochemical deposition over a period of 22 days 
(Ghani et al 2012). They quantified silver release from HAAg coatings into 
phosphate buffer solution. The phosphate buffer solution was changed daily to mimic 
continuous replenishment of body fluids in vivo and therefore non-cumulative levels 
were measured. The amount of silver in the elution fluids was measured on days 10, 
15 and 22. Silver was found to be released at each of the three time points with the 
highest amount of silver measured at 10 days and the lowest amount at 22 days 
(Ghani et al 2012). Ghani et al (2012) did not measure silver release over the first 24 
hours, however, the results of their study indicate that silver release from HAAg 
reduces over time. As a result, it is hypothesised that after preconditioning surfaces, 
the release of silver would be slower, hence accounting for the improved 
cytocompatibility. (Release of silver from HAAg coatings into fetal calf serum over 
a wider range of time points (including 24 hours) will be presented in Chapter Five). 
Surprisingly, EDX analysis results showed that the reductions in the percentage of 
silver observed after preconditioning were not significant. This may be due to loss of 
other elements in addition to silver. It could also be due to the number of silver ions 
initially released being a very small proportion of the total number of silver ions. 
Further studies to determine the overall amount of silver within the coatings using 
atomic absorption spectroscopy or ICP MS (rather than a percentage as measured by 
EDX) may be of value. Extraction of silver into nitric acid could be used to quantify 
the amount of silver within the coating after preconditioning. It has already been 
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shown by Sandrucci et al that preconditioning removes silver ions from silver-
containing surfaces, which indicates that overall silver levels (but not necessarily the 
percentage) within the substrate would be reduced (Sandrucci et al 2005). This is an 
explanation for the improved cytocompatibility associated with preconditioning.   
 
An alternative explanation for the lack of significant reductions in the percentage 
content after preconditioning that should be considered is that silver content 
reduction may not be the only reason for the increased cytocompatibility associated 
with preconditioning. As the percentage of silver was not reduced on preconditioned 
surfaces, it is possible that the effect of preconditioning could be associated with 
other factors such as the deposition of proteins. One observation that supports this 
theory is that the percentage of live cells on HAAg (P24) surfaces was equal to that 
of controls that did not contain silver. Furthermore, there were no differences in the 
cell viability between HAAg10, 50 and 100 (P24) surfaces. Furno et al (2004) 
concluded that silver ions were able to penetrate protein-conditioning films and 
maintain their bactericidal activity (Furno et al 2004).  Similarly in our study, a 
substantial amount of the silver may have resided in the preconditioning film 
resulting in the reductions in silver content detected by EDX being insignificant. The 
finding of improved viability on preconditioned surfaces may be partly due to less of 
the silver being in a biologically active ionised form due to binding to serum proteins 
such as albumin (Schierholtz et al 1998). The number of ions involved in this process 
would be very difficult to measure. However, it should be noted that the study by 
Furno et al suggested that not all silver bound to proteins is inactivated as their 
conditioned substrates did not exhibit any loss of antibacterial activity (Furno et al 
2004). The following chapter of this thesis will present the effect of preconditioning 
on the antibacterial activity of HAAg and HAAgFn surfaces.  
 
Another EDX analysis finding was that after preconditioning, additional elements 
such as Cl, K, N and Mg were incorporated into the coatings. Other studies have 
concluded that immersion in simulated body fluids affects the composition and 
consequently may influence the biological behaviour of HA coatings (Zhang et al 
2003; Garcia-Gareta et al 2013). It has also been noted by other studies that 
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preconditioning may affect the crystallinity of ceramics and result in different apatite 
phases, which may contribute towards the increased cytocompatibility (Foppiano et 
al 2007). Additionally, as silver is part of the crystalline structure of HAAg, the 
release of silver from HAAg coatings would imply that HA resorption occurs. Future 
studies of the crystallographic structure of HAAg using X-ray diffraction analysis 
would be able to assess this. 
 
Surface Topography 
The increased time period and higher current density used for electrochemical 
deposition may have contributed to the increased roughness of HAAg100 compared 
with HAAg50 and HAAg10. Higher current densities are associated with more 
vigorous hydrogen evolution and the overall process is less efficient as a larger 
proportion of brushite crystals are unable to survive the turbulent environment of a 
high current density and are thus lost (Redepenning et al 1996). Redepenning et al 
(1996) reported that the crystals that do survive this environment would be expected 
to adhere better resulting in coatings with an overall greater integrity (Redepenning 
et al 1996). The same current density and time was used to produce HA coatings, 
which were not as rough as HAAg100 indicating that the silver content affects the 
topography of these surfaces. Previous X-ray diffraction analysis of HAAg showed 
peaks that were sharper than those observed for HA suggesting that the Ag+ ion 
incorporation may increase the crystallinity (Ghani et al 2012). The reduction in Ra 
observed on preconditioned surfaces was not statistically significant for all surfaces. 
Nevertheless, it was evident from the scanning electron micrographs that the crystal 
morphology was markedly different after preconditioning. This may be due to the 
fact that when a hydroxyapatite surface is immersed into a simulated body fluid, 
resorption of hydroxyapatite and the deposition of an apatite layer on the surface as 
described by Kokubo et al, may occur (Kokubo et al 1990; Kokubo 1998). 
Fibroblasts are known to be sensitive to surface topography and previous studies 
have shown that reductions in roughness even on a nanometric scale are associated 
with improved fibroblast attachment, proliferation or viability (Wang et al 2009; 
Ranella et al 2010; Pennisi et al 2011; Wang et al 2011; Teng et al 2012; Zhou et al 
2012). However, many factors such as wettability and surface chemistry influence 
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fibroblast responses, which change the way fibroblasts to respond to surfaces. This 
may enable these cells to grow on rougher surfaces despite the fact that they usually 
respond better to smoother surfaces. (Lydon and Clay 1985; Ranella et al 2010; 
Lopez-Santos et al 2013). 
 
Potential Implications of Preconditioning Resulting in Increased Cytocompatibility 
The finding that preconditioning is necessary before HAAg surfaces become 
cytocompatible, suggests that in clinical practice HAAg may be cytotoxic initially; 
and a short time period (up to 24 hours) may be required for cells to attach to these 
surfaces. The clinical implications of this delay are not known. In clinical practice, 
preconditioning prior to implantation with autologous serum in order to promote 
earlier soft tissue attachment would be an option, but would be logistically less 
convenient.  
 
Effects of Hydroxyapatite and Fibronectin 
Cells attaching to HA demonstrated greater cell spreading than cells cultured on Pol; 
but HA was not associated with significantly greater cell metabolism than Pol. HAFn 
was the only surface to increase cell metabolism compared with Pol. HA and HAFn 
did not improve the percentage of live cells compared with Pol as cell viability was 
already more than 90% on Pol controls. HAFn was the only surface to significantly 
increase cell metabolism compared with Pol. This is in keeping with the findings of 
Sawyer et al (2005) who found that HA alone was not a good substrate for cell 
attachment, but that RGD functionalisation was necessary to promote full cell 
spreading (Sawyer et al 2005). Additionally, Pendegrass et al (2010) showed that cell 
areas and attachment were not greater on HA than on Pol in vitro; but HAFn was 
greater than both Pol and HA (Pendegrass et al 2010a). However, the same study 
found that in vivo, HA resulted in significantly better soft tissue attachment than 
uncoated surfaces in addition to HAFn resulting in better soft tissue attachment than 
HA (Pendegrass et al 2010a). This raises the possibility that in vivo the differences 
between HA and HAFn as well as the differences between HA and Pol could be 
 122 
more marked than the differences seen in vitro. This could potentially be due to the 
longer duration of in vivo experiments.  
 
In the presence of silver, fibronectin did not have a consistent beneficial effect on 
cell metabolism. Fibronectin did not improve cell viability. There was a trend that 
HAAgFn increased cell metabolism compared with HAAg; but this was only 
statistically significant for HAAg50. This suggests that silver counteracts some of the 
effects of fibronectin on cell metabolism. 
 
It is known from previous studies that some fibronectin adsorbed onto 
hydroxyapatite coatings is lost after immersion into fetal calf serum. Pendegrass et al 
(2012) showed that only one fifth of the initial fibronectin coating remained on 
substrates after 24 hours in fetal calf serum, but that this remaining fibronectin 
resulted in a sevenfold fold increase in fibroblast attachment (Pendegrass et al 
2012b). It is possible that increasing the fibronectin concentration may have resulted 
in more marked effects on cell viability, metabolism and morphology. However, 
increasing the fibronectin concentration may also increase the bacterial colonisation. 
Therefore, it was decided to determine the effect of the concentration of fibronectin 
used in this experiment on bacterial colonisation before consideration of increasing 
the amount the fibronectin used. 
 
Limitations of This Study 
It is important to determine the effect of HAAg/HAAgFn coatings on cell viability as 
this chapter has done. However, it would have also been useful to directly assess in 
vitro cell attachment. SEM showed that cells present on control surfaces and 
preconditioned HAAg/HAAgFn surfaces. The cell viability assay also showed that 
viable cells were present surfaces. Non-adherent cells had been removed from the 
surface by rinsing with phosphate buffered saline prior to visualisation. However, the 
strength of cell attachment was not measured. The method of using a flow apparatus 
where shear stress is applied to detach cells from surfaces could not be used for this 
study. This is because the roughness of the surfaces would result in turbulent flow 
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rather than laminar flow (Pendegrass et al 2010b). Immunolocalisation of cell 
vinculin markers has been previously shown to correlate with measures of 
biophysical strength. This technique was attempted but was not successful due to 
autofluorescence resulting in uninterpretable images. An alternative approach would 
be to use sintered hydroxyapatite for vinculin bioassay experiments as this has been 
shown not to produce autofluorescence. However, the results of this may not be 
applicable to electrochemically deposited coatings due to differences in topography. 
Soft tissue dermal contact will be assessed in vivo. 
 
Future Directions 
It would be useful to assess the effect of HAAg and HAAgFn surfaces on other cell 
types to widen the potential clinical applicability of this coating. In contrast to 
fibroblasts, osteoblasts are known to respond better to rougher surfaces. Osteoblasts 
have been reported to respond well to surfaces with similar Ra microroughness levels 
to the surfaces investigated in this study (Kunzler et al 2007; Teng et al 2012; Zink et 
al 2012). It is well known that hydroxyapatite increases osteoblast adhesion. Studies 
have also shown that the addition of fibronectin improves osteoblast responses 
further (Deligianni et al 2006; Schönmeyr et al 2008; Fernández et al 2012)). If 
osteoblasts were found to respond well to HAAg and HAAgFn, this technique could 
be useful for the intraosseous portion of osseointegrated transcutaneous implants as 
well as more widely for other orthopaedic implants such as arthroplasty prostheses.  
This would be advantageous because hip and knee arthroplasties are associated with 
an infection rate of approximately 1%, which is associated with significant morbidity 
and substantial economic costs. 
 
Ghani et al (2012) have shown that HAAg100 has antibacterial activity (Ghani et al 
2012). However, the antibacterial activity of HAAg50 and HAAg10 as well as the 
effect of adsorption of fibronectin and preconditioning has not been studied. The 
next chapter of this thesis explores this before proceeding onto in vivo experiments. 
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3.5 CONCLUSION 
In conclusion, incorporation of silver into HA and HAFn coatings results in 
cytotoxicity. After serum-preconditioning HAAg and HAAgFn coatings become 
cytocompatible. This suggests that in clinical practice, after a period of contact with 
serum following implantation, these coatings would be expected to support viable 
fibroblast growth. Before conducting in vivo studies, it is necessary to assess the 
antibacterial activity of these coatings. This will be presented in the next chapter of 
this thesis. 
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CHAPTER FOUR 
In Vitro Assessment of Bacterial Colonisation on 
Hydroxyapatite, Silver and Fibronectin Coatings 
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4.1  INTRODUCTION 
The infection rate of osseointegrated transcutaneous implants has been reported to 
vary between approximately 18% and 55% (Tillander et al 2010; Brånemark 2014). 
The majority of infections have been superficial soft tissue infections (Brånemark 
2014). Staphylococcus aureus (S aureus) is known to be the commonest infecting 
organism (Tillander et al 2010). A range of other organisms have been found to 
cause infection e.g. Coagulase negative Staphylococcus; Streptococcus Groups A, B 
and G, Enterococci and Pseudomonas aeruginosa (P aeruginosa) (Tillander et al 
2010).  In clinical cases of the ITAP model, infections have been caused by S aureus 
and P aeruginosa (Chimutengwende-Gordon 2010, unpublished). As discussed in 
Chapter One, for soft tissue to win the ‘race for the surface’ against bacteria, it is 
necessary to prevent bacterial adhesion and hence biofilm formation on the surface 
of the implant. It is also important to prevent bacterial colonisation within the 
surrounding tissues. Early infection of surgical implants (i.e. within three months 
postoperatively) is believed to develop due to the introduction of bacteria into the 
tissues at the time of surgical implantation (Moran et al 2010). The introduction of 
very small numbers of bacteria intraoperatively may cause infection (Gosden et al 
1998). Late infections may also result from intraoperative bacterial contamination 
with low virulence organisms or when bacteria become dormant for extended time 
periods (Trampuz and Widmer 2006; Ribeiro et al 2012). However, later infections 
are often more likely to occur as a result of haematogenous spread of bacteria from 
other tissues (Moran et al 2010; Ribeiro et al 2012).  Silver released from an implant 
surface would be expected to reduce bacterial colonisation and the risk of infection 
associated with surgery; but it is important that this is not at the expense of tissue 
integration (Agarwal et al 2010).  For this reason I have utilised a coating that 
combines hydroxyapatite and fibronectin with silver. The rationale is to manage the 
‘race for the surface’ where tissue integration is promoted over bacterial colonisation 
and biofilm formation.  
 
Chapter Three has shown that HAAg and HAAgFn surfaces are cytocompatible after 
preconditioning. Depending on the method of coating and the surface characteristics, 
HA coatings may be associated with increased bacterial colonisation and could 
 127 
potentially increase the risk of infection (Smith et al 2006; Laure et al 2008). It is 
however encouraging that electrodeposited HA coatings have been shown to promote 
bacterial colonisation to a lesser degree than plasma-sprayed coatings due to 
increased surface roughness and wettability (Mathew et al 2014). Fibronectin has 
also been shown to increase the colonisation of some bacterial species such as S 
aureus, which contains fibronectin-binding proteins (Henderson et al 2010). Delmi et 
al (1994) demonstrated that S aureus and S epidermidis adhesion was significantly 
greater on coverslips of stainless steel, pure titanium and titanium-aluminium-
nobium alloy coated with fibronectin compared with albumin-coated controls. The 
presence of anti-fibronectin immunoglobulin G (IgG) antibodies, but not of 
preimmune IgG, reduced the extent of Staphylococcal adhesion by 70-90% (Delmi et 
al 1994).  
 
Some studies have suggested that adsorption of blood proteins inactivates silver due 
to binding of silver ions (Schierholz et al 1998). It is possible that preconditioning 
surfaces with serum may result in less silver being in a biologically active ionised 
form due to binding with proteins. This would be expected to result in reduced 
antibacterial activity. However, it has been shown that coating surfaces with serum 
or albumin (a hydrophilic component of serum) provides a barrier to bacterial 
adhesion and so may counteract the effects of binding silver (Pascual et al 1986; 
Kinnari et al 2005). Furno et al found that preconditioning silver surfaces with 
plasma does not inhibit antibacterial activity (Furno et al 2004).  
 
Although, Ghani et al have demonstrated that HAAg100 has antibacterial activity 
against S aureus, it is necessary to determine if this activity is affected by fibronectin 
and serum-preconditioning. As the lower silver content surfaces tested in Chapter 
Three (i.e. HAAg50 and HAAg10) were less cytotoxic to fibroblasts (before 
preconditioning) they may have a benefit over HAAg100 and so it would also be 
valuable to test the antibacterial activity of these surfaces. 
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The aim of this chapter is to assess the antibacterial activity of the HAAg and 
HAAgFn surfaces tested in Chapter Three against S aureus and P aeruginosa. The 
effect of these coatings on both biofilm formation and bacteria in surrounding 
planktonic suspensions will be described. This chapter also aims to determine if the 
antibacterial activity of these surfaces is maintained after serum-preconditioning.  
 
It was hypothesised that: 
1. The HAAg and HAAgFn surfaces would reduce S aureus and P aeruginosa 
colonisation compared with HA, HAFn and Pol controls. 
 
2. The higher content silver coatings would have greater antibacterial activity. 
 
3. HAFn would increase bacterial colonisation, but the addition of silver 
(HAAgFn) would counteract the effects of HAFn on promoting bacterial 
colonisation. 
 
4. HAAg and HAAgFn surfaces would maintain their antibacterial activity after 
serum-preconditioning. 
 
 
 
 
 
 
 
  
 129 
4.2  MATERIALS AND METHODS 
4.2.1  Bacterial Challenges 
10 mm x 3 mm titanium alloy (Ti6Al4V) discs were prepared using the methods 
described in Section 3.2.1. 106 colony forming units (cfu) of S aureus ATCC 29213 
was used to challenge Pol, HA, HAFn, HAAg10, HAAgFn10, HAAg50, 
HAAgFn50, HAAg100, HAAgFn100 surfaces at P0 and P24. Pol, HA, HAFn, 
HAAg100, HAAgFn100 surfaces at P0 and P24 were also challenged with a clinical 
isolate of P aeruginosa F1896 (106 cfu as well as a smaller challenge of 5 x 104 cfu). 
Each disc was placed into a 1 mL planktonic suspension of the bacteria in nutrient 
broth (Oxoid Ltd, Basingstoke, UK). The samples were then incubated for 24 hours 
at 37°C on a shaking tray at 50 revolutions per minute (rpm). 
 
4.2.2  Biofilm Direct Colony Counts 
The samples were rinsed with phosphate buffered saline in order to remove poorly 
adhered bacteria. The attached biofilms that had formed on the surfaces were 
removed by ultrasonication in phosphate buffered saline for two minutes. The 
resultant bacterial suspension was vortexed for 10 seconds to separate the bacterial 
aggregates and serially diluted in phosphate buffered saline over a 6-log range. Three 
discs per group were used and 10 μL of each dilution was plated onto agar (Oxoid 
Ltd, Basingstoke, UK) in triplicate. Columbia horse blood agar plates were used for 
surfaces challenged with S aureus. MacKonkey agar plates were used for surfaces 
that had been challenged with P aeruginosa. The plates were incubated at 37°C. 
After 24 hours, the colonies were counted. The number of colony forming units per 
mL (cfu/mL) was calculated. 
 
4.2.3  Planktonic Direct Colony Counts 
The planktonic bacterial suspensions that discs had been immersed in were also 
serially diluted and plated. Direct colony counts were performed using the same 
method as for the biofilm direct colony counts described above in Section 4.2.2. 
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4.2.4  Scanning Electron Microscopy 
The bacterial colonisation and the presence of glycocalyx/biofilm formation on two 
discs per group was visualised using SEM. The method for SEM preparation 
described in Section 3.2.6 (Appendix 1.2) was used. 
 
4.2.5  Statistical Analysis 
The data were analysed using SPSS, version 21.0 for Windows (Chicago, US). Non-
parametric tests were performed as the data did not fit the assumptions for parametric 
testing. The Kruskall Wallis test was used to determine whether the groups were 
from the same population distribution. Pair-wise Mann-Whitney U tests were used to 
perform comparisons between individual groups. Due to the large range of cfu/mL, 
colony count data was logarithmically transformed for presentation in box-and-
whisker plots. A post-hoc Benjamini-Hochberg analysis was carried out for the data 
from the S aureus bacterial challenge experiments as more than 20 comparisons were 
made. Median values and 95% confidence intervals are presented in Appendix 4. 
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4.3  RESULTS 
4.3.1  Direct Colony Counts for S aureus 
 4.3.1.2  Biofilm Direct Colony Counts 
Greater numbers of bacteria were present within biofilms that formed on HA 
compared with Pol (p=0.008). There was a further increase in the numbers of 
bacteria within biofilms formed on HAFn compared with HA (p=0.001). Non-
preconditioned HAAg surfaces reduced bacterial colonisation compared with Pol, 
HA and HAFn controls (p<0.05. Exact individual p values for each comparison are 
shown in Appendix 4.1.2). Increasing the silver content, increased the degree of 
antibacterial activity. HAAg100 and HAAgFn100 showed the greatest antibacterial 
activity and there was complete suppression of bacterial colonisation on these 
surfaces. After preconditioning, some bacterial colonisation occurred on HAAg100 
surfaces. However, the numbers of bacteria colonising HAAg100 (P24) surfaces 
remained significantly lower than the control surfaces (HAAg100 (P24) compared 
with Pol (P24) p=0.005). There was a reduction of 1.997 x 106 cfu/mL on HAAg100 
(P24) compared with HA (P24), which is equivalent to a 99.85% reduction in 
bacterial colonisation. There was a reduction of 1.983 x 106 cfu/mL on HAAgFn100 
(P24) compared with HAFn (P24) (99.15% reduction). After preconditioning, 
HAAg10 and HAAg50 lost their antibacterial activity compared with Pol, but fewer 
bacteria colonised these surfaces than HA (p=0.04 and 0.02 respectively). It was 
noted that reduced numbers of bacteria colonised Pol, HA and HAFn control 
surfaces after they were preconditioned (p=0.001, 0.088 and 0.000 respectively). In 
contrast increased numbers of bacteria colonised HAAg and HAAgFn surfaces after 
they were preconditioned (HAAg10 p=0.002; HAAgFn10 p=0.000; HAAg50 
p=0.001; HAAgFn50 p=0.020; HAAg100 p=0.000; HAAgFn100 p=0.000). 
HAAg100 was the only surface that maintained an antibacterial effect after 
preconditioning compared with Pol (P24) surfaces (p=0.005). Fibronectin resulted in 
an increase in bacterial colonisation on HAAg100 (P24) but did not affect the 
bacterial colonisation on other HAAg (P24) surfaces (Figure 4.1). 
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Figure 4.1  Results for number of S aureus colony forming units per mL within 
biofilms presented as log10 transformed numbers: (a) non-preconditioned surfaces 
and (b) preconditioned surfaces. 
a
b
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4.3.1.2  Planktonic Direct Colony Counts 
HAAg100 and HAAgFn100 had the greatest antibacterial activity and were the only 
surfaces to reduce bacterial colonisation compared with all three control surfaces 
before and after serum-preconditioning (p<0.05. Exact individual p values for each 
comparison are shown in Appendix 4.1.5). HAAg100 (P24) was associated with a 
2.493 x 107 cfu/mL reduction in planktonic colonisation compared with HA (P24)  
(99.72% reduction). HAAgFn100 (P24) reduced planktonic colonisation by 1.994 x 
107 cfu/mL compared with HAFn (P24) (99.68% reduction). Fibronectin increased 
bacterial colonisation when adsorbed onto HAAg50 (P24) (p=0.000). This effect was 
not observed on other surfaces (Figure 4.2). 
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Figure 4.2  Results for number of S aureus colony forming units per mL within 
planktonic suspensions presented as log10 transformed numbers: (a) non-
preconditioned surfaces and (b) preconditioned surfaces. 
a
b
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4.3.2  Direct Colony Counts for P aeruginosa 
4.3.2.1  Biofilm Direct Colony Counts (106 cfu challenge) 
HAAg100 (P0) reduced P aeruginosa colonisation within biofilms significantly 
compared with HA (p=0.001). Although the numbers of bacteria within P 
aeruginosa biofilms were fewer on HAAg100 than on Pol, there was no statistically 
significant difference (p=0.059). There was no difference between HAAg100 and 
HAAgFn100 (p=0.963). However, HAAgFn100 was the only surface to reduce 
bacterial colonisation compared with Pol (p=0.040). After preconditioning 
HAAg100 +/- Fn no longer had any antibacterial activity against P aeruginosa 
compared with Pol, HA and HAFn controls (p<0.05. Exact individual p values for 
each comparison are shown in Appendix 4.2.2) (Figure 4.3). 
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Figure 4.3  Results for number of P aeruginosa colony forming units per mL within 
biofilms presented as log10 transformed numbers: (a) non-preconditioned surfaces 
and (b) preconditioned surfaces. 
a
b
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4.3.2.2  Planktonic Direct Colony Counts (106 cfu challenge) 
There were no differences in planktonic bacterial colonisation between the groups. 
HAAg100 +/- Fn (before and after preconditioning) did not have an antibacterial 
effect compared with controls (p=0.114) (Figure 4.4).  
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Figure 4.4  Results for number of P aeruginosa colony forming units per mL within 
planktonic suspensions presented as log10 transformed numbers: (a) non-
preconditioned surfaces and (b) preconditioned surfaces. 
a
b
 139 
 
4.3.2.3  Biofilm Direct Colony Counts (5 x 104 cfu challenge) 
HAAg100 +/- Fn decreased bacterial numbers within biofilms compared with 
controls whether preconditioned or not (p<0.05. Exact individual p values for each 
comparison are shown in Appendix 4.1) (Figure 4.2.5). HAAgFn100 reduced 
bacterial colonisation compared with HAAg100 (p=0.000), however, after 
preconditioning there was no difference in bacterial colonisation between HAAg100 
and HAAgFn100 (p=0.055). There was a reduction of 2.5 x 106 cfu/mL on 
HAAg100 (P24) compared with HA (P24), which is equivalent to a 62.5% reduction 
in bacterial colonisation. There was a reduction of 4.3 x 106 cfu/mL on HAAgFn100 
(P24) compared with HAFn (P24) (71.66% reduction). 
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Figure 4.5  Results for number of P aeruginosa colony forming units per mL within 
planktonic suspensions presented as log10 transformed numbers: (a) non-
preconditioned surfaces and (b) preconditioned surfaces. 
a
b
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4.3.2.4  Planktonic Direct Colony Counts (5 x 104 cfu challenge) 
Similarly to the results presented above for biofilm colony counts, HAAg100 +/-Fn, 
whether preconditioned or not, reduced bacterial numbers within the planktonic 
suspensions significantly compared with the controls (p=0.000) (Figure 4.6). 
HAAgFn100 reduced bacterial colonisation compared with HAAg100 before and 
after preconditioning (p=0.000 and p=0.014 respectively). There was a reduction of 
3.87 x 109 cfu/mL on HAAg100 (P24) compared with HA (P24), which is equivalent 
to a 92.14% reduction in bacterial colonisation. There was a reduction of 6.65 x 109 
cfu/mL on HAAgFn100 (P24) compared with HAFn (P24) (97.08% reduction). 
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Figure 4.6  Results for number of P aeruginosa colony forming units per mL within 
planktonic suspensions presented as log10 transformed numbers: (a) non-
preconditioned surfaces and (b) preconditioned surfaces. 
a
b
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4.3.3  Scanning Electron Microscopy S aureus 
SEM findings were in keeping with the direct colony count results. The least 
bacterial colonisation was seen HAAg100 (before and after preconditioning). 
Extensive glycocalyx formation was observed on HA and HAFn and to a lesser 
extent on HAAg10 and 50 surfaces. Increased glycocalyx formation occurred on 
surfaces coated with fibronectin. After preconditioning, reduced bacterial growth 
was seen on Pol surfaces. This effect was not clearly observed on HA and HAFn. 
Preconditioning appeared to increase bacterial numbers on HAAg10 and 50 (+/- Fn). 
Differences in bacterial colonisation on HAAg100 and HAAgFn100 after 
preconditioning were not clear. Scanning electron micrographs showing S aureus 
colonisation on preconditioned are presented in Fig 4.7 (i) and (ii). 
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Figure 4.7 (i)  Scanning electron micrographs showing S aureus colonisation on (a) 
Pol (P24) (b) HA (P24) (c) HAFn (P24) (d) HAAg10 (P24). The red arrows indicate 
glycocalyx formation.  
 
 
 
 
 
a! b!
c! d!
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Figure 4.7 (ii)  Scanning electron micrographs showing S aureus colonisation on (e) 
HAAgFn10 (P24) (f) HAAg50 (P24) (g) HAAg100 (P24) (h) HAAgFn100 (P24). 
The red arrows indicate glycocalyx formation.  
 
 
 
 
 
 
 
 
 
 
 
e! f!
g! h!
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4.3.4  Scanning Electron Microscopy P aeruginosa 
The least bacterial colonisation was seen HAAg100 and HAAgFn100 (before and 
after preconditioning). There was no clear difference in bacterial colonisation 
associated with the presence of fibronectin. Heavy bacterial growth was present on 
control surfaces, with the presence of glycocalyx formation on HA and HAFn 
surfaces. Clear differences in numbers of bacteria on HAAg100 and HAAgFn100 
surfaces after preconditioning were not observed. Scanning electron micrographs 
showing P aeruginosa colonisation on preconditioned surfaces are presented in 
Figure 4.8.  
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Figure 4.8  Scanning electron micrographs showing P aeruginosa colonisation (5 x 
104 cfu challenge) on (a) Pol (P24) (b) HA (P24) (c) HAFn (P24) (d) HAAg100 
(P24) (e) HAAgFn100 (P24). The red arrows indicate glycocalyx formation. 
 
 
 
 
a!
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4.4  DISCUSSION 
This chapter has shown that electrochemically deposited HAAg100 suppresses S 
aureus colonisation before and after preconditioning in fetal calf serum. P 
aeruginosa colonisation was also suppressed by HAAg100 before and after 
preconditioning when a smaller bacterial challenge was used. 
 
Effect of Preconditioning on Antibacterial activity 
Although HAAg100 and HAAgFn100 exerted an antibacterial effect compared with 
controls after preconditioning, some antibacterial activity was lost. This may be due 
to the same reasons that preconditioning increased the cytocompatibility of surfaces 
i.e. the slower release of silver after preconditioning. The observation that HAAg 
surfaces reduced planktonic bacterial numbers also indicates that silver is released 
from HAAg surfaces into the surrounding fluid. Studies of release kinetics of HAAg 
would be of value and will be conducted from porous ITAP flanges in Chapter Five 
in preparation for the in vivo study. 
 
Interestingly, the effect of preconditioning on S aureus colonisation was different on 
controls and HAAg surfaces. Less bacterial colonisation was observed on Pol discs 
after they were preconditioned. Similar findings have been previously reported by 
other studies where adhesion of bacteria was significantly inhibited on surfaces 
treated with serum or proteins due to the formation of a barrier to bacterial adhesion 
(Pascual et al 1986; Paulsson et al 1993; Wassall et al 1997; Kinnari et al 2005).  
Hydrophilic proteins within serum such as albumin are believed to be responsible for 
this phenomenon as bacteria adhere better to hydrophobic surfaces (Pascual et al 
1986; Kinnari et al 2005; Harris and Richards 2006). Conversely, Antoci et al (2007) 
ound an abundance of live adherent bacteria on titanium rods coated with serum 
(Antoci et al 2007b). The reason for this conflicting finding is unclear, but 
differences in the initial surface characteristics of the underlying substrate may be 
relevant. Further research on the wettability of these surfaces may be of value and 
will be conducted in Chapter Five. Reductions in S aureus colonisation were also 
seen on HA and HAFn but were less marked than those seen on Pol. Indeed, large 
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numbers of bacteria in the range of more than 106 colonies remained present on HA 
and HAFn surfaces after preconditioning meaning this reduction is unlikely to be 
clinically useful. The reduction in S aureus colonisation on Pol is also not likely to 
be exploited clinically as Pol would be unsuitable as a surface for osseointegrated 
transcutaneous implants due to inadequate soft tissue attachment in vivo (Pendegrass 
et al 2006a). Preconditioning HAAg surfaces had the opposite effect to 
preconditioning controls and there was an increase in S aureus colonisation. If silver 
from preconditioned HAAg coatings had become bound to proteins and some silver 
had been inactivated as discussed earlier, it is expected that the effect of this 
postulated increase in wettability would have been counteracted.  
 
The effects of preconditioning on P aeruginosa colonisation were less marked and 
less consistent than those observed with S aureus. P aeruginosa biofilm formation 
was significantly reduced on controls when the lower bacterial challenge was 
administered; but there was no difference when a higher bacterial challenge was used 
and there was no difference in planktonic colonisation. Planktonic P aeruginosa 
colonisation associated with HAAg and HAAgFn increased after preconditioning 
when the lower bacterial challenge was used. No other significant differences were 
associated with preconditioning. P aeruginosa is a ‘notorious’ producer of 
glycocalyx (Neut et al 2005). This may be responsible for the finding that 
preconditioning had less of an effect on reducing P aeruginosa biofilm formation on 
controls compared with S aureus. Increased glycocalyx formation may also be a 
potential reason for the less marked effect of preconditioning on P aeruginosa 
colonisation on HAAg surfaces. This is because it may cause P aeruginosa to be less 
sensitive to the antibacterial effects of HAAg meaning that any inactivation of silver 
by the proteins from the preconditioning film would have a reduced effect. As 
discussed in Chapter One, it has been suggested that the encasement of bacteria by 
glycocalyx prevents penetration of antimicrobial agents through biofilms and 
physically prevents access to the bacterial cell (Foley and Brown 1999; Donlan and 
Costerton 2002). However, as glycocalyx is composed predominantly of water, it 
may be considered that this is unlikely and that the effect of glycocalyx is mainly due 
to modification of the microenvironment leading to nutrient limitation, reduced 
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bacterial growth rates and consequently protection of the bacteria from antimicrobial 
agents (Prosser et al 1987; Stewart and Costerton 2001). This is an explanation for 
the reduced susceptibility of P aeruginosa to silver due to its increased glycocalyx 
formation. 
 
Effect of Silver Content of Coatings on Antibacterial Activity 
In terms of S aureus colonisation, HAAg50 and 10 did not perform as well as 
HAAg100 in terms of antibacterial activity. The only potential advantage of these 
lower silver content coatings is that before preconditioning they were less cytotoxic 
than HAAg100 as shown in Chapter Three. This raises the possibility that they may 
be able to promote earlier attachment of viable fibroblasts but this is not conclusive. 
After preconditioning there was no difference in HAAg50 and 10 groups in terms of 
cytotoxicity compared with HAAg100. Therefore, only HAAg100 surfaces were 
challenged with P aeruginosa as HAAg10 and HAAg50 would thus be less clinically 
useful due to this.  
 
Differences in Colonisation between P aeruginosa and S aureus 
P aeruginosa was less susceptible to HAAg100 than S aureus, which may be due to 
increased glycocalyx formation as discussed above. In particular, P aeruginosa 
biofilm bacteria were much more resistant to the antibacterial effects of HAAg than 
S aureus biofilm bacteria as indicated by the considerably lower percentage 
reductions of P aeruginosa biofilm cfu/mL compared with S aureus.  When the 106 
cfu bacterial challenge was used, HAAg100 (before preconditioning) suppressed S 
aureus colonisation completely but only reduced P aeruginosa biofilm bacterial 
numbers compared with HA and HAFn and not compared with Pol. After 
preconditioning HAAg100 had no significant antibacterial effect on P aeruginosa 
even compared with HA.  When the bacterial challenge was reduced by a factor of 
50 to 5 x 104 cfu/mL, HAAg100 still did not suppress P aeruginosa colonisation 
completely but reduced colonisation compared with all controls before and after 
preconditioning. It is possible that the administration of bacterial challenges of 106 
and 5 x 104 cfu P aeruginosa colony forming units for a 10 mm x 3 mm disc (surface 
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area of 251 mm2) could be considered excessively large quantities of bacteria which 
should rarely be encountered clinically in the early post-operative period before a 
soft tissue seal forms. Therefore, the fact that these surfaces were only antibacterial 
to P aeruginosa with the smaller bacterial challenge may still make these surfaces 
clinically useful.  It is possible that with a smaller bacterial challenge HAAg10 and 
HAAg50 may have been able to demonstrate a greater antibacterial effect on S 
aureus. If HAAg surfaces are exposed to just a few bacteria it would be more likely 
to be able to suppress P aeruginosa as well S aureus colonisation completely. This is 
relevant as infection of surgical implants may start with small numbers of bacteria 
colonising the surface (Gosden et al 1998). 
 
As S aureus is the most common organism causing infection of osseointegrated 
transcutaneous implants (Tillander et al 2010), the effect of HAAg against S aureus 
is particularly important. It was encouraging to ascertain that HAAg100 was able to 
withstand such a large bacterial challenge of 106 cfu of S aureus.  Further challenges 
with other bacterial strains would be of interest for future research. For example, 
challenges with Acinetobacter Baumannii, a multi-drug resistant bacterium that has 
become a significant cause of war-related traumatic soft tissue infections may be 
relevant to ITAP (Guerrero et al 2010). Challenges with bacteria isolated from 
clinical infections of ITAP or other transcutaneous implants would be of particular 
value. 
 
It is likely that increasing the silver content in the electrolyte solution would have 
produced a greater antibacterial effect. However, a higher silver content is likely to 
increase the cytotoxicity. This approach would have required further assessment of 
the effects on fibroblasts. If higher silver contents were found to be cytocompatible 
after preconditioning, there would still be an increased risk of adverse local tissue 
effects in vivo as well as higher circulating blood levels and potentially an increased 
risk of systemic toxicity. 
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Although this study found that P aeruginosa was less susceptible to HAAg than S 
aureus other researchers have found the opposite and have concluded that gram-
negative bacteria are more susceptible to silver ions than gram-positive bacteria 
(Feng et al 2000; Kawahara et al 2000). It has been proposed that the increased 
thickness of the peptidoglycan in the cell walls of gram-positive bacteria protect the 
cell from penetration of silver ions into the cytoplasm (Feng et al 2000). Kawahara et 
al tested the susceptibility of a range of gram-negative and gram-positive oral 
bacteria and concluded that gram-positive bacteria were less susceptible due to the 
fact that peptidoglycans are negatively charged resulting in the thicker peptidoglycan 
wall of gram-positive bacteria allowing less positively charged silver ions to reach 
the plasma membrane (Kawahara et al 2000). A reason for this conflicting finding is 
that the gram-negative bacteria tested in these studies were not P aeruginosa 
specifically. On the other hand, Niakan et al (2013) found a slight decrease in the 
antimicrobial activity of silver against P aeruginosa compared with S aureus, which 
is in keeping with this study (Niakan et al 2013). Additionally, it has been shown that 
silver has varying inhibitory effects on different strains of P aeruginosa (Palanisamy 
et al 2014). It is likely that the degree of glycocalyx production varies between 
different strains of P aeruginosa, which would result in differences in the 
susceptibility to silver and other antimicrobials. 
 
Effects of Fibronectin on Bacterial Colonisation 
The adsorption of fibronectin onto preconditioned HAAg100 surfaces significantly 
increased S aureus colonisation to the extent that HAAgFn100 (P24) was not 
antibacterial compared with Pol; (although it was still antibacterial compared with 
HA and HAFn (P24)). In addition to the possibility of some inactivation of silver 
associated with fibronectin, fibronectin contains Staphylococcal binding sites 
(Bozzini et al 1992). The results of this study indicate that silver does not counteract 
the effect of these binding sites. It has been shown that functionalisation of 
biomaterials with the RGD sequence of fibronectin, which is responsible for cell 
binding, does not increase adhesion of S aureus, S epidermidis, Streptococcus 
mutans and P aeruginosa  (Maddikeri et al 2008; Shi et al 2008). Therefore, RGD 
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coatings may be less likely to increase bacterial colonisation than fibronectin and 
would ultimately be more commercially acceptable. 
 
The significant increase in S aureus colonisation associated with fibronectin was not 
observed with P aeruginosa. This is likely to be due to differences in fibronectin 
binding sites. Decreased hydrophobicity caused by adsorption of fibronectin may 
also contribute to the reduced adhesion of bacteria (Dexter et al 2001). Similarly to 
this study, previous research has shown that P aeruginosa has a lower affinity for 
fibronectin than S aureus. For example, Plotkowski et al (1993) exposed coverslips 
coated with plasma or cellular fibronectin to radiolabelled bacteria. They showed that 
adhesion of S aureus to coverslips coated with fibronectin was significantly greater 
than adhesion to control coverslips coated with bovine serum albumin. There was no 
difference in P aeruginosa adhesion to fibronectin coated or control coverslips 
(Plotkowski et al 1993). It is also noted that when the lower bacterial challenge was 
used in this chapter, fibronectin was associated with a reduction in P aeruginosa 
colonisation on HAAg100 surfaces (before preconditioning). This is in keeping with 
the findings of studies on the colonisation of the upper respiratory tract and 
adherence of gram-negative bacilli to epithelial cells. An inverse relationship 
between cell-surface fibronectin and the adherence of gram-negative bacteria to these 
cells has been described (Woods et al 1980; Woods et al 1981; Abraham et al 1983; 
Simpson et al 1985; Woods 1987). Woods et al trypsinised buccal epithelial cells and 
reduced the amount of fibronectin on the cell surface. The loss of fibronectin 
increased the adherence of P aeruginosa (Woods et al 1981). It has been postulated 
that gram-negative bacterial adhesion to fibronectin-coated surfaces could be 
enhanced by proteolytic enzymes produced by the bacteria that are able to degrade 
fibronectin (Abraham et al 1983; Woods 1987). The clinical implications of this are 
that proteases produced by P aeruginosa in vivo that degrade fibronectin could result 
in any inhibitory effects of fibronectin coatings on P aeruginosa adhesion being lost. 
It may also mean that fibroblasts are less likely to win the ‘race for the surface’ 
against P aeruginosa. This is because if these coatings are colonised with P 
aeruginosa, the effect of fibronectin on soft tissue attachment could be reduced due 
to degradation of fibronectin.  
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It is possible that other strains of P aeruginosa may behave differently and colonise 
fibronectin-coated surfaces to a greater extent as contrary to the research discussed 
above, some studies have found that P aeruginosa binds to fibronectin and that 
fibronectin enhances P aeruginosa adherence (Mohammad et al 1988; Baleriola-
Lucas and Wilcox et al 1998). Fibronectin-binding is known to be strain specific 
with different strains of the same species having different affinities for fibronectin. 
Studies on a range of S epidermidis strains have illustrated this point and shown that 
the adhesion of some strains may be increased by fibronectin coatings while the 
adhesion of other strains of the same species is decreased (Herrmann et al 1988; 
Dunne and Burd 1993; Dexter et al 2001). 
 
Limitations of This Study 
Fetal calf serum was chosen over simulated body fluid for preconditioning as it 
contains serum proteins such as albumin and globulins and so was more 
representative of the in vivo environment than simulated body fluids.  Nonetheless, it 
could be argued that a limitation of this study is that plasma would have been more 
representative as it contains clotting factors such as fibrinogen in addition to serum 
proteins. This may be relevant as S aureus contains fibrinogen-binding proteins.  
Another potential limitation of the in vitro work presented in this chapter and 
Chapter Three is that the coatings were applied to solid surfaces but will be applied 
to a porous titanium alloy for the in vivo studies. Bacterial colonisation and cell 
viability are likely to be different on a porous surface and this may result in the effect 
of the coatings being different when applied to a porous surface. This may render the 
findings of these in vitro studies less representative of what will occur in vivo. It 
would not have been feasible to apply these coatings to the porous structure that will 
be used in vivo as the bacteria and cells would have fallen though the pores due to 
the larger size of the pores that will be used (based on the results of Chapter Two). 
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4.5 CONCLUSION 
This study has shown that electrochemically deposited HAAg surfaces have 
antibacterial activity against both S aureus and P aeruginosa in vitro. Before 
preconditioning, complete suppression of S aureus biofilm formation was observed 
on HAAg100 and HAAgFn100 when challenged with 106 cfu/mL. After serum-
preconditioning more than 99% of the antibacterial activity of HAAg100 and 
HAAgFn100 against S aureus compared with HA and HAFn controls was 
maintained for both biofilm and planktonic colonisation. P aeruginosa was less 
susceptible to the antibacterial effects of HAAg100 and HAAgFn100 than S aureus. 
HAAg100 and HAAgFn100 resulted in smaller reductions in P aeruginosa 
colonisation and only demonstrated significant antibacterial activity after 
preconditioning when a smaller bacterial challenge of 5 x 104 cfu/mL was used. 
When considering the results of this chapter in conjunction with those from Chapter 
Three, the findings indicate that fibroblasts would win the ‘race for the surface’ 
against bacteria on HAAg100 and HAAgFn100 after serum-preconditioning 
depending on the strain and the quantity of the bacteria they are exposed to. It is 
important that the antibacterial effects of the HAAg coatings persist for a sufficient 
period of time for cell attachment to occur. This may mean that antibacterial activity 
is required until a soft tissue seal has formed, which may be between two and four 
weeks. The duration of the release of silver from the HAAg coating (when applied to 
porous titanium implants) will be studied in Chapter Five. The in vivo performance 
of these coatings applied to porous titanium will be presented in Chapters Six and 
Seven of this thesis.  
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CHAPTER FIVE 
Preparation of Transcutaneous Pins with Hydroxyapatite, 
Silver and Fibronectin-Coated Porous Titanium Alloy 
Flanges 
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5.1  INTRODUCTION 
A transcutaneous pin in vivo ovine model will be used in Chapters Six and Seven to 
study the effects of porous titanium alloy flanges coated with HAAgFn on soft tissue 
integration and bacterial colonisation. The HAAg100 and HAAgFn100 coatings that 
were shown in Chapters Three and Four to have antibacterial activity and to promote 
viable fibroblast growth after serum-preconditioning will be used to coat the flanges. 
The flanges will have a pore size of 700 μm and a strut size of 300 μm, as this was 
found to support soft tissue ingrowth and revascularisation in Chapter Two. This 
chapter presents the transcutaneous pin design and the characterisation of the 
coatings produced on the flanges. It is important to determine that the coatings 
produced on the porous titanium alloy flanges have a similar composition and 
topography to the coatings selected from the in vitro studies as the aim is to produce 
a similar effect on fibroblasts and bacteria in vivo. The coatings should be present 
throughout the porous structure without occluding the pores.  
 
It is also important to determine the release of silver from the coatings. The in vivo 
studies will be conducted over a four-week period in order to allow adequate time for 
a soft tissue seal to form. Ideally, silver should continue to be released until cells 
have been able to attach and it may be of value to have continued silver release for 
two to four weeks until the soft tissue seal has formed. Electrochemically deposited 
HAAg coatings have previously been shown to provide a controlled and sustained 
release of low levels of silver ions over 22 days. Ghani et al (2012) demonstrated 
median silver release levels of 444 ppb (4.116 μmol/L) at 10 days, 376.5 ppb (3.490 
μmol/L) at 15 days and 170 ppb (1.576 μmol/L) at 22 days. These levels were found 
to have bactericidal activity in vitro (Ghani et al 2012).  The amount of silver 
released and the amount of silver passing into the blood circulation must be below 
toxic levels to avoid local and systemic toxicity. The results of the in vitro sections of 
this thesis indicate that cells may not attach initially due to local toxicity but that 
following exposure to serum for up to 24 hours the local toxic effects will be 
reversed. The in vitro bacterial colonisation studies presented in this thesis have 
indicated that the level of release (even when eukaryotic cells are able to attach) 
would be bactericidal. In other words there is a ‘window of opportunity’ when 
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surfaces allow cell growth but at the same time prevent viable bacterial attachment. 
In vivo, the porous implants used will have a larger surface area than those tested in 
vitro. This means that although the composition of coatings used in vivo will be 
similar to those tested in vitro, the absolute silver content will be greater. If the 
overall silver content of the coatings and the amounts released into the tissues are not 
sufficiently low, local cellular toxicity may persist for longer than 24 hours and may 
have a detrimental effect on wound healing. Systemic toxic effects such as argyria 
and argyrosis may also occur. Argyria and argyrosis occur due to the deposition of 
silver in the dermis and cornea and/or conjunctivae resulting in irreversible 
discolouration of the tissues (Drake and Hazelwood 2005; Lansdown 2010). Total 
body silver concentrations ranging from 3.8 to 6 g have been found to produce 
argyria and argyrosis (Gosheger et al 2004; Lansdown 2010). Other systemic toxic 
effects of silver that have been described include leucopenia, liver and renal toxicity 
(Choban and Marshall 1987; Gamelli et al 1993; Chaby et al 2005; Trop et al 2006). 
 
Chapter Three has shown that the topography of HA and HAAg coatings is altered 
by preconditioning. Differences in topography influence wettability of surfaces 
(Wenzel 1936). Wettability is known to affect cell spreading and attachment. Studies 
have demonstrated improved cell attachment to hydrophilic surfaces (Teare et al 
2000; Shen and Horbett 2001). Other studies have found that increased wettability 
improves cell attachment up to a point and that moderate wettability produces the 
most favourable cellular responses (van Wachem et al 1987; Tamada and Ikada 
1993; Lee et al 1998; Kim et al 2007). It would be of interest to determine if the 
wettability of surfaces is affected by preconditioning. Additionally, the effect of 
serum-preconditioning on the crystallinity of HAAg coatings has not been studied. 
Foppiano et al (2006) showed that the crystallinity of ceramics is altered by 
preconditioning and they postulated that changes in crystallinity may contribute to 
improved cytocompatibility of preconditioned surfaces (Foppiano et al 2006; 
Foppiano et al 2007). XRD analysis of bioactive glass coatings showed that the 
intensity of peaks corresponding to crystalline phases is reduced after immersion in 
simulated body fluids (Foppiano et al 2006).  
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The aim of this chapter was to produce HAAgFn coatings on porous titanium alloy 
and to determine the topography and composition of the coatings as well as the 
release of silver from the coatings. Additionally, this chapter aimed to assess the 
crystallinity and wettability of the coatings and the effect of serum-preconditioning 
on the coatings. 
 
It was hypothesised that HAAgFn coatings with a similar topography and 
composition to the coatings tested in vitro could be applied throughout porous 
titanium alloy structures. It was also hypothesised that serum-preconditioning would 
reduce the crystallinity and increase the wettability of coatings. Finally, it was 
hypothesised that the  release of silver would be sustained over a four-week period 
and that the release rate would reduce over time. 
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5.2  MATERIALS AND METHODS 
5.2.1  Transcutaneous Pin Designs and Coatings 
Transcutaneous pins with a laser sintered porous titanium alloy flange (pore size 700 
μm and strut size 300 μm) (Eurocoatings, Trentino, Italy) were used. A dome-shaped 
flange was designed in an attempt to further increase soft tissue integration. Laser 
sintering was used instead of the electron beam manufacturing technique reported in 
Chapter Two because it was able to produce structures with a finer surface finish 
(Koike et al 2011a). Figure 5.1 is a photograph of the basic pin design. The flanges 
were either uncoated (PT) or coated with HA (PT-HA), HAFn (PT-HAFn), 
HAAg100 (PT-HAAg) or HAAgFn100 (PT-HAAgFn).  
 
 
Figure 5.1  Photograph of the transcutaneous pin design. 
 
 
 
 
 
 
10mm!
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5.2.2  Surface Preparation 
5.2.2.1  Cleaning of Implants 
The pins were ultrasonicated in 10% Decon 90 for 20 minutes. An air gun was used 
to fire debris out from within the pores of the implants before and after 
ultrasonication in 10% Decon 90. This was followed by ultrasonication in Industrial 
Methylated Spirits for 20 minutes.  
 
5.2.2.2  Electrochemical Deposition 
As described previously, a 0.13 M calcium phosphate monobasic solution was used 
with 100 mg of AgNO3 added per litre of solution to produce HAAg coatings (in 
view of the findings from Chapter Three and Four that HAAg100 had the most 
antibacterial activity whilst being cytocompatible after preconditioning). The current 
density and time period used to produce HA and HAAg100 coatings in the in vitro 
chapter did not produce a uniform coating throughout the porous structures. As a 
result the current density and time period were modified. Electrochemically 
deposited coatings were produced using a current density of 58 mA/cm2 for 270 
seconds because this was the highest current density and longest time period that 
produced uniform coatings of both HA and HAAg. 
 
5.2.2.3  Sterilisation 
Implants were sterilised with dry heat at 160°C for one hour. 
 
5.2.2.4  Adsorption of Fibronectin 
Fibronectin was adsorbed onto the porous flanges by immersing implants (with the 
intraosseous and transcutaneous pin portions masked) into a solution containing 2745 
ng of fibronectin for 1.5 hours. This was in order to coat the flanges with 6.37 
ng/mm2 of fibronectin (equivalent to the amount of fibronectin used for the in vitro 
experiments). This technique has been described previously (Pendegrass et al 2010a).  
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5.2.3  Surface Characterisation 
Separate flanges without the transcutaneous pins were manufactured specifically for 
surface characterisation.  
 
5.2.3.1  Surface Topography, Coating Morphology and Thickness 
SEM was performed to visualise the surface topography and morphology of all 
coatings on the outer surface of the implants (n=3, N=6). Additionally, SEM was 
used to measure the thickness of HA and HAAg coatings on the outer surface of the 
implant and within the central pores after embedding samples in LR White Resin 
(n=2, N=4). The embedded samples were cut longitudinally through the centre with 
the Exakt diamond edge saw and polished (using the polishing technique described 
in Section 3.2.1). A ruler was used to measure the coating thickness. The 
measurements in millimetres were transformed to micrometres by taking into 
account the magnification bar of the scanning electron micrographs. 
 
5.2.3.2  Elemental Composition and Percentage of Silver 
EDX analysis was performed to determine the Ca/P ratio of HA coatings and to 
measure the atomic and weight percentage of Ag within coatings (n=3, N=6). 
 
5.2.3.3  Silver Release 
The amount of silver released into fetal calf serum from PT-HAAg was measured 
over a four-week period (n=3). PT-HA was used as a control. The flanges were 
placed in 5 mL of fetal calf serum at room temperature. Flanges were removed on 
days 0 (at 4 hours and 8 hours), 1 (at 24 hours), 2, 3, 4, 5, 8, 11, 14, 18 and 28. 
Flanges were placed into a fresh fetal calf serum solution at each time point. 
Inductively Coupled Plasma Mass Spectrometry (ICP-MS) (Dr Barry Sampson, 
Trace Element Laboratory, Imperial College London, UK) was used to quantify the 
silver content in elution fluids. This allowed the silver release between time points to 
be determined. 
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5.2.3.4  Absolute Silver Content of Coatings 
Coatings were removed from PT-HA and PT-HAAg flanges by immersion in 2 N 
nitric acid (HNO3) for 30 minutes. SEM and EDX analysis was performed to confirm 
that the coatings had been removed from these samples. ICP-MS (Dr Barry 
Sampson, Trace Element Laboratory, Imperial College London, UK) was performed 
to measure the silver content of coatings extracted into the HNO3 solution. 
 
5.2.3.5  X-ray diffraction analysis 
X-ray diffraction analysis (XRD) (Dr George Georgiou, Department of Biomaterials 
and Tissue Engineering, Eastman Dental Unit, University College London, UK) was 
performed on solid discs - Pol, HA, HAFn, HAAg, HAAgFn, HAAg after serum-
preconditioning for 24 hours (P24) and HAAgFn P24 (n=3). The preconditioned 
surfaces were tested in order to observe the effect of contact with serum on 
crystallinity. The same electrochemical deposition method used for porous flanges 
described in section 5.2.2 was used. Adsorption of fibronectin onto disc surfaces was 
performed by addition of a 20 μL droplet containing 500 ng of fibronectin. XRD 
analysis was performed using a Brüker D8 Advance Diffractometer (Brüker, UK) 
operated with Ni-filtered Cu Kα radiation. Data were collected from 2θ 10° to 100° 
with a count time of 0.1 seconds per point with a Brüker Lynx Eye detector. Due to 
the detection of background noise, further data collection was carried out for HA, 
HAAg and HAAgP24 with a longer count time of 1 second per point. Peaks in the 
resultant diffraction patterns were identified by comparison with pure Ti, HA and Ag 
diffraction patterns from the Inorganic Crystal Structure Database (ICSD). 
 
5.2.3.6  Wettability 
Fresh samples of the same surfaces (on solid discs) that underwent XRD analysis 
were assessed. The KSV CAM 200 goniometer (KSV Instruments, Finland) was 
used for contact angle measurement. A precision syringe was used to allow precise 
control over the volume of a droplet of ultrapure water that was placed on each disc 
surface. Images were collected each second for 10 seconds. The CAM 200 computer 
software was used to measure the contact angle between the droplet and the surface 
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(on both the left and the right side of the droplet). Figure 5.2 shows the angles 
measured for contact angle measurement. 
    
  
Figure 5.2 Contact angle measurement. A lower contact angle (θ) indicates 
increased hydrophilicity (i.e. wettability): (a) a hydrophilic surface and (b) a 
hydrophobic surface. 
 
5.2.4  Statistical Analysis 
Data were analysed using SPSS, version 21.0 for Windows (Chicago, US). As 
described in the previous chapters of this thesis, non-parametric tests were performed 
as the data did not fit assumptions for parametric testing. The Kruskall Wallis test 
was used to determine if differences existed between the groups. Mann-Whitney tests 
were used to perform pair-wise comparisons. 
  
a
θ
b
θ
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5.3  RESULTS 
5.3.1  SEM and EDX Analysis 
The electrochemically deposited coatings on the porous titanium alloy flanges 
contained a combination of plate-like, needle-shaped and globular crystals similar to 
that observed on solid discs for the in vitro experiments from Chapter Three. The 
coatings on the porous flanges were more uniform in their appearance than those 
seen on the solid discs. EDX analysis showed that there was no significant difference 
in the percentage silver content between PT-HAAg +/- Fn and the HAAg100 +/- Fn 
coatings used for the in vitro experiments (Kruskall Wallis Test: weight percentage 
p=0.357, atomic percentage p=0.611). (Table 5.1). The median calcium:phosphate 
atomic percentage ratio for electrochemically deposited HA coatings was 1.74 (95% 
confidence interval 1.62 to 1.86).  The median calcium:phosphate weight percentage 
ratio was 2.25 (95% confidence interval 2.09 to 2.41).  This indicated that these HA 
coatings were close in composition to pure stoichiometric HA. SEM images are 
shown in Figure 5.3. There were no statistically significant differences between the 
thickness of the coatings (p=0.336). However, there was a non-significant trend that 
PT-HAAg coatings were thicker than PT-HA coatings (p=0.645 outer surface 
p=0.161 inner surface) and coatings on the outer surface of implants were thicker 
than coatings on the inner pores (p=0.161 PT-HA, p=0.798 PT-HAAg). Table 5.2 
summarises the thickness of the coatings. SEM images of resin-embedded implants 
with coatings are shown in Figure 5.4. 
 
Surface Ag Atomic % median value 
 and (95% confidence interval) 
Ag Weight % median value 
 and (95% confidence interval) 
HAAg100  
(in vitro disc) 
0.665 (0.527 to 0.723) 2.985 (2.416 to 3.286) 
HAAgFn100  
(in vitro disc) 
0.595 (0.500 to 0.7111) 2.630 (2.160 to 3.098) 
PT-HAAg  
(in vivo flange) 
0.700 (0.582 to 0.757) 3.175 (2.672 to 3.405) 
PT-HAAgFn  
(in vivo flange) 
0.610 (0.591 to 0.652) 2.950 (2.854 to 3.119) 
Table 5.1  Silver percentages within HAAg coatings measured by EDX analysis. 
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Figure 5.3  Scanning electron micrographs of flanges (a and b) Uncoated PT (c and 
d) PT-HA (e and f) PT-HAAg (g and H) PT-HAAgFn.  
 
a b
 c  d
 e  f
 g  h
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Surface Coating Thickness (μm)  
median value and (95% confidence interval) 
PT-HA  
(outer surface) 
47 (30 to 76) 
PT-HA  
(inner pores) 
36 (12 to 55) 
PT-HAAg  
(outer surface) 
56 (24 to 101) 
PT-HAAg  
(inner pores) 
46 (31 to 82) 
Table 5.2  Thickness of coatings. 
     
 
  
Figure 5.4  SEM images of resin-embedded implants with coatings. (a) PT-HA 
(outer surface of implant). (b) PT-HA (inner pores). (c) PT-HAAg (outer surface of 
implant).  (d) PT-HAAg (inner pores). 
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HA coating!
PT!
b! Resin!HA coating!
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5.3.2   Silver Release 
The silver release was greatest over the first 24 hours and then gradually reduced 
over time. The release rate was slowest between days 11 and day 28. Silver 
continued to be released from PT-HAAg throughout the whole 28-day test period. 
The release of silver from PT-HAAg over the 28 days is presented in Figure 5.5. 
Negligible amounts of silver were released from the HA-coated control implant 
(0.025 μmol/L at 48 hours).  
 
 
Figure 5.5  Box-and-whisker plot showing the release of silver from PT-HAAg over 
28 days.  
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5.3.3  Absolute Silver Content of Coatings 
The HA control contained negligible amounts of silver (11.19 μmol/L), whereas the 
median silver content of HAAg and HAAg P24 was 362.67 μmol/L and 240.76 
μmol/L respectively. Due to the low n number, the differences between these 
coatings were not statistically significant (p=0.276). 
 
 
Figure 5.6  Box-and-whisker plot showing the silver content of coatings. 
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5.3.4  X-ray diffraction analysis 
XRD analysis of HA and HAAg coatings showed peaks at 31.8°, 32.3° and 33° 
corresponding to the presence of hydroxyapatite. The addition of fibronectin did not 
result in any differences to XRD patterns. Results from HAAg coatings showed 
peaks at 38.1°, 38.3° and 44.5° corresponding to the presence of silver. The HA peak 
intensity relative to titanium peaks was greater for HAAg coatings than for HA 
coatings which indicated that HAAg coatings were thicker. Preconditioning did not 
affect the crystallinity of these coatings. Figure 5.7 shows XRD patterns. 
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Figure 5.7  XRD patterns for (a) HA, HAAg and HAAg (P24) (b) Zoomed-in image 
to highlight silver peaks. 
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5.3.5  Wettability 
The uncoated Pol surfaces were significantly more hydrophobic than HA+/-Ag+/-Fn 
(p<0.05. Exact individual p values are shown in Appendix 5). HA+/-Ag+/-Fn 
surfaces were very hydrophilic with low contact angles. Preconditioning did not 
significantly affect the wettability of HAAg or HAAgFn (p=0.310 and p=0.171 
respectively). Overall, there were no significant differences in wettability between 
HA+/-Ag+/-Fn surfaces (Table 5.3 and Figure 5.8). 
 
Surface Contact Angle (°)  
median value and  
(95% confidence interval) 
Pol 74.86 (70.36 to 79.35) 
HA 10.91 (1.38 to 15.34) 
HAFn 8.69 (-5.98 to 46.64) 
HAAg 10.11 (2.44 to 13.55) 
HAAgFn 9.45 (1.30 to 13.98) 
HAAg (P24) 17.09 (0.35 to 37.30) 
HAAgFn (P24) 12.79 (11.18 to 14.23) 
Table 5.3  Contact angles for each surface. 
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Figure 5.8  Images of contact angles taken with the CAM 200, KSV Instruments  
(a) Pol (b) HA (c) HAFn (d) HAAg (e) HAAgFn (f) HAAgFn (P24).  
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5.4  DISCUSSION 
SEM and EDX Analysis 
This study has shown that electrochemical deposition is able to produce HA and 
HAAg coatings throughout the porous titanium alloy structures with a similar 
morphology and composition to the coatings produced on the solid discs used in the 
in vitro chapters of this thesis. The HAAg produced in the in vitro section of this 
thesis supported viable fibroblast growth after serum-preconditioning and had 
bactericidal activity. The electrochemical deposition technique produced coatings 
with median thicknesses of less than 50 µm throughout the porous structures. It is 
possible that altering the thickness of coatings may influence the effects of the 
coatings on promoting tissue attachment. Svehla et al (2002) found that increasing 
the thickness of HA coatings from 50 to 100 µm increased bone fixation and 
ongrowth and resulted in less resorption of the coating (Svehla et al 2002). It is not 
known whether increasing the HA and/or HAAg coating thickness would have a 
similar affect on soft tissue integration. It is also unclear how bacterial colonisation 
would be affected by increasing the thickness of these coatings. It was decided not to 
attempt to achieve a thicker coating as increasing the thickness further would reduce 
the space within the pores for soft tissue infiltration which could potentially 
counteract the effect of the selected pore size of 700 µm on soft tissue integration. 
Furthermore, it has been shown that bonding strength between micro-scale HA 
coatings and metal substrates decreases with increasing coating thickness (Aksakal et 
al 2010; Sonmez et al 2014).  
 
Silver Release and Silver Content 
 ICP-MS showed that the greatest amount of silver release occurred within the first 
24 hours. The release rate reduces over time, explaining why preconditioning 
reverses the cytotoxic effect of coatings. The release was sustained over the 28 days 
at a slow rate indicating that the coating persists for 28 days. The levels of silver 
released at 28 days were low (median 4.14 µmol/L) but remained greater than levels 
shown to have bactericidal activity in vitro (Ghani et al 2012). 
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The levels of silver released indicate that the HAAg coatings are unlikely to cause 
systemic toxicity. Normal silver whole blood or serum levels may range up to 10 
µg/L (Parelli and Piolatto 1992). The overall cumulative release of silver at 28 days 
was 229 µmol/L (i.e. 0.0247 µg/L). The release was measured into 5 mL of fetal calf 
serum, which is a very small volume in comparison to the average 70 kg adult human 
blood volume of approximately 5 litres (Pocock and Richards 2004). As a result, the 
amount of silver released from these implants into the blood circulation will be 
diluted by a factor of approximately 1000-fold. Additionally, the proportion of the 
silver released into tissues surrounding the implants (represented by the fetal calf 
serum) that will be absorbed, enter the circulation and be retained is unknown 
(Lansdown 2010). The blood volume is continually replenished in vivo and 90% of 
absorbed silver will be eliminated in faeces through biliary excretion and a smaller 
variable amount of will be excreted in urine (Perrelli and Piolatto 1992; Lansdown  
2010; Ghani et al 2012). The size of the implant will be scaled up for human use but 
not to the extent that will overcome the aforementioned factors. Silver blood levels 
will be measured in vivo in Chapter Six to test this theory. 
 
The median absolute silver content of HAAg-coated flanges was 362.669 µmol/L 
(i.e. a total of 1.813 µmol in the 5 mL). This is equivalent to 0.196 mg, which would 
be a safe overall implant silver load even after scaling the implant up several times 
for use in humans. This implant silver load is well below the No Observable Adverse 
Effect Level (NOAEL) of 10 g silver (World Health Organization, 2003). It is also 
well below the levels previously shown to produce argyria and argyrosis (Gosheger 
et al 2004; Lansdown 2010). The reduction of absolute silver content within HAAg 
coatings was not statistically significant. The small n number (n=3, N=1) would 
account for the fact that these differences were not detected as statistically 
significant. Due to availability of implants, costs and clinical relevance, the 
experiment was not repeated with a larger n number. The information from the 
release study, which showed that silver is released, answered the question as to 
whether silver is lost from the coating.  
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X-ray diffraction analysis 
The HA and HAAg coatings were semi-crystalline with some HA peaks displaying 
intermediate broadness. The X-ray diffraction pattern was not affected by serum-
preconditioning. A more highly crystalline coating would be expected to be less 
resorbable and persist for a longer time period (Overgaard et al 1999; Xue et al 
2004). A further area of study that was not assessed in this chapter is the composition 
of the coatings and the thickness of the coatings after the 28-day period in fetal calf 
serum. The release study has shown that some silver is released for 28 days 
indicating that some coating is present; but the components of the coating remaining 
after 28 days are unknown. It is possible that after 28 days very little coating remains 
and/or that a greater proportion of HA is lost than silver. It could be argued that 
developing a more highly crystalline coating in order to increase the longevity of the 
coating would be beneficial. However, this argument is not necessarily true as that 
the coating only needs to be present for short period. Strictly speaking, the ‘race for 
the surface’ only requires the coating to be present to repel bacteria while promoting 
cells attachment and during the formation of initial cell monolayer. It may not be 
necessary for the HA component of coating to be present for weeks in order for a 
robust soft tissue seal to occur. In vitro (Chapters Three and Four), cell attachment 
and bacterial inhibition is seen to occur within the first 24 hours.  
 
There is conflicting evidence in the literature on the effect of crystallinity on tissue 
ingrowth. A number of studies have shown that decreased crystallinity is associated 
with enhanced bone ingrowth (De Bruijn et al 1994; Overgaard et al 1999). Xue et al 
(2004) showed that increased crystallinity is beneficial for bone tissue integration 
(Xue et al 2004). Chou et al (1999) found that increased crystallinity of HA was 
associated with reduced in vitro fibroblast attachment but lower crystallinity surfaces 
resulted in elevated medium pH, which was associated with reduced fibroblast 
proliferation rates (Chou et al 1999). The variation in results may be due to 
differences in experimental conditions such as coating manufacturing technique, 
purity, thickness and topography.    
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Wettability 
HA and HAAg surfaces were hydrophilic. This was expected due to the surface 
chemistry of HA and further enhancement of the wettability due to roughness 
(Wenzel 1936). Serum-preconditioning did not result in further increases in 
wettability. This suggests that changes in wettability do not contribute to the 
increased cytocompatibility of coatings after preconditioning. Hydrophilicity is 
associated with increased cell adhesion and decreased bacterial adhesion and is 
therefore a desirable characteristic for ITAP flange coatings (Wilson et al 2005; 
Murakami et al 2012; Wu et al 2013).  
 
5.5 CONCLUSION 
This chapter has established that the inner pores of porous titanium alloy flanged 
transcutaneous pins can be coated using electrochemical deposition. The current 
density and time period for the electrochemical deposition process was modified to 
obtain coatings with a morphology and composition that was similar to that achieved 
in the in vitro experiments. Release of non-toxic levels of silver reduced over time 
but continued for 28 days. The coatings were semi-crystalline and hydrophilic. The 
coating method used in this chapter will be used to coat implants for in vivo 
investigation. 
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CHAPTER SIX 
The Effect of Porous Titanium Alloy Transcutaneous Pins 
Coated with Hydroxyapatite, Silver and Fibronectin on Soft 
Tissue Integration: An In Vivo Ovine Model 
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6.1  INTRODUCTION 
The key finding from Chapter Two was that a fully porous titanium alloy structure 
with a pore size of 700 μm and strut size of 300 μm (P700 S300) promotes soft tissue 
ingrowth, cellularity and vascularisation.  This suggests that soft tissue could 
potentially win the ‘race for the surface’ against bacteria on P700 S300 porous 
titanium alloy structures despite the potential of porous materials to increase 
bacterial adhesion (Shin and Akao 1997; Braem et al 2013). However, in a 
transcutaneous pin model there will be greater exposure to bacteria, which may 
affect the outcome of the ‘race for the surface.’ As a result application of 
antibacterial coatings to porous titanium alloy may be beneficial and could have the 
potential to influence soft tissue integration indirectly. In vivo studies are necessary 
to evaluate the effect of porous titanium alloy flanged transcutaneous pins with and 
without HAAgFn coatings before use in humans. Both soft tissue integration and 
bacterial colonisation must be assessed in order the determine the effect on the ‘race 
for the surface.’ This chapter presents an assessment of in vivo soft tissue integration.  
 
A large animal model was used as it was considered to be more representative of 
human clinical conditions than a small animal model. For example, it allowed 
investigation of an ITAP device with a flange consisting of the potential pore sizes 
that would be used clinically. A well-established ovine model was used with ITAP 
pins being inserted through both the near and far cortex of the tibia (Pendegrass et al 
2006a). An amputation model was not used for ethical reasons. Sheep were selected 
as their tibiae are of sufficient length to allow implantation of up to four implants 
along the length of the bone, which is useful when testing multiple coatings and 
allows a reduction in the numbers of animals used. Additionally, sheep have been 
used by a number of research groups for histological studies of soft tissue integration 
as their skin possesses soft tissue characteristics, such as thickness and mobility, 
which are similar to human skin (Larsson et al 2012). A pig model would be an 
alternative as pig skin anato resembles human skin more closely than sheep. In 
particular, pig skin has a sparse hair follicle pattern and the vascular organisation, 
collagen and elastin content is very similar to that of humans (Winter 1974; Avon et 
al 2005; Sullivan et al 2001; Swindle et al 2012). However, their shorter legs would 
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be a significant disadvantage. Comparisons between soft tissue integration into 
porous coated osseointegrated transcutaneous implants in both pig and sheep have 
shown similar cutaneous responses indicating that wound healing mechanisms in 
sheep are similar to pigs (Jeyapalina et al 2012; Holt et al 2013). 
 
Other animal models of soft tissue integration of osseointegrated transcutaneous 
implants studies have found that a porous titanium alloy subdermal barrier reduces 
epithelial downgrowth but that marsupialisation is not eliminated (Jeyapalina et al 
2012; Isackson et al 2011). However, these studies did not assess the effect of fully 
porous titanium alloy and used porous titanium alloy surface coatings with smaller 
pore sizes. Additionally, these studies have compared porous titanium alloy with 
solid implants only and have not made comparisons with drilled holes or studied the 
effect of bioactive or antibacterial coatings (Isackson et al 2011; Jeyapalina et al 
2012).  
 
This chapter aimed to determine whether osseointegrated transcutaneous pins with a 
fully porous titanium alloy flange (P700 S300) reduce epithelial downgrowth and 
increase epithelial attachment, dermal attachment, soft tissue ingrowth and 
vascularisation compared with the standard ITAP drilled flange design. The study 
also aimed to determine if the combination of hydroxyapatite, silver and fibronectin 
coatings would enhance the soft tissue attachment.  The in vitro studies presented in 
Chapters Three and Four  have shown that HA and HAFn coatings promote 
increased fibroblast spreading compared with uncoated titanium alloy. HAFn 
resulted in the greatest fibroblast metabolism. HAAg and HAAgFn coatings are 
antibacterial and support viable fibroblast growth after preconditioning in serum for 
24 hours. HAAgFn was not associated with improved fibroblast viability compared 
with HAAg suggesting that silver may counteract some of the effects of fibronectin. 
However, the effect on in vivo soft tissue attachment cannot be predicted from this in 
vitro data. The in vitro studies also showed that addition of fibronectin resulted in 
increased S aureus colonisation but decreased P aeruginosa colonisation. As a result 
of these findings as well as the finding from Chapter Two that P700 S300 porous 
titanium alloy structures enhance soft tissue integration, it was hypothesised that: 
 181 
 
1. Transcutaneous pins with a porous titanium alloy flange (P700 S300) would 
reduce epithelial downgrowth, increase epithelial and dermal attachment and 
improve soft tissue ingrowth and vascularisation of tissue within pores 
compared with the standard ITAP drilled-hole flange model and a straight 
non-flanged pin.  
 
2. HA coatings would further enhance the effects of PT on soft tissue 
integration and HAFn, HAAg and HAAgFn would improve soft tissue 
integration compared with HA.  
 
3. HAAgFn would not increase the soft tissue integration compared with 
HAAg. This was hypothesised in view of the finding from Chapter Three that 
HAAgFn was not associated with increased fibroblast viability compared 
with HAAg. 
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6.2  MATERIALS AND METHODS 
6.2.1  Transcutaneous Pin Designs and Coatings 
The transcutaneous pin design and coatings described in Chapter Five were used. In 
addition, the current standard ITAP pin (DF) was used as a control. This consists of a 
flat flange with 24 drilled holes (with a diameter of 700 μm) and a tapered 
intraosseous stem. The flange and the stem are coated with plasma sprayed HA 
(Plasma Biotal Ltd, Derbyshire, UK). A straight pin (SP) without a flange was 
included as a control for DF (in order to mirror the surfaces that will be studied in the 
bacterial colonisation study that will be presented in Chapter Seven). Table 6.1 
summarises the implant designs and coatings used. Photographs of the control pin 
designs are shown in Figure 6.1. The surface preparation method described in 
Section 5.2.2 was employed. 
 
Implant and Coating Abbreviation 
Straight pin SP 
Standard ITAP pin (drilled-hole flange) DF 
Porous Ti6Al4V flange PT 
Porous Ti6Al4V flange with HA PT-HA 
Porous Ti6Al4V flange with HAFn PT-HAFn 
Porous Ti6Al4V flange with HAAg PT-HAAg 
Porous Ti6Al4V flange with HAAgFn PT-HAAgFn 
Table 6.1  Summary of transcutaneous pins and coatings. 
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Figure 6.1  Photographs of the control pins (a) SP and (b) DF. 
 
6.2.2  Ovine Model to Assess In Vivo Soft Tissue Attachment 
Skeletally mature female sheep (Mules) n=6 weighing between 66 and 88 kg were 
used. The same premedication and anaesthesia detailed in Section 2.2.2 was used. 
Perioperative analgesia was maintained with fentanyl transdermal patches (75 
μm/hour) (Duragesic®, Janssen Pharmaceuticals, NJ, USA). 
 
6.2.2.1  Surgical Procedure 
Both hindlegs were shaved and prepared with povidone iodine scrub and solution. 
Implants were inserted along the length of the tibiae under aseptic conditions. A 
separate 15 mm longitudinal skin incision over the medial aspect of the tibia was 
made. A periosteal elevator was used to expose the bone. A 4.2 mm hole was drilled 
through both cortices. A conical reamer was used prior to insertion of DF pins. The 
pins were inserted using a T-handle. Flanged implants were positioned with the 
flange placed subdermally. The intraosseous portion of the pins was a self-tapping 
threaded screw with the exception of DF, which was a tapered press-fit implant. The 
skin and subcutaneous tissues were closed with interrupted 2-0 vicryl sutures. Opsite 
spray dressing, mepitel, gauze and a crepe bandage were used to dress the wounds. 
The order of implantation of pins was alternated for each animal in order to account 
a!
 10mm!
b!
 10mm!
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for the usual reduction in soft-tissue thickness from the proximal to the distal end of 
the tibia. Intraoperative photographs showing the insertion of pins are shown in 
Figure 6.2.  
 
      
      
Figure 6.2  Intraoperative photographs showing (a) incision of the skin and 
subcutaneous tissue. (b) Drilling of a 4.2 mm drill-hole into the bone. (c) Insertion of 
a PT-HA pin. (d) Four pins that have been inserted into one tibia.  
 
6.2.2.2  Postoperative course 
Cefalexin was administered for three days postoperatively. The fentanyl patch was 
replaced two days after surgery. The wounds were reviewed weekly to assess for 
clinical evidence of infection. The wounds were re-dressed after each wound review. 
Four weeks postoperatively, the hindlegs were amputated following euthanasia with 
approximately 0.7 mL/kg of intravenous pentobarbitone sodium. A four-week time 
period was chosen in order to allow sufficient time for a soft tissue seal to form. The 
implants were removed en bloc with the overlying soft tissues and the underlying 
a! b!
c! d!
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periosteum and tibia using a hack saw. Care was taken not to disrupt the interface 
between the soft tissue and the implant. 
 
6.2.3  Hard Grade Resin Histology 
6.2.3.1  Histological Processing 
The protocol used in Section 2.2.4 (Appendix 1.1) was used.  
 
6.2.3.2  Histological Sectioning 
The method for histological sectioning described in Section 2.2.4 was used. 
However, instead of a transverse section, a longitudinal section was taken through 
the centre of each specimen. Additionally, the slides were mounted with coverslips 
using Pertex® xylene-based mounting medium (CellPath plc, Hemel Hempstead, 
UK) prior to visualisation with the Zeiss microscope. 
 
6.2.4  Histological Analysis 
Two sections were analysed for each implant. The following outcomes were 
measured:  
(a) Epithelial downgrowth (mm) 
(b) Percentage epithelial attachment 
(c) Percentage subepithelial (i.e. dermal) attachment 
A line intercept method was used to measure epithelial downgrowth, epithelial 
attachment and subepithelial attachment as described by Pendegrass et al (2006) 
(Figure 6.3). The thickness of the epithelial and subepithelial tissue layers was 
measured and the percentage of these layers in contact with the implant surface 
was calculated.  
(d) Percentage soft tissue fill within the inner pores. The semi-quantitative 
assessment described in Section 2.2.4 was used. 
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(e) Number of cell nuclei/mm2 within the inner pores - Fibroblast nuclei were 
counted within a defined area and the number of nuclei per mm2 was 
calculated. 
(f) Number of blood vessels/mm2 within the inner pores - The blood vessels 
were counted within a defined area and the number of blood vessels per mm2 
was calculated. 
 
 
 
Figure 6.3 Schematic diagram showing the measurements for epithelial 
downgrowth, epithelial and subepithelial attachment for a flanged implant (Adapted 
from Pendegrass et al 2006). 
 
6.2.5  Measurement of Silver Blood levels 
Whole blood samples were collected for measurement of silver levels pre-induction 
(day 0) and then daily for three days post-operatively (days 1, 2 and 3). This was 
followed by weekly blood sampling for three weeks (days 10, 17 and 24). A final 
sample was taken prior to euthanasia on day 28. The blood samples were stored in a 
standard trace element tube with EDTA and frozen at -20°C until dispatch for 
analysis. Silver blood levels were measured by ICP-MS (Dr Barry Sampson, Trace 
Element Laboratory, Imperial College London, UK). 
 
Subepithelial !
layer attachment !
Bone!
Implant!
Epithelial !
downgrowth!
Epithelial !
layer !
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6.2.6  Statistical Analysis 
Non-parametric testing as described in Section 2.2.5 of this thesis were used. 
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6.3  RESULTS 
6.3.1  Postoperative Clinical Outcomes 
All sheep remained clinically well throughout the study period. However, one pin 
site in one sheep (a PT implant) was complicated by intraoperative haemorrhage. 
Haemostasis was achieved prior to wound closure following application of pressure. 
There was continued bleeding from the wound during the first five postoperative 
days and a haematoma formed. At three weeks postoperatively, clinical evidence of 
soft tissue infection (i.e. erythema, warmth and a purulent discharge) was observed at 
this pin site. No systemic signs of sepsis were observed, however, the sheep 
displayed signs of pain and intermittently would not bear weight fully on the affected 
limb. A five-day course of intravenous cephalexin was started at this point and the 
signs of infection resolved. There was no clinical evidence of infection or any other 
complications affecting the other sheep or any of the other pins in this sheep. All pins 
were included in the analysis. However, data for epithelial downgrowth for the pin 
that had been complicated by infection was removed by SPSS as an extreme outlier. 
Figure 6.3 shows some examples of the appearance of pin sites from the 
postoperative period.  
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Figure 6.4  Postoperative photographs of pin sites at (a) two weeks, (b) three weeks 
and (c) four weeks. (d) The pin that was complicated by infection at three weeks.  
 
 a!  b!
 c!  d!
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6.3.2  Epithelial Downgrowth 
SP resulted in the greatest degree of epidermal downgrowth. Epithelium was seen to 
migrate from the incised edges vertically down along the entire transcutaneous 
portion of SP implants down to the intraosseous portion. This resulted in a tract 
being present from the exterior down to the bone. DF reduced epithelial downgrowth 
compared with SP (p=0.000). PT resulted in a further reduction in epithelial 
downgrowth compared with DF (p=0.027). The addition of coatings to PT did not 
result in any further reduction in epidermal downgrowth. Similarly to PT, PT-HAFn, 
PT-HAAg and PT-HAAgFn reduced epidermal downgrowth compared with DF 
(p=0.003, p=0.017 and p=0.001 respectively). However, PT-HA did not significantly 
reduce epidermal downgrowth compared with DF (p=0.052). 
 
 
Figure 6.5  Box-and-whisker plot showing the degree of epithelial downgrowth 
associated with each implant. 
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Figure 6.6 (i) Histological sections demonstrating the degree of epithelial 
downgrowth (DG) associated with SP implants. (a) Low magnification image (x2.5) 
showing epithelium separate from side of implant and migrating vertically 
downwards along length of transcutaneous portion. (b) Higher magnification image 
(x20) showing epithelial downgrowth. (c) Epithelium migrating beneath a blood clot 
and fibrinous exudate rich in polymorphonuclear cells (green arrows). (d) The 
epithelium has migrated along the entire length of the transcutaneous portion of the 
implant. The adjacent dermal tissue (D) contains a high-density inflammatory 
infiltrate of lymphocytes, neutrophils, macrophages and foreign body giant cells. 
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DG!
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D!
DG!
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Figure 6.6 (ii) Histological sections demonstrating the degree of epithelial 
downgrowth associated with implants. (e) DF at x2.5 magnification. (f) DF at x40 
magnification. The red arrows indicate the presence of blood and exudate within the 
gap between the epithelium and the implant (g and h). There is reduced epithelial 
downgrowth around PT implants and a reduced amount of blood and exudate in the 
gap between the epithelium and the implant. (i) PT-HA. (j) PT-HAAgFn. 
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6.3.3  Percentage Epithelial Attachment  
SP was associated with the lowest percentage epithelial attachment. DF increased 
epithelial attachment compared with DP (p=0.045). However, there was no 
difference between DF and PT implants irrespective of coating (p=0.859).  A very 
wide variation in percentage epithelial attachment between implants from the same 
group was observed for all implant types, ranging from 0 to 100%.  
  
Implant % Epithelial Attachment 
median value and 
(95% confidence interval) 
SP 0.000     (-10.008 to 26.675) 
DF 63.430   (21.261 to 83.215) 
PT 100.000 (40.339 to 98.679) 
PT-HA 79.055   (29.939 to 89.306) 
PT-HAFn 85.700   (35.580 to 91.102) 
PT-HAAg 100.000 (25.616 to 91.050) 
PT-HAAgFn 40.600   (16.124 to 80.743) 
Table 6.2  Percentage epithelial attachment. 
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Figure 6.7 (i)  Histological sections showing epithelial attachment to implants. (a) 
Lack of epithelial attachment to SP. The epithelial layer (E) terminates within the 
dermis and there is a gap between the implant and the soft tissues. (b) Epithelium 
attaching to the side of a DF implant. (c) Lack of epithelial attachment to a DF 
implant. (d) Failure of the epithelium to attach to a PT implant. The epithelium is 
partly in contact with a clot. 
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Figure 6.7 (ii)  Histological sections showing epithelial attachment to implants. (e) 
Epithelial layer completely in contact with a PT implant. (f) Partial contact between 
the epithelium and a PT-HAFn implant. (g) Epithelium attaching to a PT-HAAg 
implant. (h) Lack of epithelial attachment to a PT-HAAg implant. 
e!    20μm!
PT!E!
 f!  ! 100μm!
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6.3.4  Percentage Subepithelial/Dermal Attachment 
PT-HAFn had the highest median value for percentage dermal attachment (87.6%). 
SP was associated with the lowest median percentage dermal attachment (0%). DF 
was associated with greater dermal attachment than SP (p=0.017). PT was associated 
with greater dermal attachment than DF (p=0.020). The addition of coatings to PT 
did not result in any further statistically significant improvements in dermal 
attachment (HA p=0.590, HAFn p=0.091, HAAg p=0.410, HAAgFn p=0.443). 
There was greater dermal attachment to PT-HA, PT-HAFn, PT-HAAgFn than to DF 
(p=0.014, p=0.002 and p=0.004 respectively), but there was no significant difference 
between PT-HAAg and DF (p=0.089). PT-HAFn improved dermal attachment 
compared with PT-HA (p=0.023). PT-HAAgFn improved dermal attachment 
compared with PT-HAAg (p=0.039). There was no difference between PT-HA and 
PT-HAAg (p=0.977).  
 
 
Figure 6.8  Box-and-whisker plot showing dermal attachment to implants. 
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Figure 6.9 (i)  Histological sections showing dermal attachment to implants. (a) 
Absence of dermal attachment to SP. There is a layer of exudate (arrows) along the 
side of the implant. The migrating epithelium (E) separates the dermis (D) from the 
exudate layer. The dermis contains a heavy infiltration of inflammatory cells. (b) 
Gap between the soft tissues and SP. The arrows indicate polymorphonucelar cells, 
macrophages and lymphocytes within the soft tissues. (c) x100 magnification image 
of inflammatory cells in tissue adjacent to SP. (d) Areas of lack of the dermal 
attachment to the flange of a DF implant (arrows). 
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 198 
  
  
   
Figure 6.9 (ii)  Histological sections showing dermal attachment to implants. (e) 
Dermal tissue has failed to attach to DF. Fewer inflammatory cells are seen within 
the tissue adjacent to DF than within the tissue adjacent to SP. (f) Dermal tissue 
attaching to the transcutaneous portion of PT. (g) Few inflammatory cells are seen 
within the dermal tissue attaching to PT. (h) Dermis attaching to PT-HAFn flange. (i) 
Few inflammatory cells are present within the dermal tissue attaching to a PT-HAAg 
flange. (j) Dermal tissue attachment to the transcutaneous portion of PT-HAAgFn. 
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6.3.5  Percentage Soft Tissue Fill within the Inner Pores 
The percentage soft tissue fill within the inner pores of PT was significantly greater 
than that of DF (p=0.000). The addition of coatings to PT did not result in any 
further increases in percentage soft tissue fill. There was a trend that PT-HAFn was 
associated with a greater median percentage soft tissue fill than PT-HA (90% and 
82.5% respectively) and PT-HAAgFn was associated with a greater median 
percentage soft tissue fill than PT-HAAg (90% and 80% respectively), but these 
differences were not statistically significantly different (p=0.068 and p=0.143). The 
only statistically significant difference between the coatings was that PT-HAFn was 
associated with greater soft tissue fill within the pores than PT-HAAg (p=0.002). 
 
 
Figure 6.10  Box-and-whisker plot showing the percentage soft tissue fill within the 
inner pores of each implant. 
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Figure 6.11 (i)  Histological sections demonstrating the percentage soft tissue fill 
within the inner pores of implants. (a and b) Incomplete soft tissue fill within a DF 
pore (P). (c and d) Intimate contact between PT pore edges and soft tissue PT. 
Increased collagen deposition is seen at the pore periphery. 
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Figure 6.11 (ii)  Histological sections demonstrating the percentage soft tissue fill 
within the inner pores of implants. Soft tissue fills the pores of all PT implants 
irrespective of the coating. There is intimate contact between the pore edges and the 
soft tissue. (e) PT-HA (f and g) PT-HAFn (h) PT-HAAg (i and j) PT-HAAgFn. 
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6.3.6  Number of Cell Nuclei/mm2 within the Inner Pores 
There was a greater cell nuclei density within the inner pores of PT than DF 
(p=0.018).  There were no differences between PT, PT-HA, PT-HAFn, PT-HAAg 
and PT-HAAgFn (p=0.889). 
 
 
Figure 6.12  Box-and-whisker plot showing the number of nuclei/mm2 within the 
inner pores. 
 
 
 
 
            
2
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Figure 6.13  Histological sections demonstrating the cell nuclei density within the 
inner pores of implants. (a) DF has the lowest cell nuclei density. (b) PT (c) PT-
HAFn (d) PT-HAAg. 
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6.3.7  Number of Blood Vessels/mm2 within the Inner Pores  
There was a greater blood vessel density within the inner pores of PT than DF 
(p=0.002).  The addition of coatings to PT did not result in further increases in blood 
vessel ingrowth (p>0.05. Appendix 6.6.2). Similarly to PT, PT-HAFn, PT-HAAg 
and PT-HAAgFn were associated with a greater blood vessel density within the inner 
pores than DF (p=0.001, p=0.005 and p=0.005 respectively); but there was no 
significant difference between PT-HA and DF (p=0.102). PT-HAAg was associated 
with a greater blood vessel density within the inner pores than PT-HA (p=0.024). 
 
 
Figure 6.14  Box-and-whisker plot showing the number of blood vessels/mm2 within 
the inner pores of each implant. 
 
 
             
2
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Figure 6.15 (i)  Histological sections demonstrating the density of blood vessels 
(arrows) within the inner pores of implants. (a) DF has the lowest blood vessel 
density. (b) PT (c) PT-HA (d) PT-HAFn. 
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Figure 6.15 (ii)  Histological sections demonstrating the density of blood vessels 
(arrows) within the inner pores of implants. (e and f) PT-HAAg (g and h) PT-
HAAgFn. 
 
e!   50μm! f!   20μm!
a!   50μm!  50μm!g! h!   20μm!
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6.3.8  Silver Blood Levels  
Trace levels of silver (less than 10 nmol/L) were detected in all blood samples 
throughout the 28-day experimental period. There was no increase in silver blood 
levels postoperatively and there were no statistically significant differences in silver 
blood levels between time periods (p=0.067).  
 
 
Figure 6.16  Box-and-whisker plot showing the silver whole blood levels over four 
weeks.  
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6.3.9  Correlation Analysis 
The Spearman’s rho analysis identified associations between variables. There was a 
negative correlation between dermal attachment and epithelial downgrowth. This 
was significant at the 0.01 level (p=0.000, Correlation Coefficient=-0.439). A 
positive correlation, which was significant at the 0.01 level, was observed between 
dermal attachment and epithelial attachment (p=0.000, Correlation 
Coefficient=0.412). Positive correlations were observed between percentage soft 
tissue fill, cell nuclei density and blood vessel density within the inner pores 
(Appendix 6.7). A weak positive correlation existed between dermal attachment and 
percentage soft tissue fill of the inner pores. This was significant at the 0.05 level 
(p=0.048, Correlation Coefficient=0.246). There was no significant association 
between dermal attachment and cell nuclei density or blood vessel density within the 
inner pores (Appendix 6.7). 
 
 
Figure 6.17  Correlation between dermal attachment and epithelial downgrowth. 
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Figure 6.18  Correlation between dermal attachment and epithelial attachment. 
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6.4  DISCUSSION 
Effect of a Porous Titanium Alloy Flange on Soft Tissue Integration  
This study has shown that using a fully porous titanium alloy flange reduces 
epithelial downgrowth and increases dermal attachment as well as ingrowth of 
vascularised soft tissue into pores compared with the standard drilled-hole ITAP 
flange. This has not been previously shown. The only other study of the effect of the 
ITAP model using a fully porous titanium alloy flange was conducted by Dowling et 
al (2014). In contrast to the findings of this chapter, Dowling et al did not find that 
use of a porous titanium alloy flange significantly decreased epithelial downgrowth. 
However, they did find that the porous titanium alloy flange improved soft tissue 
infiltration, vascularisation and cellularity within pores compared with the standard 
drilled-hole ITAP flange (Dowling et al 2014). They used a P700 S300 structure as 
used in this chapter but the implant consisted of two layers of pores in contrast to the 
dome-shaped flange with four layers of pores used in this study. It is postulated that 
this difference in the shape of the flange was a key factor in the increased success of 
the model used in this thesis. A flange with rounded, smooth edges rather than a 
flange with sharper edges was designed for this study so that the metalwork would be 
less prominent at the edges. Ideally subcutaneous orthopaedic implants should be 
low profile with rounded edges to avoid soft tissue irritation and abrasion, which 
would be detrimental to soft tissue healing (Mudgal and Jupiter 2006; Day and 
Franko 2007; Jupiter et al 2009). The results of this study indicate that this is a 
particularly important consideration for ITAP.  
 
Comparison with Other Porous Titanium Alloy Transcutaneous Pin Models 
The results of the previous studies in the literature on the effect of porous titanium 
alloy transcutaneous pins on soft tissue integration are variable. A lapine model of 
transcutaneous pins with a subcutaneous disc found that a porous titanium alloy 
surface coating with average pore sizes of approximately 400 µm was associated 
with a seven-fold reduction in infection risk compared with uncoated smooth 
implants (Isackson et al 2011). The implants were inserted into the dorsal 
subcutaneous tissues of the rabbits. This study included a bacterial challenge and 
animals were euthanised between five and 14 weeks post-op. Histological 
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assessment demonstrated improved tissue ingrowth into porous coated implants. 
Organised fibrotic capsules that were separate from the implant surface were seen to 
be present around uncoated smooth implants. They did not find any statistically 
significant differences in epithelial downgrowth or soft tissue attachment between 
porous coated and smooth implants. The dermal attachment to the transcutaneous 
portion of the pins was very low for both groups (approximately 5 to 6%) (Isackson 
et al 2011). These poor results may have been due to the infection that was induced. 
The fact that the pins were not bone anchored would be expected to lead to increased 
interfacial motion, which would also affect the results. A study of porous titanium 
rods (pore sizes ranging from 40 to 160 µm) inserted into the backs of rats found 
approximately 30% soft tissue ingrowth after three weeks and 50% at four to six 
weeks (Farrell et al 2014). The results with the larger pore sizes and the flanged 
design used in this chapter were considerably better. However, the lack of bone-
anchoring and differences between species may also contribute to the discrepancy in 
results.  
 
Jeyapalina et al (2012) used a bone-anchored transcutaneous pin model in sheep. 
They found that a porous titanium alloy surface coating eliminated infection of 
transcutaneous pins with a subdermal disc implanted into sheep metacarpals 
compared with a 25% infection rate of their solid pins. However, they found that 
marsupialisation was present around all implants. They found that epithelial 
downgrowth was reduced around porous-coated implants, but did not report whether 
the reduction was statistically significant. Photographs of the implants showed the 
lack of a seal with visible migration of the solid control implants and also the porous-
coated implants to a lesser degree. They did not report data on epithelial and dermal 
attachment (Jeyapalina et al 2012). On clinical assessment of the pin sites from this 
chapter, the epithelial migration was not visible, (this was only visible 
microscropically). This could be interpreted to suggest that the fully porous design 
and the larger pore sizes used in this chapter were advantageous. However, the fact 
that Jeyapalina et al used a load-bearing amputation model that continued for nine 
months is likely to have affected the results and therefore, it is difficult to make 
direct comparisons. 
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Effect of Hydroxyapatite, Silver and Fibronectin Coatings on Soft Tissue Integration  
The coatings studied in this chapter did not have any statistically significant 
advantages over PT. The median dermal attachment of PT was 80% and the median 
soft tissue fill of inner pores was 90%. The median epithelial downgrowth was 1.2 
mm. It may be difficult to achieve significant improvements or 100% soft tissue 
attachment with the model used in this chapter. In this animal model, the sheep 
mobilised fully weight-bearing from the first postoperative day. Although this is not 
an amputation model, weight-bearing that occurred would create some movement at 
the skin-implant interface before the soft tissue-implant seal had been able to form. 
In humans there would be a rest period where the implant is not loaded during the 
early wound-healing period.  For this reason, it may be unrealistic to achieve better 
results with this model. There is also more exposure to bacteria than there would be 
in humans as inevitably dressings become soiled during the immediate postoperative 
period in sheep, whereas in humans care is taken to avoid this. Additionally, cleaning 
of pins sites was not included in this model. In human clinical practice, regular 
cleaning of pins sites is a strategy that may prevent infection and hence enhance the 
soft tissue seal (Ferreira and Marais 2012). 
 
Hydroxyapatite 
Although there were no statistically significant differences when coatings were 
added to PT, PT-HA lost some of the beneficial effects associated with PT. The 
reduction in epithelial downgrowth associated with PT-HA compared with DF was 
not statistically significant. PT and all other coatings reduced epithelial downgrowth 
significantly. Additionally, PT-HA was the only PT implant that was not associated 
with significantly improved blood vessel ingrowth compared with DF. Previous 
studies have found that HA has a favourable effect on soft tissue integration (Oddy et 
al 2005; Pendegrass et al 2006a; Smith et al 2006; Larsson et al 2012). Moroni et al 
(2001) showed that HA coated external fixator pins reduce the rate of pin tract 
infection (Moroni et al 2001). They did not measure soft tissue attachment but 
showed that improved strength of fixation at the bone-pin interface corresponded 
with reduced infection. It can be speculated that the reduced infection may be due to 
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an improvement in the soft tissue-implant seal due to less motion at the interface due 
to the improved osseointegration. Smith et al (2006) found that fully HA coated 
transcutaneous pins increased dermal attachment despite also increasing bacterial 
colonisation (Smith et al 2006).  
 
The negative effect of HA may be due to increased bacterial colonisation. It is 
postulated that the combination of HA with PT that are both known to promote 
bacterial colonisation resulted in a sufficient increase in bacterial colonisation to 
allow bacteria to win the ‘race for the surface.’ This is investigated in Chapter Seven. 
It was considered that the rough surface topography of the electrochemically 
deposited HA may have contributed to the less favourable soft tissue attachment 
observed as fibroblast attachment has been shown to be impaired on rougher surfaces 
(Ranella et al 2010; Chimutengwende-Gordon et al 2011; Teng et al 2012). 
However, it is unclear how this would contribute to reduced soft tissue integration as 
the surface chemistry and wettability of the HA would be expected to overcome the 
effects of the roughness. Several in vivo studies have found that roughness does not 
reduce soft tissue attachment or reactions (Zitzmann et al 2002; Abrahamsson et al 
2002; Kim et al 2006). Another alternative potential explanation for the effect of HA 
that was considered is that the HA coatings release debris, which over time leads to a 
foreign body reaction that is detrimental to soft tissue integration. However, a foreign 
body reaction was not observed around PT-HA implants in this study. 
 
Fibronectin 
PT-HAFn did not have a negative effect although, similarly to HA, HAFn would be 
expected to promote adhesion of some bacterial strains. The in vitro sections of this 
thesis have shown that fibronectin has a variable effect on different bacterial strains, 
increasing colonisation of gram-positive bacteria while decreasing gram-negative 
bacterial colonisation. The effect that the fibronectin has on bacterial colonisation 
thus depends on the bacteria in the vicinity of the implant. It is expected that the 
sheep would be exposed primarily to Staphylococci (Smith et al 2006). Therefore, a 
net overall increase in bacterial colonisation would be expected. It is possible that 
when fibronectin is added to HA, despite its potential to increase bacterial 
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colonisation, cells are able to win the ‘race for the surface’ due to earlier soft tissue 
adherence. This would lead to reduced bacterial colonisation and allow HAFn to 
overcome any loss of beneficial effects associated with HA. 
 
HAFn and HAAgFn significantly improved dermal attachment compared with HA 
and HAAg respectively. This is interesting as it shows that fibronectin is not 
completely counteracted by silver as indicated by the in vitro study. The fact that 
fibronectin had an effect with HAAg in vivo but not in vitro may be associated with 
the longer duration of the in vivo study. A higher concentration of fibronectin may 
have a greater effect on soft tissue attachment but this may also risk further increases 
in bacterial colonisation.  
 
Silver 
HAAg coatings did not produce any adverse soft tissue reactions and silver blood 
levels were negligible. This indicates that the levels of silver used in this study are 
safe. PT-HAAg was associated with increased vascularisation within the inner pores 
compared with PT-HA. Additionally, PT-HAAg (and PT-HAAgFn) maintained the 
beneficial effects that PT had on epithelial downgrowth and vascularity over DF that 
PT-HA had lost. This indicates that silver had some effect. However, PT-HAAg did 
not result in greater percentage dermal attachment than DF. The effect of silver 
coatings without HA or increasing the concentration of silver may have a different 
effect. Alternative coating methods that could potentially be used to coat porous 
implants with silver while producing a sustained release similar to that observed with 
electrochemical deposition include covalently bonding silver to the implant surface 
using a silanisation technique (Antoci et al 2007a; Antoci et al 2007b; Juan et al 
2010) sol-gel coating (Babapour et al 2011), anodisation (Wafa et al 2015) and silver 
nanoparticle coatings (Wang et al 2014).  
 
It is possible that despite not having a beneficial effect on soft tissue attachment, 
silver could reduce bacterial colonisation, which could be of value in terms of 
preventing infection. If this were to be the case, the fact that this study has shown 
there is no adverse soft tissue reaction associated with silver would be useful. 
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Although the ‘race for surface’ theory is that soft tissue attachment is inversely 
proportional to bacterial colonisation, in practice the relationship between the two 
variables may be more complex and less predictable. The study by Smith et al (2006) 
illustrates this. Fully HA coated transcutaneous pin resulted in better dermal contact 
than uncoated, partly coated or diamond-like carbon (DLC) coated implants. The 
fully HA coated pins were covered in an exudate deposit and were associated with 
the greatest bacterial colonisation despite the effects on soft tissue attachment. The 
DLC coated pins were associated with the least bacterial colonisation but less soft 
tissue attachment than the HA coated pins (Smith et al 2006). It is expected that a 
more straightforward inversely proportional relationship between tissue integration 
and bacterial colonisation is only seen in the very early stages of soft tissue 
attachment. However, in the very early stages of soft tissue attachment, it is likely 
that a soft tissue seal would not have formed around any implants and differences in 
epithelial downgrowth, soft tissue attachment, cell nuclei and/or vascularisation may 
not be apparent. A study investigating the rate of soft tissue attachment by using a 
time course may be useful and would show the rate of formation of the soft tissue 
seal, which may affect long-term infection rates. 
 
Correlation Between Variables  
As expected, there was a negative correlation between epithelial downgrowth and 
dermal attachment. There was also a positive correlation between epithelial 
attachment and dermal attachment. This correlations were of moderate strength 
(rather than high strength) indicating that increasing dermal attachment alone is not 
necessarily sufficiently reliable to increase epithelial attachment. Adjunctive design 
features to specifically increase epithelial attachment may help to improve success 
rates e.g. coating the transcutaneous portion of the implant with proteins that enhance 
keratinocyte attachment (Gordon et al 2010; Pendegrass et al 2012a).  It was noted 
that the results for epithelial attachment were extremely variable and ranged between 
0 and 100% for all groups. Histology sections also showed that in some cases where 
there was minimal epithelial downgrowth and good dermal attachment, epithelium 
was separate from implant. It is possible that epithelium had attached to the implant 
in these cases, but due to the soft tissue-implant seal not being robust, the epithelial 
attachment was disrupted due to soft tissue movement at the interface. 
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The correlations between pore soft tissue fill, blood vessel and cell nuclei density 
were of moderate strength. Blood vessel and cell density was not significantly related 
to dermal attachment. This suggests that other factors influence soft tissue 
integration. Factors that may contribute include bacterial colonisation and differences 
in soft tissue thickness, movement of soft tissues at the skin-implant interface and 
differences in the speed of wound healing between individual sheep.  
 
Limitations 
The sheep with the pin complicated by infection was treated with intravenous 
antibiotics. It was deemed necessary to take this course of action in the sheep’s best 
interest and to prevent suffering. It is possible that this may have had an effect on the 
results for all the pins implanted into that sheep. It may have also resulted in a 
reduction in the bacterial colonisation around the non-infected pins. An alternative 
course of action would have been to terminate the study at the point that the infection 
occurred (three weeks postoperatively) or to exclude the results of that sheep from 
the study. Terminating the study early potentially may have reduced the time 
available for a soft tissue seal to form. Excluding the sheep from the study would 
have reduced statistical power. Replacing the sheep is not ideal in the interest of 
reducing the numbers of animals sacrificed and did not seem necessary as on 
reviewing the data collected from the sheep treated with antibiotics, they were 
generally in keeping with the findings from the other sheep. In clinical practice, 
differences in the way individual patients respond in terms of wound healing and 
infections occur which require treatment with antibiotics. In a clinical trial, the data 
collected from patients treated for complications such as infection would often be 
included.  
 
Another limitation of this study is that an assessment of mechanical strength of 
attachment was not made. This study measured soft tissue contact rather than 
attachment. An assessment of mechanical strength using peel tests would have 
necessitated a separate cohort of animals because the samples used for histological 
assessment had been embedded in resin and so could not be used for peel testing. As 
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epithelial downgrowth is known to be a key factor leading to infection and failure of 
ITAP, the detection of a reduction in epithelial downgrowth associated with PT 
implants is expected to be a reasonably good predictor for the likelihood of improved 
success of the ITAP. Therefore, in view of results of this chapter showing these 
advantages associated PT, sacrificing more animals in order to do peel tests is not 
necessarily essential. 
 
6.5  CONCLUSION 
This is the first study to demonstrate that a fully porous titanium alloy ITAP flange 
reduces epithelial downgrowth and increases dermal attachment, cell nuclei density 
and blood vessel ingrowth compared with the current standard ITAP model. This is a 
useful finding that has potential to be exploited for clinical application. The addition 
of coatings to PT did not significantly improve soft tissue integration. HA coatings 
resulted in a loss of the favourable effect of PT over DF on epithelial downgrowth 
and vascularisation. PT-HAFn had the highest median value for percentage dermal 
attachment and was statistically significantly better than PT-HA and PT-HAAg but 
was not statistically significantly better than PT. PT-HAAgFn improved dermal 
attachment compared with PT-HAAg demonstrating the potential for fibronectin to 
enhance soft tissue attachment. HAAg coatings did not improve soft tissue 
integration, but did not produce any adverse effects. The effect of these surfaces on 
bacterial colonisation will be presented in the next chapter and will be considered in 
conjunction with the findings from this chapter.  
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CHAPTER SEVEN 
In Vivo Bacterial Colonisation on Porous Titanium Alloy 
Transcutaneous Pins Coated With Hydroxyapatite, Silver 
and Fibronectin 
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7.1  INTRODUCTION 
A range of factors including surface energy, hydrophobicity, porosity and chemical 
composition of biomaterials affect bacterial adhesion and the susceptibility of 
different biomaterials to infection (Oga et al 1993). The finding from Chapter Six 
that a P700 S300 porous titanium alloy flanged transcutaneous pin improves in vivo 
soft tissue integration, indicates that this design feature has the potential to reduce 
infection rates for ITAP patients. Ideally, the porous titanium alloy flanges should 
also be associated with decreased bacterial colonisation, otherwise despite the soft 
tissue integration results, it would not be possible to conclude that infection 
susceptibility is reduced. If the bacterial colonisation were to be increased by porous 
titanium it is likely to affect long-term results adversely. It is particularly important 
to determine the effect on in vivo bacterial colonisation as previous studies have 
found that porous implants promote bacterial colonisation. Shin and Akao (1997) 
found that percutaneous devices composed of porous materials implanted through 
dorsal skin in a canine model increased infection. The pores produced new microbial 
foci as they created microgaps between the material and the tissue before the soft 
tissue grew into the pores. Bacteria were able to invade these microgaps (Shin and 
Akao 1997). In vitro assessment by Braem et al (2013) has demonstrated that porous 
titanium increases bacterial colonisation and that increasing pore size increases this 
effect. They studied porous titanium coatings with pore sizes ranging from 50 to 150 
μm (Braem et al 2013). Cordero et al (1994) found that both porous titanium alloy 
and cobalt-chrome implants implanted into rabbit femora required smaller bacterial 
challenges than polished surfaces to induce infection. Cobalt-chrome implants were 
easier to infect, requiring 40 times fewer bacteria to induce infection than polished 
implants, whereas porous titanium alloy implants required 15 times fewer bacteria. 
The authors considered that this was due to the ‘race for the surface’ theory as 
cobalt-chrome is less biocompatible than titanium (Cordero et al 1994).  
 
In theory, it is reasonable to expect that soft tissue would have a better chance of 
winning ‘the race for the surface’ on a porous titanium alloy flange than on a 
standard drilled-hole flange due to its effects on enhancing soft tissue integration. In 
practice, surfaces that increase soft tissue attachment may simultaneously increase 
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bacterial colonisation. For example, HA is well known to increase in vivo 
osseointegration but has been shown to also increase in vivo bacterial colonisation 
(Laure et al 2008). Wilke et al (1993) found that HA coatings increased bacterial 
colonisation while simultaneously resulting in good osseous ingrowth (Wilke et al 
1993). Vogely et al (2000) found that HA-coated implants implanted in rabbit tibiae 
increased bacterial colonisation despite being biocompatible (Vogely et al 2000). 
Despite this, there has been some promising data on the use of porous titanium. As 
discussed in the previous chapters of this thesis, studies have shown that 
osseointegrated percutaneous pins with porous titanium alloy coated subdermal 
barriers decrease infection rates, although these studies have not quantified bacterial 
numbers (Jeyapalina et al 2012; Isackson et al 2011). Furthermore, these studies did 
not use fully porous implants and used smaller pore sizes than those in this thesis. 
Consequently, the effect on bacterial colonisation in this study may be different. 
 
The soft tissue integration findings associated with the addition of hydroxyapatite, 
silver and fibronectin coatings to PT flanges may be explained by bacterial 
colonisation differences as discussed in Chapter Six. The studies described above 
have shown that hydroxyapatite is associated with increased bacterial colonisation 
(Wilke et al 1993; Vogely et al 2000; Laure et al 2008).  This may account for the 
finding that HA coatings resulted in a loss of the favourable effect of PT over DF on 
epithelial downgrowth and blood vessel ingrowth. Conversely, other studies have 
demonstrated that hydroxyapatite and other calcium phosphate ceramics have an 
antimicrobial effect in vitro (Opalchenova et al 1996; Opalchenova et al 1996b; 
Arciola et al 1999). These findings suggest that variations in the surface properties or 
topography of different hydroxyapatite coatings may result in different effects on 
bacterial colonisation. In this study, there were no significant differences in soft 
tissue integration between PT-HAAg and PT, but this result does not necessarily 
indicate that bacterial colonisation will be similar on these two surfaces. As the ‘race 
for the surface’ relationship is not always entirely predictable, the silver-containing 
coatings may have an antibacterial effect despite the soft tissue integration results. 
Porous titanium with sol-gel silver containing coatings have been shown to have 
equivalent biocompatibility to hydroxyapatite while having an antibacterial effect 
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(Qu et al 2011). Moojen et al (2009) found that hydroxyapatite-tobramycin coatings 
had a significant antibacterial effect compared with hydroxyapatite in a lapine model. 
However, these coatings did not significantly improve bone contact compared with 
hydroxyapatite (Moojen et al 2009). 
 
The aim of this chapter was to assess the bacterial colonisation on porous titanium 
alloy flanged transcutaneous pins coated with combinations of hydroxyapatite, silver 
and fibronectin coatings.  
 
In view of the findings from Chapter Six, it was hypothesised that: 
1. DF would decrease bacterial colonisation compared with SP and PT would 
decrease bacterial colonisation compared with DF.  
 
2. PT-HA would not decrease bacterial colonisation compared with DF; but PT-
HAFn, PT-HAAg and PT-HAAgFn would decrease bacterial colonisation 
compared with DF. 
 
3. PT-HAAg and HAAgFn would decrease bacterial colonisation compared 
with PT due to the antibacterial action of the silver.  
 
Fibronectin coatings were not expected to reduce bacterial colonisation significantly 
because apart from the improved dermal attachment no other significant differences 
in in vivo soft tissue integration were demonstrated in Chapter Six. However, due to 
the increased dermal attachment, it was hypothesised that there would potentially be 
a non-significant reduction in bacterial colonisation. 
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7.2  MATERIALS AND METHODS 
7.2.1  Implants and Coatings 
The same implant designs and coatings studied in Chapter Six were used for these 
experiments (Section 6.2.1). 
 
7.2.2  Ovine Model to Assess Bacterial Colonisation 
The ovine model (n=6) and the surgical procedure described in Section 6.2.2 was 
used with a separate cohort of sheep. The sheep weighed between 76 and 97 kg. The 
method was modified by omitting the administration of postoperative antibiotics. 
Dressings were removed at ten days postoperatively. A pilot study (n=1) was carried 
out before proceeding to the n=6 study in order to refine the methods.  
 
7.2.3  Microbiological Sampling 
At four weeks postoperatively, the animals were euthanised (as described in Section 
6.2.2). Following this, soft tissue samples were taken for microbiological analysis. 
All samples were taken using an aseptic technique. 
 
The following samples were taken: 
7.2.3.1  Sample 1: Skin Surface Swab  
A swab of the skin at the skin-implant interface was taken. Care was taken to ensure 
that the swabbing technique was as uniform as possible for each pin site. This sample 
was taken to give an indication as to whether or not each pin came into contact with 
(i.e. was challenged with) a similar number of bacteria from the environment. 
 
7.2.3.2  Sample 2: Superficial Soft Tissue Biopsy  
A biopsy of the superficial soft tissues (epidermis and minimal superficial dermis) 
was taken.  The skin was incised with a No. 15 blade sterile scalpel and a sample of 
approximately 4 mm x 4 mm x 4 mm was taken and weighed. 
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7.2.3.3  Sample 3: Deep Soft Tissue Biopsy  
A biopsy of the deep soft tissues was taken. The dermal tissue at the deepest part of 
the transcutaneous portion of the pin was incised with a fresh No. 15 blade sterile 
scalpel and a sample of approximately 4 mm x 4 mm x 4 mm was taken and 
weighed. For flanged implants this dermal tissue was overlying the flange. For the 
straight pin the dermal tissue was overlying the bone.     
 
7.2.3.4  Sample 4: Deep Soft Tissue-Implant Interface Swab  
 Soft tissue overlying the flange was peeled back with forceps and a No.15 blade 
sterile scalpel. The flange was swabbed taking care to ensure that the swabbing 
technique was as uniform as possible for each pin site. For the straight pin, the 
deepest part of the transcutaneous pin was swabbed. 
 
7.2.3.5  Sample 5: The Retrieved Implant  
After the above samples were taken, the implant was retrieved. 
 
7.2.4  Microbiological Analysis of Samples 
7.2.4.1  Direct Colony Counts 
Samples 1, 2, 3 and 4 were sonicated in phosphate buffered saline for four minutes. 
The tissue samples (2 and 3) were weighed prior to this. After sonication, the 
phosphate buffered saline samples were serially diluted over a 5-log range and plated 
onto Columbia horse blood agar. The undiluted sample was also plated. After 
incubation of the agar plates at 37°C for 24 hours, the colonies were counted. For 
samples 1 and 4, cfu/mL was calculated. For samples 2 and 3, cfu/mL per mg of 
tissue was calculated.  
 
7.2.4.2  Bacterial Identification 
Agar plates were inspected and each morphological type of colony was sampled and 
identified. The following assays were performed to identify bacterial strains: gram 
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staining, the catalase reaction, the oxidase test, the DNase test and methicillin 
sensitivity testing. Analytical Profile Indexing (API) identification kits (Biomérieux, 
France) were used for final identification of the bacterial strains. The protocols for 
conducting each of these tests are presented in Appendix 1.3. 
 
7.2.4.3  Scanning Electron Microscopy 
Sample 5, the retrieved implant, was prepared for SEM by fixation in formalin for 24 
hours followed by the protocol described in Appendix 1.2. SEM was carried out to 
identify the presence of bacteria and to visualise any biofilms that had formed. 
 
7.2.5  Statistical Analysis 
The statistical analyses described in section 2.2.5 were performed. Correlation 
analysis between variables from this chapter and variables from Chapter Six was 
carried out. A post hoc Benjamini-Hochberg test was used to adjust for correlations 
(as more than 20 comparisons were made). 
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7.3  RESULTS 
7.3.1  Direct Colony Counts 
7.3.1.1  Skin Surface Swab 
There were no statistically significant differences between numbers of bacteria on 
the surface of the skin at each pin site (p=0.255). 
 
 
Figure 7.1  Results for colony forming units per mL for the skin surface swabs from 
each pin type. 
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7.3.1.2  Superficial Soft Tissue Biopsy  
There was no statistically significant difference in the numbers of bacteria colonising 
the superficial soft tissues around SP and DF (p=0.355). PT was associated with 
significantly reduced superficial soft tissue bacterial colonisation compared with DF 
(p=0.000). PT-HAAg was also associated with significantly reduced superficial soft 
tissue bacterial colonisation compared with DF (p=0.000). PT-HA, PT-HAFn and 
PT-HAAgFn were not associated with a significant reduction in bacterial 
colonisation compared with DF (p=0.079, p=0.556 and p=0.171 respectively). There 
were greater numbers of bacteria colonising the superficial soft tissues around PT-
HA and PT-HAFn than around PT (p=0.000 and p=0.019). There was no difference 
between either PT-HAAg or PT-HAAgFn and PT (p=0.602 and p=0.259). PT-HAAg 
reduced bacterial colonisation compared with PT-HA and PT-HAFn (p=0.011 and 
p=0.022). PT-HAAgFn did not have this beneficial effect over PT-HA and PT-HAFn 
(p= 0.673 and p=0.343). 
 
 
Figure 7.2  Results for colony forming units per mL (per mg of tissue) within the 
superficial soft tissues around each pin type. 
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7.3.1.3  Deep Soft Tissue Biopsy  
There was no statistically significant difference between SP and DF (p=0.224). PT, 
PT-HAFn, PT-HAAg and PT-HAAgFn all reduced bacterial colonisation compared 
with DF (p=0.000). PT-HA did not reduce bacterial colonisation compared with DF 
(p=0.135) and was associated with increased bacterial colonisation compared with 
PT (p=0.008). However, there were no differences between PT and PT-HAFn, PT-
HAAg or PT-HAAgFn (p=0.526, p=0.901 or p=0.766). PT-HAFn, PT-HAAg and 
PT-HAAgFn were all associated with less bacterial colonisation than PT-HA 
(p=0.007, p=0.009 and p=0.020). There was no difference between PT-HAFn and 
PT-HAAg (p=0.861); or between PT-HAFn and PT-HAAgFn (p=0.539) or between 
PT-HAAg and PT-HAAgFn (p=0.830).  
 
 
Figure 7.3  Results for colony forming units per mL (per mg of tissue) within the 
deep soft tissues around each pin type. 
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7.3.1.4  Deep Soft Tissue-Implant Interface Swab  
DF did not reduce bacterial colonisation compared with SP (p=0.938). PT with and 
without all coatings was associated with reduced bacterial colonisation compared 
with DF (p=0.000). The addition of coatings to PT did not affect the bacterial 
colonisation (HA p=0.815, HAFn p=0.839, HAAg p=0.075, HAAgFn p=0.357). PT-
HAAg reduced bacterial colonisation compared with PT-HA (p=0.012). There were 
no other differences between the coatings. 
 
 
Figure 7.4  Results for colony forming units per mL for the deep skin-implant 
interface swabs for each pin type. 
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7.3.2  Bacterial Identification 
A mixed growth of bacteria was identified. The bacteria present were predominantly 
Staphylococci. Four strains of S xylosus and one strain each of S sciuri, Micrococcus 
spp. and S lentus were cultured from samples from all six sheep. In addition S hyicus 
and  E coli were present on samples from one sheep, a fifth strain of S xylosus was 
present on samples from another two sheep and a second strain of S sciuri was 
present on samples from another sheep (Table 7.1). 
 
Sheep ID no. 
 
Gram 
Stain 
Catalase Oxidase DNase Methicillin 
Sensitivity 
API ID 
6144/6164/6241/ 
6222/6185/6135 
Gram + 
cocci 
+ - - S 
 
S xylosus 
6736552 
6144/6164/6241/ 
6222/6185/6135 
Gram + 
cocci 
+ - - S S xylosus 
6736542 
6144/6164/6241/ 
6222/6185/6135 
Gram + 
cocci 
+ - - S S sciuri 
6336510 
6144/6164/6241/ 
6222/6185/6135 
Gram + 
cocci 
- weak + 
 
- S Micrococcus 
spp 0006100 
6144/6164/6241/ 
6222/6185/6135 
Gram + 
cocci 
+ - - S S xylosus 
6734542 
6144 
 
Gram + 
cocci 
+ - - S S xylosus 
6536672 
6144 
 
Gram + 
cocci 
+ + + S S sciuri 
6136110 
6241 
 
Gram + 
cocci 
+ - - S S hyicus 
6516051 
6241 
 
Gram - 
bacilli 
+ - - R E coli 
5144572 
6222/6185 
 
Gram + 
cocci 
weak + - - S S xylosus 
6776552 
6144/6164/6241/ 
6222/6185/6135 
Gram + 
cocci 
+ - - R S lentus 
6777750 
Table 7.1 Bacterial strains identified from sheep pin sites (+ = positive, - = negative, 
S = sensitive, R = resistant). 
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7.3.3  Correlation Analysis 
The Spearman’s rho test showed the following correlations between variables that 
were significant at the 0.01 level. There was a positive correlation between the 
numbers of bacteria within the superficial soft tissues and the deep soft tissue 
(p=0.000, Correlation Coefficient=0.470). There was a positive correlation between 
the numbers of bacteria within the deep soft tissues and the deep swab of the skin-
implant interface (p=0.000, Correlation Coefficient=0.433). There was a positive 
correlation between the numbers of bacteria within the superficial soft tissues and the 
deep swab of the skin-implant interface (p=0.000, Correlation Coefficient=0.385). 
The numbers of bacteria isolated from the skin surface swab did not correlate 
significantly with the numbers of bacteria from the soft tissues or the deep skin-
implant interface swab (p>0.05. Correlation Coefficients and p values are shown in 
Appendix 7.5). 
 
The analysis of the results from this chapter in conjunction with those from Chapter 
Six showed that there was a positive correlation between the numbers of bacteria 
from the deep swab of the skin-implant interface and epithelial downgrowth 
(p=0.000, Correlation Coefficient=0.437). There was a negative correlation between 
the deep swab bacterial numbers and percentage dermal attachment (p=0.008, 
Correlation Coefficient=-0.297). Bacterial colonisation within the superficial soft 
tissues correlated negatively with cell nuclei density (p=0.012, Correlation 
Coefficient=-0.327) and with blood vessel density (p=0.001, Correlation 
Coefficient=-0.412). The relationships between bacterial colonisation within the 
superficial or deep soft tissues and percentage epithelial or dermal attachment were 
not statistically significant (Appendix 7.5).  
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7.3.4  Scanning Electron Microscopy 
Bacteria were seen to be present on the surface of all implants. Heavy bacterial 
growth was observed on SP and DF implants and also less commonly on PT-HA 
implants. Sporadic smaller pockets of bacterial growth were observed on PT, PT-
HAFn, PT-HAAg and PT-HAAgFn but there did not appear to be a clear difference 
between the amount of bacteria observed on these four implant types. At the time of 
extraction of the implants, it was noted that there was more resistance to removal of 
the soft tissues from PT flanges (irrespective of coating) than from SP or DF 
controls. Residual soft tissue adhesion was observed on PT flanges under SEM (with 
the exception of the area where the deep soft tissue biopsy had been taken). Minimal 
soft tissue adhesion was visible on SP and DF implants. Blood clots and 
inflammatory cells were seen on SP. Extracellular polymeric substance was not 
visualised on any surfaces. 
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Figure 7.5 (i)  Scanning electron micrographs of retrieved bacteria. (a) Bacterial 
colonisation within a fibrinous exudate on SP. (b) Blood clot covering the surface of 
SP. (c) Monocytes on the surface of SP. (d) Heavy bacterial growth on SP. (e) 
Clusters of bacteria colonising a DF pin. (f) DF flange at low magnification (x70) 
showing the absence of soft tissue adhesion.  
 
a! b!
c! d!
e! f!
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Figure 7.5 (ii)  (g) DF flange at x4000 magnification showing the presence of 
bacteria and erythrocytes. (h) PT pin surface. (i) Soft tissue adhering to PT flange at 
x500 magnification. (j) Few bacteria are seen on a PT flange at x4000 magnification. 
(k) Heavy bacterial growth and erythrocytes on soft tissue covering the surface of a 
PT-HA flange. (j) Small pockets of bacteria are seen on the soft tissue covering a PT-
HAAgFn flange. 
 
 
 
g! h!
i! j!
k! l!
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7.4  DISCUSSION 
The key finding of this chapter is that PT significantly reduces bacterial colonisation 
within the superficial and deep soft tissues and on the surface of the flange compared 
with DF. This suggests that modification of the current design of ITAP to include a 
PT flange may reduce the susceptibility to infection. There were some negative 
correlations between bacterial colonisation and soft tissue integration variables. 
However, the correlations between some of these variables were weak and/or not 
statistically significant. This may be due to the fact that some surfaces that promoted 
soft tissue integration were also still able to support bacterial colonisation. For 
example, although DF was shown in the previous chapter to improve soft tissue 
integration compared with SP, it did not reduce bacterial colonisation compared with 
SP. This demonstrates the complexity of the ‘race for the surface’ where in some 
cases the relationship between tissue integration and bacterial colonisation is not 
predictable as tissue and bacteria may attach simultaneously.  
 
The addition of coatings to PT did not result in further significant reductions in 
bacterial colonisation. PT-HA was associated with greater bacterial colonisation than 
PT but did not increase soft tissue integration and resulted in a loss of the favourable 
effects of PT over DF on epithelial downgrowth and blood vessel ingrowth. 
Therefore, this method of HA-coating for PT is not recommended. Surface charge 
may be responsible for the increased bacterial colonisation observed on PT-HA. 
Hydroxyapatite is positively charged due to the presence of calcium and phosphate 
and as a result negatively charged bacteria are attracted to the surface (Clark et al 
1978; Oga et al 1993). The porosity and surface area of hydroxyapatite coatings also 
promotes bacterial colonisation (Vogely et al 2000).  
 
It could be argued that this study did not provide clear information about biofilm 
formation. SEM revealed the presence of bacteria but it was not possible to conclude 
that biofilm formation had occurred on any of the surfaces tested. Clusters of bacteria 
and areas of heavy bacterial growth were observed, but extracellular polymeric 
substance (as had been identified with SEM for the in vitro studies) was not seen. A 
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longer time period or a larger bacterial challenge may have been necessary for 
biofilm (or extracellular polymeric substance) formation to be observed. 
Furthermore, environmental SEM would be more sensitive in detecting the presence 
of extracellular polymeric substance, as the samples would not be dried prior to 
analysis. 
 
 Effects of Control Surfaces 
An interesting finding was that DF did not significantly reduce bacterial colonisation 
compared with SP. This may partly explain the fact that despite improved soft tissue 
integration compared with SP, infection is still a high risk with the current ITAP 
design. A potential reason for this finding is that although DF improves soft tissue 
attachment, it does not improve it to a great enough degree to overcome the effects of 
the drilled holes on promoting bacterial colonisation. Furthermore, DF is coated with 
hydroxyapatite to increase soft tissue integration. As observed with PT-HA, the 
presence of hydroxyapatite may contribute to the bacterial colonisation on DF. The 
effect of an uncoated DF on bacterial colonisation has not been studied. It is possible 
that an uncoated DF could result in less bacterial colonisation but may be associated 
with poorer soft tissue integration. 
 
Fibronectin and Silver 
The effects of fibronectin varied in different ways and at different levels of the pin-
tissue interface.  Both PT-HA and PT-HAFn resulted in an increase in bacterial 
colonisation within the superficial tissues. Within the deeper tissues, PT-HA 
increased bacterial colonisation but PT-HAFn reduced it compared with PT-HA. 
This fits in with the data from Chapter Six, which showed PT-HAFn had its only 
significant beneficial effect on soft tissue integration at the subepithelial level. PT-
HAFn did not have any advantage over PT.  It would appear that PT-HAFn does not 
overcome the negative effect of PT-HA. This again points to the possibility of 
studying the use of PT with fibronectin bonded to it without hydroxyapatite. 
Dowling et al (2014) covalently bonded the RGD sequence of fibronectin to porous 
titanium using a silanisation technique (Dowling et al 2014). They did not study the 
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effect of RGD on bacterial colonisation but studied soft tissue integration. They did 
not find that RGD significantly increased soft tissue integration compared with 
uncoated surfaces but found that RGD coated porous titanium implants produced 
increased soft tissue infiltration, vascularisation and cell density compared with 
drilled hole implants coated with RGD. Porous titanium without RGD improved soft 
tissue infiltration compared with drilled-hole implants but did not have the 
advantageous effect on vascularisation and cell density (Dowling et al 2014). Several 
in vitro studies have shown that when antibacterial surfaces are functionalised with 
RGD, antibacterial activity is retained (Chua et al 2008; Maddikeri et al 2008; Shi et 
al 2008). It would be useful to determine if fewer bacteria colonise RGD coatings 
than fibronectin coatings and if increased concentrations of RGD on porous titanium 
to those used by Dowling et al may enhance soft tissue integration to a greater extent. 
If this were found to be the case, RGD may therefore become a viable alternative to 
fibronectin.  
 
Similarly to PT-HAFn, PT-HAAg did not decrease bacterial colonisation compared 
with PT. However, PT-HAAg significantly reduced bacterial colonisation on the 
flange compared with PT-HA, thus corroborating the suggestion from the Chapter 
Six results that there may be some value in using silver without HA and/or increasing 
the concentration of silver used.  
 
Bacterial Challenge 
A ‘natural’ bacterial challenge from the environment was used rather than 
inoculating the pin sites with bacteria. In clinical practice, humans may be exposed 
to small numbers from bacteria intraoperatively and may also be exposed to bacteria 
from the environment. In this way, this model may be more representative of clinical 
practice in humans. However, it is not possible to ensure that all pins in all sheep are 
exposed to the same number and strains of bacteria. These bacteria would be present 
even if an ‘artificial’ challenge had been used and would affect the results. If an 
‘artificial’ challenge had been used a strain of S aureus that has caused clinical 
infections of ITAPs would have been used to make the model more representative of 
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human conditions.  On an agar plate, the Staphylococci found to be present on the 
sheep are visually indistinguishable from S aureus. It would not be logistically 
possible to type each individual colony as there were thousands of individual 
colonies. As a consequence of this, it would not be possible to know whether the 
bacteria being counted are those from the ‘artificial’ challenge or those from the 
‘natural’ challenge. Additionally, license issues prevented the use of an ‘artifical’ 
challenge in any case. The risk of sepsis with an ‘artificial’ challenge would have 
been greater and it may have been necessary to use a shorter time period in view of 
this. As the time periods for this chapter and the previous chapter were the same in 
order to assess if the results mirrored each other, a shorter time period would have 
potentially meant it would have been too early to detect differences in soft tissue 
integration. 
 
Limitations 
The sheep were exposed to a range of bacteria from the environment in the 
immediate postoperative period. Although they were primarily exposed to 
Staphylococci, the strains were not those most commonly encountered by humans. E 
coli was identified and this has previously caused infection of osseointegrated 
transcutaneous implants (Tillander et al 2010; Brånemark et al 2014). However, this 
was only detected in samples from one sheep. This chapter assessed overall 
differences in numbers of bacteria, rather than differences in the numbers of specific 
strains. It would not have been possible to determine the differences in the numbers 
of individual strains accurately due to the fact that many strains were visually 
indistinguishable on agar plates as described above. As discussed above, there were 
thousands on individual colonies. Consequently, the individual colonies were not all 
typed and only a selection were typed that appeared visually different in order to get 
an idea of the strains present.  It is therefore also possible that other strains were 
present that appeared the same visually to strains that had been typed were not 
identified. Therefore, this chapter is not a detailed microbiological characterisation of 
isolates, but rather a snapshot of the bacteria present on the pins. However, 
identification of a surface that reduces overall bacterial numbers is clinically useful. 
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The conditions in the barnyard were inevitably ‘dirty’ compared with the conditions 
humans would normally be exposed to after having an ITAP inserted. Perioperative 
antibiotics were not administered in order to avoid suppression of bacterial 
colonisation as a bacterial challenge was desired. However, a ‘cleaner’ model with 
less exposure to bacteria as well as prophylactic antibiotics may have been more 
representative of the conditions that humans encounter. With a smaller bacterial 
challenge it is possible that results may be different as the surfaces may be able to 
resist bacterial colonisation to a greater degree. 
 
Another limitation is the potential effect of differences in the thickness of soft tissue 
between sheep. Differences in soft tissue thickness along the length of the tibiae, 
(which may affect the interfacial movement, the formation of the soft-tissue implant 
seal and consequently bacterial colonisation), were taken into account by rotating the 
position of implants in each sheep. However, overall differences in soft tissue 
thickness between sheep could not be accounted for. As a result the deep soft tissue 
biopsy may have been taken from different depths within the soft tissue for different 
animals. It is also likely that the deep soft tissue biopsy would have been taken from 
a deeper point within the tissues for SP implants than for flanged implants. This is 
because this sample was taken from the tissue overlying the flange of flanged 
implants, whereas for SP, (as there was no flange), it was taken from the tissue 
overlying the bone. This could potentially have affected the results for the deep 
samples taken from the SP-tissue interface.  
 
7.5  CONCLUSION  
The overall conclusion of this study is that incorporation of a fully porous titanium 
alloy flange into the current ITAP design has the potential to reduce the 
susceptibility of ITAP to infection. PT decreased bacterial colonisation compared 
with DF.  In conjunction with the results from the previous chapter where soft tissue 
integration was investigated, these findings indicate that soft tissue is more likely to 
win the ‘race for the surface’ against bacteria on PT than on DF. DF did not reduce 
bacterial colonisation compared with SP providing a potential explanation for the 
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infection rate associated with clinical use of ITAP despite the ability of DF to 
increase soft tissue integration. PT-HA had a negative effect and PT-HAFn was 
associated with less bacterial colonisation within the deep soft tissues than PT-HA. 
PT-HAAg reduced bacterial colonisation on the flange surface compared with PT-
HA. Further research into the use of silver and fibronectin/RGD coatings as an 
adjunct but without HA may have some potential to further enhance the effects of 
PT. However, in the clinical environment where there is less exposure to bacteria 
than in a barnyard animal model, it is a possibility that PT may be able to prevent 
bacterial colonisation to a greater degree and adjunctive coatings may not be 
required. 
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CHAPTER EIGHT 
General Discussion and Conclusions 
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8.1  DISCUSSION 
Key Findings and Contributions to Current Knowledge 
The overall aim of this thesis was to develop a fully porous ITAP flange with 
appropriate coatings in order to enable soft tissue to win the ‘race for the surface’ 
against bacteria. The key finding and original contribution to current knowledge 
from this thesis is that a fully porous titanium alloy flange with a pore size of 
700 µm and a strut size of 300 µm increases dermal attachment and soft tissue 
ingrowth, cellularity and vascularisation of tissue within pores, whilst reducing 
epithelial downgrowth and bacterial colonisation compared with the drilled-
hole ITAP flange which is currently used  to treat amputees.  The in vitro studies 
found that electrochemically deposited HAAg coatings with and without adsorbed 
fibronectin had antibacterial activity and were cytocompatible while maintaining 
antibacterial activity after serum-preconditioning for 24 hours. The hypothesis that 
HAAg and/or HAAgFn coatings applied to the fully porous ITAP flange would 
further enhance soft tissue integration and decrease bacterial colonisation was not 
found to be true in vivo.  
 
Chapter One of this thesis reviewed the background behind the development of 
osseointegrated transcutaneous amputation prostheses and explained the ITAP 
design, which is based on the deer antler. The problem of infection and how the 
success rate is dependent on soft tissue winning the ‘race for the surface’ against 
bacteria was considered. As a result of this review, potential strategies to enhance 
soft tissue integration and decrease bacterial colonisation associated with ITAP were 
selected for investigation in the subsequent chapters.  
 
In order to improve dermal integration, which is the basis of the ITAP concept, 
Chapter Two presented a histological study of the effect of a range of porous 
titanium alloy structures on soft tissue integration.  The aim of this chapter was to 
select an appropriate porous structure that could be taken forward in subsequent 
investigations. Porous titanium alloy cylinders with interconnected pores were 
implanted into the paraspinal muscles of sheep and left in situ for four weeks. It was 
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hypothesised that more open porous titanium alloy structures with larger pore sizes 
would improve soft tissue integration. The results proved this hypothesis 
demonstrating that three of the more open structures (P1000 S400, P1000 S200 and 
P700 S300) resulted in the greatest soft tissue ingrowth. P700 S300 supported 
revascularisation of tissues to the greatest degree and as a result this was the structure 
selected for the ITAP flange for use in a transcutaneous pin model in Chapters Six 
and Seven of this thesis.  
 
In order to further promote soft tissue attachment and at the same time reduce 
bacterial adhesion appropriate coatings were investigated in Chapters Three and 
Four. The effect of incorporation of silver into HA and HAFn coatings on fibroblast 
viability and bacterial colonisation was studied in vitro. Silver was incorporated into 
these coatings using electrochemical deposition. Chapter Three hypothesised that 
HAAg and HAAgFn coatings with low silver concentrations would be 
cytocompatible. HAAg and HAAgFn coatings were found to be initially cytotoxic to 
fibroblasts, but after serum-preconditioning for 24 hours, these coatings were found 
to support viable fibroblast growth. This finding suggested that in a clinical setting, 
HAAg would be cytotoxic initially; and that a short time period of contact with the 
patient’s serum after implantation (up to 24 hours) may be required to enable cells to 
attach to these surfaces. Chapter Four studied bacterial colonisation on HAAg and 
HAAgFn. It was hypothesised that HAAg and HAAgFn surfaces would reduce S 
aureus and P aeruginosa colonisation compared with HA, HAFn and Pol controls 
and that HAAg and HAAgFn surfaces would maintain their antibacterial activity 
after serum-preconditioning. The hypothesis was proven that these coatings had 
antibacterial activity against both S aureus and P aeruginosa. After serum-
preconditioning more than 99% of the antibacterial activity of HAAg100 and 
HAAgFn100 against S aureus compared with HA and HAFn controls was 
maintained for both biofilm and planktonic colonisation. P aeruginosa was found to 
be less susceptible to the antibacterial effects of HAAg and HAAgFn than S aureus 
and these coatings were only able to maintain significant antibacterial activity after 
serum-preconditioning when a smaller challenge of P aeruginosa was administered 
(i.e. a challenge of 5 x 104 cfu/mL compared with 106 cfu/mL).   
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Bringing together the research findings from Chapters Two, Three and Four, a 
transcutaneous pin with a fully porous titanium alloy flange having a pore size of  
700 µm and a strut thickness of 300 µm was investigated and reported in Chapter 
Five. Electrochemically deposited HA and HAAg coatings were produced 
throughout the porous structure. Fibronectin was adsorbed onto the surfaces by 
immersion of the implants in a solution of fibronectin. Surface characterisation 
showed that HA and HAAg coatings were semi-crystalline and hydrophilic. Silver 
release into fetal calf serum was sustained for 28 days but reduced over time. The 
silver levels released were levels previously shown to be bactericidal but below 
levels known to cause tissue or systemic toxicity. These transcutaneous pins were 
implanted along the length of the tibiae of twelve sheep and left in situ for four 
weeks. The current ITAP drilled-hole flange design and a straight pin were used as 
controls. A histological assessment of soft tissue integration was presented in 
Chapters Six. This chapter showed that the porous titanium alloy flange significantly 
reduced epithelial downgrowth and increased dermal attachment compared with the 
drilled-hole flange. The fully porous flange also increased soft tissue fill, cellularity 
and vascularisation within pores. Chapter Seven showed that the fully porous 
titanium alloy flange reduced bacterial colonisation within the superficial and deep 
soft tissues and on the surface of the flange compared with the drilled-hole flange. 
The addition of HA with or without silver and/or fibronectin coatings did not 
significantly increase soft tissue integration or decrease bacterial colonisation further 
compared with uncoated porous titanium alloy. HA coatings were associated with 
increased bacterial colonisation within the soft tissues and resulted in a loss of some 
of the favourable soft tissue integration effects of the porous flange compared with 
the drilled-hole flange.  
 
Implications of the Effect of Using a Porous Flange for ITAP and Limitations  
The results of the research presented in this thesis indicate that incorporating a fully 
porous flange into the ITAP design should reduce the susceptibility of ITAP to 
infection by increasing the ability of soft tissue to win the ‘race for the surface’ 
against bacteria. However, although the porous titanium alloy was found to improve 
soft tissue attachment and decrease bacterial colonisation, it did not eliminate 
epithelial downgrowth or bacterial colonisation and did not result in 100% soft tissue 
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attachment. This may be partly due to the postoperative conditions resulting in more 
exposure to bacteria than would be expected in a human model. Additionally, human 
skin has less hair, intraoperatively laminar flow systems are used, postoperatively 
dressings are changed and pin sites cleaned when necessary. In human clinical 
practice the interface is rested during the first few weeks until the soft tissues have 
healed sufficiently and the loading of the ITAP device is gradually increased over a 
period of several months (Kang et al 2010). Although an amputation model was not 
used in this thesis, the animals mobilised bearing full weight immediately 
postoperatively. This is expected to have resulted in more movement at the interface 
during the early postoperative period than would occur in clinical human practice 
and this may have affected the results. It could be argued that the main drawback of 
this research is that an animal model cannot be fully representative of the conditions 
in human clinical practice. Furthermore, although determining the effect on early soft 
tissue attachment and bacterial colonisation is important when studying the ‘race for 
the surface’ and should influence the long term outcomes, the long term effect is 
unknown and it may be necessary to assess this before proceeding onto clinical trials.     
 
Coatings 
The fact that the addition of silver and fibronectin overcame some of the negative 
effects of HA indicates that research on a range of concentrations of silver and 
fibronectin coatings without HA may be of value. It is also possible that the initial 
cytotoxicity associated with electrochemically deposited HAAg coatings 
(demonstrated in the in vitro studies of this thesis) may have contributed to the fact 
that HAAg coatings overall did not have a significant benefit. Preconditioning 
HAAg-coated flanges with simulated body fluids or autologous serum pre-
implantation would be expected to overcome this cytotoxicity but at the same time 
would be expected to reduce the magnitude and duration of the antibacterial effect 
and may therefore be counterproductive. The coatings were kept deliberately thin 
(less than 100 µm) in order to avoid a significant reduction in the space within the 
pores for tissue ingrowth. However, the presence of the coatings would inevitably 
have some effect on the space within the pores. It is possible that this was another 
factor affecting the results of the coatings applied to the porous flanges. Increasing 
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the pore size to take into account the thickness of the coatings may be able to 
compensate for this effect.  
General Clinical Applicability  
Although, the main intended application of the findings from this research is for 
improving the success of ITAP, the findings could also be applied to other 
transcutaneous devices. For example, external fixator pin tract infection is a common 
problem, with reports of infection rates ranging between 3.9% and 100% 
(Parameswaran et al 2003; Coester et al 2006; Antoci et al 2008). Improving soft 
tissue integration at the skin-implant interface would also be beneficial for 
preventing infection of external fixator pins. Addition of a porous flange to external 
fixator pins may have the potential to reduce infection susceptibility. A potential 
disadvantage of flanged external fixator pins is that multiple pins are used in one 
limb and they are eventually removed. A more robust soft tissue seal is likely to 
make subsequent removal of the external fixator pins more difficult leading to soft 
tissue trauma and problems with wound healing at the site of pin removal. A flange 
with fewer layers of pores than the flange developed in this thesis (e.g. two layers) 
may reduce the risk of this problem while improving soft tissue integration, although 
to a lesser degree than with the ITAP flange.  
 
The coatings developed in this thesis may be more likely to produce favourable in 
vivo results for osseointegration than for soft tissue integration due to the rough 
topography (Marinucci et al 2006; Osanthanon et al 2011; Teng et al 2012; Costa et 
al 2013).  If HA has a more favourable effect on osseointegration, the susceptibility 
of HA to promote bacterial colonisation could be overcome. Further investigation of 
porous metals coated with electrochemically deposited HAAg (with and without 
fibronectin) to assess the effect on osseointegration would be useful to determine if 
these coatings could play a role in preventing loosening and bacterial colonisation of 
the intraosseous portion of ITAP or for uncemented arthroplasty surgery. This may 
be of particular value for revision surgery, where infection is an increased risk and 
particularly for revision surgery undertaken for infected arthroplasty (Suarez et al 
2008; Mortazavi et al 2010). Additionally, this coating technique could be applied to 
endoprosthetic replacements with porous collars e.g. for tumour resection (Gupta et 
 246 
al 2006; Myers et al 2007; Spiegelberg et al 2009; Coathup et al 2013; Batta et al 
2014; Coathup et al 2015). 
 
Future Work in Preparation for Clinical Translation 
It is hoped that the advantages of the porous flange demonstrated in this thesis will 
be translated clinically. It may be useful to study the effect of a number of other 
strategies that could be used in conjunction with the porous-flanged implant and may 
increase the likelihood of success.  
 
Suture Immobilisation of Skin to the Flange  
Suturing of the soft tissues to the porous flange in order to immobilise the skin-
implant interface during the healing process may enhance the soft tissue seal (Bobyn 
et al 1982; Kang et al 2010). The 700 µm pores used for the flange may be too small 
to allow a needle to pass through it and struts from adjacent layers would make 
suturing the tissues to the flange technically difficult. To overcome this, larger pores 
at the junction between the flange and the transcutaneous portion of the implant 
could be incorporated into the design to allow the tissues to be sutured to the implant. 
It would be important to use an absorbable suture and to avoid excessive suturing in 
order to reduce the amount of foreign material, which may cause a foreign body 
inflammatory response and delayed wound healing (Carr et al 2009; Sönmez et al 
2009; Hansen and Gottrup 2014).   
 
Epithelial Attachment  
The porous flanges did not significantly increase epithelial attachment suggesting 
that design modifications to increase epithelial attachment specifically may be 
necessary. Laminin and E-cadherin have been shown to increase keratinocyte 
attachment and could be used to coat the transcutaneous portion of the implant 
(Gordon et al 2010; Pendegrass et al 2012a). Alternatively, coating the 
transcutaneous portion of the implant with layers of porous titanium alloy could 
potentially increase epithelial attachment. Studies to determine if the same porous 
structure as used for dermal tissue integration promotes epithelial tissue integration 
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would be necessary. However, if any of the porous titanium alloy coating were to be 
present on the portion of the pin that has penetrated the skin and is external to the 
tissues, there would be a risk of attracting bacteria onto the external pin surface. This 
risk could be reduced by either coating the porous titanium alloy coating with an 
antibacterial coating or using an antibacterial collar or sponge to cover the external 
pin and to protect the skin-implant interface from bacteria. The use of other coatings 
(including antibacterial coatings) and methods of external local delivery of 
antimicrobials (including the use of antibacterial collars or sponges) are discussed in 
the following sections. 
 
Other Coatings 
Although the effect of a porous titanium flange may be sufficient to prevent bacterial 
colonisation and reduce the risk of infection of ITAP, the use of other coatings that 
could be applied to the fully porous flange could be investigated with the aim of 
further reducing the risk of infection. Hydrophilic coatings such as poly(ethylene 
glycol) brush coatings with RGD (PEG-RGD) have been found to prevent adhesion 
of bacteria while allowing cell adhesion and spreading (Subbiahdoss et al 2010a; 
Muszanska et al 2014). RGD coatings may have the potential to be used as an 
alternative to fibronectin to increase soft tissue integration (Dowling et al 2012; 
Dowling et al 2014). Further investigation of the ability of RGD coatings to promote 
soft tissue integration and to determine whether bacterial colonisation is reduced on 
RGD coatings compared with fibronectin would be of value. Alternative methods of 
application of silver coatings have been discussed in Chapter Six (Section 6.4). The 
Agluna coating has been used for tumour endoprostheses and recently for coating the 
ITAP flange. This coating involves anodisation of titanium alloy followed by 
absorption of silver from an aqueous solution and has been found to reduce early 
periprosthetic infection rates (Wafa et al 2015). The use of sutures loaded with 
antimicrobials such as triclosan to close soft tissues has been associated with a 
reduced rate of surgical site infection and therefore may be an additional strategy that 
could help reduce infection rates of ITAP (Galal and El-Hindawi 2011; Sajid et al 
2013; Okada et al 2014; Serrano et al 2015). 
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External Local Delivery of Antimicrobials to the Skin-Implant Interface  
It may be useful to deliver antimicrobial agents to the interface to reduce the 
bacterial load. Antibiotic-impregnated collars are currently being investigated to 
prevent external fixator pin site infection (Arthritis Research UK 2010).  A similar 
collar could be placed over the skin-implant interface of ITAP and would be changed 
regularly. An externally attached refillable device for automated release of 
antibiotics or antiseptics is an alternative option that may reduce the exposure of the 
soft tissues to bacteria (Bansal 2013). It would be important to ensure that the 
antimicrobial agent used is not cytotoxic and does not inhibit normal wound healing. 
 
The Effect of Patient Factors  
Research on ITAP has focused on modifying implant and/or surgical factors. 
However, patient factors are also relevant. ITAP patients are selected carefully and to 
date, patients with comorbidities such as peripheral vascular disease and diabetes 
have not been included in clinical trials. Other factors such as age, smoking, alcohol 
consumption, nutritional status, decreased host immunity and medications such as 
glucocorticoids and non-steroidal anti-inflammatory medications also affect wound 
healing (Guo and DiPietro 2010). General hygiene and likelihood of compliance with 
the rehabilitation programme must be considered. As outcomes vary between ITAP 
patients despite careful selection, there may be other differences between individual 
patients that affect wound healing. For example, differences in blood flow to the skin 
have not been studied for ITAP patients. Laser Doppler flowmetry could be used to 
evaluate blood flow to the skin (Zografos et al 1992).  If differences were identified 
between patients, the cause would need to be considered. Further assessment of 
factors affecting wound healing in current ITAP patients may increase our 
understanding of why a successful skin-implant seal is formed in some patients but 
not others.  
 
8.2  GENERAL CONCLUSIONS  
The work presented in this thesis has shown that more open porous structures 
increase soft tissue integration more than less open structures with smaller pore sizes. 
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The overall hypothesis that the addition of a fully porous flange to the ITAP design 
increases soft tissue integration and decreases bacterial colonisation compared with 
the current drilled-hole ITAP flange was found to be true. In vitro, HAAg and 
HAAgFn coatings were found to have antibacterial activity while maintaining viable 
fibroblast growth after serum-preconditioning (mimicking the in vivo environment). 
However, in vivo, the hypothesis that the addition of HAAg and HAAgFn coatings 
would further enhance soft tissue integration and decrease bacterial colonisation was 
not confirmed. The porous flange did not completely eliminate epithelial 
downgrowth or bacterial colonisation, however, the significant improvements in soft 
tissue integration and reductions in bacterial colonisation represent a step forward for 
infection prevention of ITAP. There may be the potential to achieve more favourable 
results in a human model with improved perioperative hygiene conditions. 
Differences between individual coatings identified that HA resulted in a loss of some 
of the beneficial effects of the fully porous flange on soft integration (specifically 
epithelial downgrowth and vascularisation) compared with the drilled-hole flange. 
HA coatings were associated with increased bacterial colonisation within the soft 
tissues. Therefore, this method of HA-coating is not recommended for ITAP. Further 
modification of the technique used by altering the current density, the time period for 
electrochemical deposition and the amount of fibronectin and silver added to HA 
may have the potential to lead to more favourable results. Fibronectin improved 
dermal attachment when added to HA and HAAg coatings and the addition of silver 
to HA reduced bacterial colonisation. Further investigation of fibronectin and/or 
silver coatings without HA may be of value. Overall, the results indicate that a fully 
porous titanium alloy flange with a pore size of 700 µm and a strut size of 300 µm, 
without the addition of coatings, has the potential to increase the ability of soft tissue 
to win the ‘race for the surface’ against bacteria. It is therefore postulated that a fully 
porous flange should reduce the susceptibility of ITAP to infection compared with 
the current drilled-hole flange design. It is planned that a modified ITAP design with 
a fully porous flange will be translated into clinical practice.  
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APPENDIX 
1  Laboratory Protocols 
1.1 Histology Processing Protocol for implants retrieved from in vivo experiments 
(Centre for Biomedical Engineering, University College London). 
Fixation  
10% buffered formal saline       
 
3 days 
Serial Dehydration  
50% *IMS 50 % distilled water   
75%IMS 25% distilled water 
85% IMS 15% distilled water 
95% IMS 5% distilled water   
100% IMS (repeated twice)   
 
3 days 
3 days 
3 days 
3 days 
3 days x 2 
Defatting  
Choroform  
 
3 days x 2 
Clearing  
100% IMS  
3 days x 2 
Embedding in Resin 
50% IMS 50% LR White resin   
100% White resin  
(Under vacuum) 
 
3 days x 2 
3 days x 2 
Cast in LR White Resin  
1 drop of accelerator per 10 mL of resin.  
24 hours 
(in fridge) 
 
*IMS = Industrial Methylated Spirits 
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1.2  SEM preparation of biological samples 
(Centre for Biomedical Engineering, University College London). 
Wash  
Phosphate buffered saline       
 
5 minutes x 2 
Fixation 
2.5% Glutaraldehyde in 0.1 M sodium 
cacodylate buffer, pH 7.4 
 
30 minutes 
Wash  
0.1 M sodium cacodylate buffer   
 
5 minutes x 2 
Serial Dehydration 
IMS 20% 
IMS 30% 
IMS 40% 
IMS 50% 
IMS 60% 
IMS 70% 
IMS 80% 
IMS 90% 
Ethanol 90% 
Ethanol 96% 
Ethanol 100%   
 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
5 minutes x 2 
10 minutes x 2 
15 minutes x 2 
 
Transition Solvent 
Hexamethyldisalazane 
 
2 minutes x3 
Dry in fume hood   24 hours 
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1.3 Bacterial identification protocols 
(Based on Standard Operating Procedures from the Division of Orthopaedic and 
Accident Surgery, University of Nottingham). 
 
1.3.1. Gram stain 
1. Use a sterile inoculation loop to transfer a drop of bacterial suspension 
culture to a microscope slide. 
2. Spread a culture to form an even film of approximately 1.5 cm in the centre 
of the slide.  
3. Allow to air dry and then heat fix with a gentle flame. 
4. Flood the slide with Crystal Violet staining reagent for 1 minute and then 
gently wash the slide with water. 
5. Flood the slide with Gram’s iodine stain and wait for 1 minute before 
washing with water. 
6. Flood the slide with the decolourising agent (50:50 acetone:ethanol) and 
leave for 5 seconds before washing with water. 
7. Flood the slide with Neutral Red counterstain. 
8. Flood the slide with water and allow to dry. 
9. Add a cover slip and mount with DPX mounting medium. 
10. View the slide at x100 magnification under oil immersion. 
 
1.3.2 Catalase Test 
The catalase test is used to determine if bacteria possess the enzyme catalase. 
Catalase catalyses the breakdown of hydrogen peroxide to oxygen and water: 
 
2H2O2 →  2H2O + O2 
 
Bacteria that possess catalase include Staphylococci and Micrococci. Catalase 
negative bacteria include Streptococci and Enterococci. 
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1. Use a Pasteur pipette to place a drop of hydrogen peroxide solution onto a 
microscope slide. 
2. Use a sterile disposable inoculation loop to smear a colony of the bacteria to 
be tested onto a cover slip. 
3. Lower the cover slip onto the hydrogen peroxide on the slide. 
4. The appearance of gas bubbles (i.e. oxygen) indicates the presence of 
catalase. 
 
Set up controls using Staphylococcus epidermidis (catalase positive) and 
Enterococcus faecalis (catalase negative). 
 
1.3.3 Oxidase Test 
The oxidase test is used to determine if bacteria possess cytochrome oxidase, an 
enzyme of the bacterial electron transport chain. Oxidase positive bacteria possess 
cytochrome oxidase or indophenol oxidase (an iron-containing haemoprotein) and 
can utilise oxygen for energy production with an electron transport chain. Examples 
of oxidase positive bacteria include Pseudomonas aeruginosa and Neisseria 
gonorrhoea. Examples of oxidase negative bacteria include Staphylococcus aureus 
and Escherichia coli. 
1. Lay an oxidase test strip (Fluka-40560) in a petri dish that has been pre-
moistened with a few drops of sterile distilled water. 
2. Transfer a small amount of the bacterial culture to be tested to the strip using 
a sterile inoculation loop. 
3. Gently spread the bacterial culture along the surface of the strip. 
4. Observe the strip for 10 to 30 seconds. The appearance of a deep blue colour 
indicates that the bacteria are oxidase positive. The blue colour occurs as 
N,N-dimethyl-p-phenylenediamine and α-napthol within the test strips react 
to form the coloured compound indophenol blue in the presence of 
cytochrome oxidase. 
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Set up controls using Pseudomonas aeruginosa as a positive control and Escherichia 
coli as a negative control. 
 
1.3.4 DNase test 
The DNase test is used to identify Staphylococci that produce extracellular DNase 
(Deoxyribonuclease) ". DNase hydrolyses DNA in media containing DNA. The 
oligonucleotides liberated by the hydrolysis are soluble in acid. The addition of 
hydrochloric acid in the presence of a positive reaction results in a clear zone around 
the inoculum. Most strains of Staphylococcus aureus are DNase positive; however, 
some strains of MRSA are not. Some strains of coagulase negative Staphylococci 
e.g. Staphylococcus epidermidis may result in weak reactions to the test. 
1. Inoculate a DNase agar plate with a heavy inoculum of the test bacteria into 
the centre of the plate. Use a spot of approximately 5 mm in diameter. 
2. Incubate the plates at 37°C for 18 to 24 hours. 
3. Flood each plate with 0.5 M hydrochloric acid to a depth of approximately 2 
mm. 
4. Observe the presence of a clear zone around the inoculum for DNase positive 
bacteria. 
 
Set up controls using Staphylococcus aureus Oxford as a positive control and 
Staphylococcus epidermidis (F1228) as a negative control 
 
1.3.5 Methicillin Sensitivity Test 
The Methicillin sensitivity test is used to determine whether isolated strains of 
Staphylococci are methicillin sensitive resistant.  
1. For each test organism prepare a suspension with an inoculum turbidity 
equivalent to a McFarland Standard of 0.5. 
2. Inoculate Tryptone Soya agar plates with and without methicillin with the test 
organism. 
3. Incubate plates at 37°C for 24 hours. 
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4. All isolates will grow on agar plates without methicillin. Methicillin resistant 
isolates will also grow on plates containing methicillin. 
 
Use MRSA F1228 as a methicillin resistant control and Staphylococcus aureus 
Oxford as a methicillin sensitive control. 
 
1.3.6 Analytical Profile Indexing 
The Analytical Profile Index (API) test kits (Biomérieux) are used to identify 
bacteria to the species level. Different test kits are used depending on the organism to 
be identified. For example, API Staph is used to identify Staphylococci and 
Micrococci. API 20 Strep is used to identify Streptococci or Enterococci. API 20E is 
used to identify Enterobacteriacae and other non-fastidious gram-negative bacteria. 
Each test kit contains test strips containing miniaturised biochemical tests within 
microtubes. The microtubes are inoculated with a suspension of the test organism. 
The reagents within the microtubes test for the presence of products of bacterial 
metabolism specific to certain bacterial species.  
1. Subculture the test organism onto appropriate agar and incubate for 18 to 24 
hours at 37°C.  
2. Use API medium to prepare a homogenous bacterial suspension with a 
turbidity equivalent to 0.5 McFarland standard. 
3. Use a sterile pastette to carefully fill each of the microtubes (but not the 
cupules) within the API test strip with the inoculum. Ensure anaerobiosis in 
the ADH and URE tests (See reagent list and reading table below) by filling 
the cupules with mineral oil to form a convex meniscus. 
4. Close the inoculation box and incubate for 18 to 24 hours at 37°C. 
5. Following the incubation period, follow the instructions in the booklet 
supplied with the API Biomérieux test kit. Some kits may require the addition 
of further reagents to develop the reactions. 
6. Read the reactions by comparing the colour of each microtube within the test 
strip to the reading table in the API Biomérieux Instruction booklet. Write the 
results on the results sheet. The tests are separated into groups of three and a 
value of 1, 2 or 4 is assigned for each positive test. (An example of an API 
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Staph test strip with positive reactions, the reagent list/reading table and a 
results sheet are shown below). 
7. Generate a seven-digit numerical profile by adding the values corresponding 
to positive reaction for each group. 
8. Identify the bacterial species by looking up the seven-digit numerical profile 
in the Analytical Profile Index Manual or by entering the numerical profile 
into the apiwebTM identification software. 
 
An example API Staph test strip with positive reactions (Staphylococcus xylosus) 
 
Reagent list/reading table 
 
Results sheet 
 
!
 
TESTS 
 
ACTIVE INGREDIENTS 
 
REACTIONS/ENZYMES 
 
RESULT 
NEGATIVE POSITIVE 
0 No substrate Negative control red - 
GLU D-glucose (Positive control) (D-GLUcose)  
 
 
 
red 
 
 
 
 
yellow 
FRU D-fructose Acidification (D-FRUctose) 
MNE D-mannose Acidification (D-manNosE) 
MAL D-maltose Acidification (MALtose) 
LAC D-lactose Acidification (LACtose) 
TRE D-trehalose Acidification (D-TREhalose) 
MAN D-mannitol Acidification (D-MANnitol) 
XLT xylitol Acidification (XyLiTol) 
MEL D-melibiose Acidification (D-MELibiose) 
 
NIT 
 
potassium nitrate 
 
Reduction of NITrates to nitrites 
NIT 1 + NIT 2 / 10 min 
Colourless 
-light pink 
red 
 
PAL 
 
β-naphthyl phosphate 
 
Alkaline Phosphatase 
ZYM A + ZYM B / 10 min 
yellow violet 
VP sodium pyruvate Acetyl-methyl-carbinol production (Voges 
Proskauer) 
  
RAF D-raffinose Acidification (RAFfinose)  
 
red 
 
 
yellow 
XYL D-xylose Acidification (XYLose) 
SAC D-saccharose (sucrose) Acidification (SACcharose) 
MDG methyl-αD-glucopyranoside Acidification (Methyl-αD-Glucopyranoside) 
NAG N-acetyl-glucosamine Acidification (N-Acetyl-Glucosamine) 
ADH L-arginine Arginine DiHydrolase yellow orange-red 
URE urea UREase yellow red-violet 
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2.  Chapter Two Statistics   
 2.1  M
edian Values and (95%
 confidence intervals)   
Implant 
Percentage soft tissue fill 
Cell nuclei/mm
2 
Blood vessel/mm
2 
Zone 1 
Zone 2 
Zone 3 
Zone 1 
Zone 2 
Zone 3 
Zone 1 
Zone 2 
Zone 3 
P1000 S400 
100 
(constant) 
 
97 
(94.28 to 
100.52) 
100 
(84.89 to 
107.11) 
3074 
(831.95 to 
4662.05) 
3733 
(859.91 to 
5017.69) 
3618 
(1130.85 to 
5372.75) 
4 
(1.52 to 
9.44) 
3 
(0.12 to 
10.4) 
3 
(-2.32 to 
12.96) 
P1000 S200 
100 
(97.54 to 
101.03) 
100 
(94.22 to 
101.50) 
100 
(87.94 to 
102.06) 
5059 
(3330.45 to 
6312.70) 
4527 
(2402.37 to 
5439.06) 
5000 
(3004.61 to 
6293.96) 
8 
(4.28 to 
10.29) 
10 
(4.52 to 
12.05) 
8 
(2.83 to 
11.74) 
P700 S400 
40 
(11.84 to 
78.66) 
35 
(18.61 to 
53.89) 
25 
(7.27 to 
37.73) 
1190 
(-409.57 to 
2953.57) 
700 
(-392.4 to 
2157.9) 
584.5 
(131.82 to 
970.68) 
4.5 
(-1.03 to 
9.03) 
1 
(-2.5 
to 6.5) 
2.5 
(-1.29 to 
6.29) 
P700 S300 
100 
(92.45 to 
103.55) 
95 
(30.19 to 
125.81) 
100 
(92.43 to 
103.55) 
1389 
(-390.62 to 
7151.82) 
1243 
(172.19 to 
3993.41) 
1306 
(266.55 to 
4168.65) 
15 
(3.67 to 
34.33) 
6 
(0.92 to 
16.28) 
11 
(2.92 to 
15.08) 
P700 S200 
88 
(62.09 to 
103.57) 
87.5 
(59.3 to 
103.36) 
90 
(45.07 to 
108.27) 
815 
(363.3 to 
1315.36) 
604 
(420.53 to 
749.47) 
551.5 
(-99.65 to 
1662.32) 
3 
(0.48 to 
8.52) 
1.5 
(-0.2 to 
3.87) 
0 
(constant) 
P500 S400 
27.5 
(-10.14 to 
62.64) 
22.5 
(-8.31 to 
53.31) 
10 
(-20.1 to 
55.1) 
250 
(-317.35 to 
985.35) 
268.5 
(-249.11 to 
835.11) 
251 
(-316.48 to 
984.48) 
0 
(-1.09 to 
2.09) 
0 
(-0.55 to 
1.05) 
0 
(-2.18 to 
4.18) 
P500 S300 
60 
(48.43 to 
74.43) 
45 
(33.44 to 
57.41) 
40 
(21.09 to 
57.48) 
1390 
(110.59 to 
5540.55) 
1199 
(478.45 to 
1641.83) 
821 
(71.18 to 
2351.40) 
9 
(3.25 to 
17.89) 
4 
(0.33 to 
5.39) 
0 
(-1.24 to 
2.95) 
P500 S200 
60 
(41.43 to 
75.14) 
63 
(34.17 to 
68.4) 
60 
(25.64 to 
72.93) 
890 
(-187.08 to 
3091.36) 
645 
(53.6 to 
1850.68) 
720 
(122.22 to 
2097.78) 
8 
(2.75 to 
12.96) 
4 
(1.44 to 
7.99) 
4 
(-0.42 to 
11.56) 
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2.2  Chapter Two p values  
 
Zone 1 - Percentage Fill   
Kruskall Wallis p value=0.000 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.731 0.010   0.010   
P1000 
S200 
    0.101   0.001 
P700 
S400 
   0.016 0.038 0.343  0.412 
P700 
S300 
    0.177  0.003  
P700 
S200 
       0.035 
P500 
S400 
      0.024  0.073 
P500 
S300 
       0.710 
P500 
S200 
        
 
 
 
Zone 2 - Percentage Fill 
Kruskall Wallis p value=0.000 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.731 0.010   0.010   
P1000 
S200 
    0.138   0.001 
P700 
S400 
   0.190 0.010 0.343   
P700 
S300 
    0.792  0.106  
P700 
S200 
       0.051 
P500 
S400 
      0.073  0.073  
P500 
S300 
       0.383 
P500 
S200 
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Zone 3 - Percentage Fill 
Kruskall Wallis Test = 0.000 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.534 0.010   0.010   
P1000 
S200 
    0.445   0.001 
P700 
S400 
   0.016 0.019 0.486  0.109 
P700 
S300 
    0.329  0.003  
P700 
S200 
       0.101 
P500 
S400 
      0.164 0.073 
P500 
S300 
       0.535 
P500 
S200 
        
 
Zone 1 - Cell nuclei count/mm2 
Kruskall Wallis test p=0.002 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.051 
 
0.114   0.019   
P1000 
S200 
    0.001   0.007 
P700 
S400 
   0.413 0.762 0.343   
P700 
S300 
    0.052  
 
 0.639  
P700 
S200 
       0.836 
P500 
S400 
      0.024 0.073 
P500 
S300 
       0.259 
P500 
S200 
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Zone 2 - Cell nuclei count/mm2 
Kruskall Wallis test p=0.001 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.138 0.114   0.038   
P1000 
S200 
    0.001   0.002 
P700 
S400 
   0.286 1.000 0.343   
P700 
S300 
    0.004   0.343  
P700 
S200 
       1.000 
P500 
S400 
      0.042 0.164 
P500 
S300 
       0.535 
P500 
S200 
        
 
 
Zone 3 - Cell nuclei count/mm2 
Kruskall Wallis test p=0.000 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.073 0.067   0.038   
P1000 
S200 
    0.002   0.001 
P700 
S400 
   0.016 0.914 0.686   
P700 
S300 
    0.030   0.149  
P700 
S200 
       0.101 
P500 
S400 
      0.109 0.109 
P500 
S300 
       0.902 
P500 
S200 
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Zone 1 - Blood vessel count/mm2 
Kruskall Wallis Test = 0.010 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.343 0.556   0.016   
P1000 
S200 
    0.234   0.902 
P700 
S400 
   0.016 0.914 0.114   
P700 
S300 
    0.017   0.268  
P700 
S200 
       0.234 
P500 
S400 
      0.024 0.024 
P500 
S300 
       0.535 
P500 
S200 
        
 
 
 
Zone 2 - Blood vessel count/mm2 
Kruskall Wallis test p=0.005 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.534 0.114   0.010   
P1000 
S200 
    0.008   0.165 
P700 
S400 
   0.063 
 
0.914 0.486   
P700 
S300 
    0.009   0.048  
P700 
S200 
       0.138 
P500 
S400 
      0.230 0.024 
P500 
S300 
       0.456 
P500 
S200 
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Zone 3 - Blood vessel count/mm2 
Kruskall Wallis p=0.003 
 P1000 
S400 
P1000 
S200 
P700 
S400 
P700 
S300 
P700 
S200 
P500 
S400 
P500 
S300 
P500 
S200 
P1000 
S400 
 0.234 0.914   0.352   
P1000 
S200 
    0.001   0.456 
P700 
S400 
   0.063 
 
0.067 
 
0.343   
P700 
S300 
    0.004  0.005  
P700 
S200 
       0.101 
P500 
S400 
      0.927 0.315 
P500 
S300 
       0.165 
P500 
S200 
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2.3  Chapter Two Correlation  
Spearman’s rho 
Percentage soft tissue fill  
Cell nuclei/mm
2 
Blood vessel/mm
2 
Zone 1 
Zone 2 
Zone 3 
Zone 1 
Zone 2 
Zone 3 
Zone 1 
Zone 2 
Zone 3 
Percentage 
soft tissue 
fill 
Zone 
1 
Correlation Coefficient 
 
0.877 
0.941 
0.620 
 
 
0.323 
 
 
Sig (2-tailed) 
 
0.000 
0.000 
0.000 
 
 
0.031 
 
 
Zone 
2 
Correlation Coefficient 
 
 
0.868 
 
0.610 
 
 
0.493 
 
Sig (2-tailed) 
 
 
0.000 
 
0.000 
 
 
0.001 
 
Zone 
3 
Correlation Coefficient 
 
 
 
 
 
0.621 
 
 
0.432 
Sig (2-tailed) 
 
 
 
 
 
0.000 
 
 
0.003 
Cell nuclei 
/mm
2 
Zone 
1 
Correlation Coefficient 
 
 
 
 
0.799 
0.880 
0.316 
 
 
Sig (2-tailed) 
 
 
 
 
0.000 
0.000 
0.035 
 
 
Zone 
2 
Correlation Coefficient 
 
 
 
 
 
0.765 
 
0.635 
 
Sig (2-tailed) 
 
 
 
 
 
0.000 
 
0.000 
 
Zone 
3 
Correlation Coefficient 
 
 
 
 
 
 
 
 
0.503 
Sig (2-tailed) 
 
 
 
 
 
 
 
 
0.000 
Blood 
vessel 
/mm
2 
Zone 
1 
Correlation Coefficient 
 
 
 
 
 
 
 
0.760 
0.333 
Sig (2-tailed) 
 
 
 
 
 
 
 
0.000 
0.025 
Zone 
2 
Correlation Coefficient 
 
 
 
 
 
 
 
 
0.629 
Sig (2-tailed) 
 
 
 
 
 
 
 
 
0.000 
Zone 
3 
Correlation Coefficient 
 
 
 
 
 
 
 
 
 
Sig (2-tailed) 
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2.4 Intraclass Correlation Coefficient for Semi-quantitative Percentage Soft Tissue Fill Score 
   
 Median value (and 95% Confidence Interval) 
 
Observer 1 Observer 2 
P1000 S400 100.00 (90.86 to 98.58) 100.00(96.06 to 100.83) 
P1000 S200 90.00 (84.03 to 94.30) 100.00 (94.23 to 99.66) 
P700 S400 75.00 (59.19 to 82.47) 30.00 (24.14 to 45.19) 
P700 S300 100.00 (92.06 to 99.94) 100.00 (94.59 to 100.08) 
P700 S200 85.00 (76.18 to 92.71) 87.50 (68.95 to 91.60) 
P500 S400 35.00 (16.91 to 48.09) 35.00 (15.50 to 47.00) 
P500 S300 50.00 (38.34 to 55.95) 50.00 (36.55 to 56.12) 
P500 S200 60.00 (45.45 to 62.17) 60.00 (43.69 to 62.22) 
 
 
Reliability Statistics 
Cronbach's 
Alpha N of Items 
.932 2 
 
 
Intraclass Correlation Coefficient 
 
Intraclass 
Correlationb 
95% Confidence Interval F Test with True Value 0 
Lower Bound Upper Bound Value df1 df2 Sig 
Single Measures .870a .822 .906 14.673 134 134 .000 
Average Measures .931c .902 .951 14.673 134 134 .000 
Two-way mixed effects model where people effects are random and measures effects are fixed. 
a. The estimator is the same, whether the interaction effect is present or not. 
b. Type A intraclass correlation coefficients using an absolute agreement definition. 
c. This estimate is computed assuming the interaction effect is absent, because it is not estimable 
otherwise. 
 
!
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3  Chapter Three Statistics 
 
3.1  EDX Analysis 
 
3.1.1  Percentage Silver Content - p values  
 
(Pol, HA, HAFn = 0% Ag, therefore excluded from comparisons) 
 
Kruskall Wallis 
Atomic Percentage Silver p=0.000 
Percentage Weight Silver p=0.000 
 HA 
Ag 
10 
HA 
Ag 
Fn 
10 
HA 
Ag 
50 
HA 
Ag 
Fn 
50 
HA 
Ag 
100 
HA 
Ag 
Fn 
100 
HA 
Ag 
10 
(P24) 
HA 
Ag 
Fn 
10 
(P24) 
HA 
Ag 
50 
(P24) 
HA 
Ag 
Fn 
50 
(P24) 
HA 
Ag 
100 
(P24) 
HA 
Ag 
Fn 
100 
(P24) 
HAAg 
10 
 0.037 
0.034 
0.000 
0.000 
   0.293 
0.203 
     
HAAg 
Fn10 
   0.001 
0.001 
   0.732 
0.134 
    
HAAg 
50 
   0.786 
0.483 
0.000 
0.000 
   0.660 
0.143 
   
HAAg 
Fn50 
     0.000 
0.000 
   0.832 
0.988 
  
HAAg 
100 
     0.851 
0.372 
    0.111 
0.424 
 
HAAg 
Fn100  
           0.551 
0.521 
HAAg 
10 (P24) 
       0.029 
0.153 
0.000 
0.034 
   
HAAg 
Fn10 
(P24) 
         0.000 
0.004 
  
HAAg 
50 (P24) 
         0.815 
0.988 
0.001 
0.000 
 
HAAg 
Fn50 
(P24) 
           0.001 
0.000 
HAAg 
100 (P24) 
           0.462 
0.424 
HAAg 
Fn100 
(P24) 
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3.1.2  Percentage Silver Content - Benjamini Hochberg Procedure 
 
Threshold = (i/m)Q      i = rank, m = total number of tests, Q = false discovery rate 
 
Atomic Percentage Silver 
Percentage Weight Silver 
Rank p value Threshold  (i/m)Q Reject Null Hypothesis 
(Y/N) 
1 0.000 
0.000 
0.0025 Y 
Y 
2 0.000 
0.000 
0.005 Y 
Y 
3 0.000 
0.000 
0.0075 Y 
Y 
4 0.000 
0.000 
0.01 Y 
Y 
5 0.000 
0.000 
0.0125 Y 
Y 
6 0.000 
0.001 
0.015 Y 
Y 
7 0.001 
0.004 
0.0175 Y 
Y 
8 0.001 
0.034 
0.02 Y 
N 
9 0.001 
0.034 
0.0225 Y 
N 
10 0.029 
0.134 
0.025 N 
N 
11 0.037 
0.143 
0.0275 N 
N 
12 0.111 
0.153 
0.03 N 
N 
13 0.293 
0.203 
0.0325 N 
N 
14 0.462 
0.372 
0.035 N 
N 
15 0.551 
0.424 
0.0375 N 
N 
16 0.660 
0.424 
0.04 N 
N 
17 0.732 
0.483 
0.0425 N 
N 
18 0.786 
0.521 
0.045 N 
N 
19 0.815 
0.988 
0.0475 N 
N 
20 0.988 
0.988 
0.05 N 
N 
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3.2  Surface Roughness (R
a )  
3.2.1  Surface Roughness (R
a ) - p values  
Kruskall W
allis p= 0.000 
 
Pol 
HA 
HA 
Fn 
HA 
Ag 
10 
HA 
Ag 
Fn 
10 
HA 
Ag 
50 
HA 
Ag 
Fn 
50 
HA 
Ag 
100 
HA 
Ag 
Fn 
100 
Pol 
(P24) 
HA 
(P24) 
HA 
Fn 
(P24) 
HA 
Ag 
10 
(P24) 
HA 
Ag 
Fn 
10 
(P24) 
HA 
Ag 
50 
(P24) 
HA 
Ag 
Fn 
50 
(P24) 
HA 
Ag 
100 
(P24) 
HA 
Ag 
Fn 
100 
(P24) 
Pol 
 
0.000 
 
 
 
 
 
 
 
0.742 
 
 
 
 
 
 
 
 
HA 
 
 
0.389 
0.203 
 
0.791 
 
0.000 
 
 
0.297 
 
 
 
 
 
 
 
HAFn 
 
 
 
 
0.988 
 
0.815 
 
0.001 
 
 
0.000 
 
 
 
 
 
 
HAAg10 
 
 
 
 
0.068 
0.104 
 
0.000 
 
 
 
 
0.935 
 
 
 
 
 
HAAgFn10 
 
 
 
 
 
 
0.673 
 
0.001 
 
 
 
 
0.000 
 
 
 
 
HAAg50 
 
 
 
 
 
 
0.963 
0.000 
 
 
 
 
 
 
0.002 
 
 
 
HAAgFn50 
 
 
 
 
 
 
 
 
0.002 
 
 
 
 
 
 
0.212 
 
 
HAAg100 
 
 
 
 
 
 
 
 
0.005 
 
 
 
 
 
 
 
0.035 
 
HAAgFn100  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.019 
Pol (P24) 
 
 
 
 
 
 
 
 
 
 
0.000 
 
 
 
 
 
 
 
HA (P24) 
 
 
 
 
 
 
 
 
 
 
 
0.007 
0.464 
 
0.042 
 
0.002 
 
HAFn (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.259 
 
0.536 
 
0.000 
HAAg10 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.006 
0.114 
 
0.002 
 
HAAgFn10 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.252 
 
0.000 
HAAg50 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.730 
0.000 
 
HAAgFn50 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.011 
HAAg100 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.606 
HAAgFn100 (P24) 
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3.2.2  Surface Roughness (Ra) - Benjamini Hochberg Procedure 
Rank p value Threshold 
(i/m)Q 
Reject Null 
Hypothesis (Y/N) 
1 0.000 0.00116279 Y 
2 0.000 0.00232558 Y 
3 0.000 0.00348837 Y 
4 0.000 0.00465116 Y 
5 0.000 0.00581395 Y 
6 0.000 0.00697674 Y 
7 0.000 0.00813953 Y 
8 0.000 0.00930233 Y 
9 0.000 0.01046512 Y 
10 0.000 0.01162791 Y 
11 0.001 0.0127907 Y 
12 0.001 0.01395349 Y 
13 0.002 0.01511628 Y 
14 0.002 0.01627907 Y 
15 0.002 0.01744186 Y 
16 0.002 0.01860465 Y 
17 0.005 0.01976744 Y 
18 0.006 0.02093023 Y 
19 0.007 0.02209302 Y 
20 0.011 0.02325581 Y 
21 0.019 0.0244186 Y 
22 0.035 0.0255814 N 
23 0.042 0.02674419 N 
24 0.068 0.02790698 N 
25 0.104 0.02906977 N 
26 0.114 0.03023256 N 
27 0.212 0.03139535 N 
28 0.203 0.03255814 N 
29 0.252 0.03372093 N 
30 0.259 0.03488372 N 
31 0.297 0.03604651 N 
32 0.389 0.0372093 N 
33 0.464 0.0387209 N 
34 0.536 0.03953488 N 
35 0.606 0.04069767 N 
36 0.673 0.04186047 N 
37 0.730 0.04302326 N 
38 0.742 0.04418605 N 
39 0.791 0.04534884 N 
40 0.815 0.04651163 N 
41 0.935 0.04767442 N 
42 0.963 0.04883721 N 
43 0.988 0.05 N 
 
!
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3.3  Fibroblast Viability 
 3.3.1  Percentage Live Cells - M
edian Values and (95%
 Confidence Intervals) 
Surface 
M
edian values 
and (95%
 confidence intervals) 
 
Surface 
 
M
edian values 
and (95%
 confidence intervals) 
Pol 
94.5 (90.91 to 97.2) 
Pol (P24) 
100 (95 to 99.67) 
HA 
92.58 (89.98 to 94.96) 
HA (P24) 
94.5 (90.58 to 96.86) 
HAFn 
95 (92.07 to 97.93) 
HAFn (P24) 
92.5 (86.74 to 95.37) 
HAAg10 
55 (38.3 to 60.15) 
HAAg10 (P24) 
89 (85.93 to 93.07) 
HAAgFn10 
59 (34.71 to 69.49) 
HAAgFn10 (P24) 
91 (88.44 to 94.56) 
HAAg50 
16 (11.06 to 31.18) 
HAAg50 (P24) 
87.50 (83.86 to 93.47) 
HAAgFn50 
15 (10.25 to 23.53) 
HAAgFn50 (P24) 
92.50 (87.74 to 95.04) 
HAAg100 
0 (-0.50 to 5.72) 
HAAg100 (P24) 
95 (90.47 to 96.86) 
 HAAgFn100 
0 (3.83 to 16.17) 
 HAAgFn100 (P24) 
90.5 (86.39 to 94.28) 
HAAg10 (P4) 
83 (76.71 to 85.18) 
HAAg100 (P48) 
98.5 (92.63 to 98.48) 
HAAgFn10 (P4) 
65.5 (62.09 to 70.47) 
HAAgFn100 (P48) 
94.5 (89.86 to 97.48) 
HAAg50 (P4) 
68 (65.66 to 71.11) 
 
HAAgFn50 (P4) 
50 (42.30 to 56.4) 
HAAg10 (P8) 
87 (82.59 to 88.82) 
HAAgFn10 (P8) 
86 (79.24 to 87.20) 
HAAg50 (P8) 
82 (74.96 to 82.34) 
HAAgFn50 (P8) 
81 (74.27 to 86.08) 
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3.3.2  Percentage Live Cells - p values  
 Kruskall W
allis p=0.000 
 
Pol 
HA 
HA 
Fn 
HA 
Ag 
10 
HA 
Ag 
Fn10 
HA 
Ag 
50 
HA 
Ag 
Fn50 
HA 
Ag 
100 
HA 
Ag 
Fn100 
Pol 
 
0.335 
0.597 
 
 
 
 
 
 
HA 
 
 
0.081 
0.000 
 
 
 
 
 
HAFn 
 
 
 
 
0.000 
 
 
 
 
HAAg10 
 
 
 
 
0.724 
0.000 
 
 
 
HAAgFn10 
 
 
 
 
 
 
0.000 
 
 
HAAg50 
 
 
 
 
 
 
0.684 
0.002 
 
HAAgFn50 
 
 
 
 
 
 
 
 
0.111 
HAAg100 
 
 
 
 
 
 
 
 
0.134 
HAAgFn100  
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HAAg 
10 
(P4) 
HAAg 
Fn10 
(P4) 
HAAg 
50 
(P4) 
HAAg 
Fn50 
(P4) 
HAAg 
10  
(P8) 
HAAg 
Fn10 
(P8) 
HAAg 
50 
(P8) 
HAAg 
Fn50 
(P8) 
Pol 
 
 
 
 
 
 
 
 
HA 
0.000 
 
 
 
0.001 
 
 
 
HAFn 
 
0.000 
 
 
 
0.000 
 
 
HAAg10 
0.000 
 
 
 
0.000 
 
 
 
HAAgFn10 
 
0.133 
 
 
 
0.000 
 
 
HAAg50 
 
 
0.000 
 
 
 
 
 
HAAgFn50 
 
 
 
0.000 
 
 
 
0.000 
HAAg100 
 
 
 
 
 
 
 
 
HAAgFn100  
 
 
 
 
 
 
 
 
HAAg10  (P4) 
 
0.000 
0.000 
 
0.057 
 
 
 
HAAgFn10 (P4) 
 
 
 
0.000 
 
0.000 
 
0.443 
HAAg50 (P4) 
 
 
 
0.000 
 
 
0.000 
 
HAAgFn50 (P4) 
 
 
 
 
 
 
 
0.000 
HAAg10 (P8) 
 
 
 
 
 
0.546 
0.003 
 
HAAgFn10 (P8) 
 
 
 
 
 
 
 
0.540 
HAAg50 (P8) 
 
 
 
 
 
 
 
 
HAAgFn50 (P8) 
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Pol 
(P24) 
HA 
(P24) 
HAFn 
(P24) 
HAAg 
10  
(P24) 
HAAg 
Fn10 
(P24) 
HAAg 
50 
(P24) 
HAAg 
Fn50 
(P24) 
HAAg 
100 
(P24) 
HAAg 
Fn100 
(P24) 
HAAg 
100 
(P48) 
HAAg 
Fn100 
(P48) 
Pol 
0.185 
 
 
 
 
 
 
 
 
 
 
HA 
 
0.424 
 
0.219 
 
0.219 
 
0.424 
 
0.067 
 
HAFn 
 
 
0.144 
 
0.059 
 
0.109 
 
0.059 
 
0.772 
HAAg10 
 
 
 
0.000 
 
 
 
 
 
 
 
HAAgFn10 
 
 
 
 
0.000 
 
 
 
 
 
 
HAAg50 
 
 
 
 
 
0.000 
 
 
 
 
 
HAAgFn50 
 
 
 
 
 
 
0.000 
 
 
 
 
HAAg100 
 
 
 
 
 
 
 
0.000 
 
 
 
HAAgFn100  
 
 
 
 
 
 
 
 
 
 
 
HAAg10  (P4) 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn10 (P4) 
 
 
 
 
 
 
 
 
 
 
 
HAAg50 (P4) 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn50 (P4) 
 
 
 
 
 
 
 
 
 
 
 
HAAg10 (P8) 
 
 
 
0.184 
 
 
 
 
 
 
 
HAAgFn10 (P8) 
 
 
 
 
0.002 
 
 
 
 
 
 
HAAg50 (P8) 
 
 
 
 
 
0.006 
 
 
 
 
 
HAAgFn50 (P8) 
 
 
 
 
 
 
0.002 
 
 
 
 
Pol (P24) 
 
 
 
 
 
 
 
 
 
 
 
HA (P24) 
 
 
 
0.079 
 
0.118 
 
0.963 
 
 
 
HAFn (P24) 
 
 
 
 
0.719 
 
0.988 
 
0.628 
 
 
HAAg10 (P24) 
 
 
 
 
0.406 
0.791 
 
0.091 
 
 
 
HAAgFn10 (P24) 
 
 
 
 
 
 
0.913 
 
0.791 
 
 
HAAg50 (P24) 
 
 
 
 
 
 
0.501 
0.161 
 
 
 
HAAgFn50 (P24) 
 
 
 
 
 
 
 
 
0.673 
 
 
HAAg100 (P24) 
 
 
 
 
 
 
 
 
0.203 
0.323 
 
HAAgFn100 (P24) 
 
 
 
 
 
 
 
 
 
 
0.152 
HAAg100 (P48) 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn100 (P48) 
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3.3.3  Percentage Live Cells - Benjamini Hochberg Procedure 
Rank p value Threshold 
(i/m)Q 
Reject Null 
Hypothesis (Y/N) 
1 0.000 0.00069444444444 Y 
2 0.000 0.00138888888889 Y 
3 0.000 0.00208333333333 Y 
4 0.000 0.00277777777778 Y 
5 0.000 0.00347222222222 Y 
6 0.000 0.00416666666667 Y 
7 0.000 0.00486111111111 Y 
8 0.000 0.00555555555556 Y 
9 0.000 0.00625 Y 
10 0.000 0.00694444444444 Y 
11 0.000 0.00763888888889 Y 
12 0.000 0.00833333333333 Y 
13 0.000 0.00902777777778 Y 
14 0.000 0.00972222222222 Y 
15 0.000 0.01041666666667 Y 
16 0.000 0.01111111111111 Y 
17 0.000 0.01180555555556 Y 
18 0.000 0.0125 Y 
19 0.000 0.01319444444444 Y 
20 0.000 0.01388888888889 Y 
21 0.000 0.01458333333333 Y 
22 0.000 0.01527777777778 Y 
23 0.000 0.01597222222222 Y 
24 0.000 0.01666666666667 Y 
25 0.000 0.01736111111111 Y 
26 0.001 0.01805555555556 Y 
27 0.002 0.01875 Y 
28 0.002 0.01944444444444 Y 
29 0.002 0.02013888888889 Y 
30 0.003 0.02083333333333 Y 
31 0.006 0.02152777777778 Y 
32 0.057 0.02222222222222 Y 
33 0.059 0.02291666666667 N 
34 0.059 0.02361111111111 N 
35 0.067 0.02430555555556 N 
36 0.079 0.025 N 
37 0.081 0.02569444444444 N 
38 0.091 0.02638888888889 N 
39 0.109 0.02708333333333 N 
40 0.111 0.02777777777778 N 
41 0.118 0.02847222222222 N 
42 0.133 0.02916666666667 N 
43 0.134 0.02986111111111 N 
44 0.144 0.03055555555556 N 
! 274 
45 0.152 0.03125 N 
46 0.161 0.03194444444444 N 
47 0.184 0.03263888888889 N 
48 0.185 0.03333333333333 N 
49 0.203 0.03402777777778 N 
50 0.219 0.03472222222222 N 
51 0.219 0.03541666666667 N 
52 0.323 0.03611111111111 N 
53 0.335 0.03680555555556 N 
54 0.406 0.0375 N 
55 0.424 0.03819444444444 N 
56 0.424 0.03888888888889 N 
57 0.443 0.03958333333333 N 
58 0.501 0.04027777777778 N 
59 0.54 0.04097222222222 N 
60 0.546 0.04166666666667 N 
61 0.597 0.04236111111111 N 
62 0.628 0.04305555555556 N 
63 0.673 0.04375 N 
64 0.684 0.04444444444444 N 
65 0.719 0.04513888888889 N 
66 0.724 0.04583333333333 N 
67 0.772 0.04652777777778 N 
68 0.791 0.04722222222222 N 
69 0.791 0.04791666666667 N 
70 0.913 0.04861111111111 N 
71 0.963 0.04930555555556 N 
72 0.988 0.05 N 
 
!
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3.4  Fibroblast M
etabolism 
 3.4.1  Alamar Blue Absorbance - M
edian Values and (95%
 Confidence Intervals) 
Surface 
M
edian values 
and (95%
 confidence intervals) 
 
Surface 
 
M
edian values 
and (95%
 confidence intervals) 
Pol 
24.8 (24.067 to 29.117) 
HAAg10 (P24) 
25.85 (23.792 to 26.191) 
HA 
26.15 (25.22 to 33.297) 
HAAgFn10 (P24) 
26.35 (25.218 to 27.166) 
HAFn 
31.35 (28.429 to 33.204) 
HAAg50 (P24) 
23.85 (22.451 to 26.749) 
HAAg10 
19.65 (19.496 to 19.921) 
HAAgFn50 (P24) 
25.6 (24.2 to 30.217) 
HAAgFn10 
19.5 (19.114 to 22.269) 
HAAg100 (P24) 
24.9 (24.505 to 27.004) 
HAAg50 
19.350 (19.032 to 19.634) 
 HAAgFn100 (P24) 
25.55 (25.256 to 25.909) 
HAAgFn50 
20.05 (19.716 to 20.234) 
HAAg100 (P48) 
25.6 (25.397 to 27.403) 
HAAg100 
18.2 (18.011 to 18.506) 
HAAgFn100 (P48) 
25.05 (24.674 to 26.386) 
 HAAgFn100 
18.2 (17.958 to 18.542) 
 
HAAg10 (P4) 
20.55 (20.46 to 20.874 
HAAgFn10 (P4) 
20.75 (20.519 to 22.931) 
HAAg50 (P4) 
19.8 (19.151 to 21.43) 
HAAgFn50 (P4) 
20.9 (20.732 to 21.468) 
HAAg10 (P8) 
22.1 (21.478 to 24.072) 
HAAgFn10 (P8) 
23.45 (22.251 to 24.999) 
HAAg50 (P8) 
23.2 (21.241 to 23.492) 
HAAgFn50 (P8) 
22.2 (21.86 to 23.857) 
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3.4.2  Alamar Blue Absorbance - p values  
 Kruskall W
allis p= 0.000 
 
Pol 
HA 
HAFn   
 
HAAg 
10 
HAAg 
Fn10 
HAAg 
50 
HAAg 
Fn50 
HAAg 
100 
HAAg 
Fn100 
HAAg 
10 
(P4) 
HAAg 
Fn10 
(P4) 
HAAg 
50 
(P4) 
HAAg 
Fn50 
(P4) 
Pol 
 
0.219 
0.008 
 
 
 
 
 
 
 
 
 
 
HA 
 
 
0.143 
0.000 
 
0.000 
 
 
 
0.000 
 
 
 
HAFn 
 
 
 
 
0.000 
 
0.000 
 
 
 
0.000 
 
 
HAAg10 
 
 
 
 
0.799 
0.060 
 
0.000 
 
0.000 
 
 
 
HAAgFn10 
 
 
 
 
 
 
0.219 
 
0.000 
 
0.012 
 
 
HAAg50 
 
 
 
 
 
 
0.003 
0.000 
 
 
 
0.043 
 
HAAgFn50 
 
 
 
 
 
 
 
 
0.000 
 
 
 
0.000 
HAAg100 
 
 
 
 
 
 
 
 
0.977 
 
 
 
 
HAAgFn100  
 
 
 
 
 
 
 
 
 
 
 
 
 
HAAg10  (P4) 
 
 
 
 
 
 
 
 
 
 
0.671 
0.000 
 
HAAgFn10 (P4) 
 
 
 
 
 
 
 
 
 
 
 
 
0.799 
HAAg50 (P4) 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
HAAgFn50 (P4) 
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HAAg 
10  
(P8) 
HAAg 
Fn10 
(P8) 
HAAg 
50 
(P8) 
HAAg 
Fn50 
(P8) 
HAAg 
10  
(P24) 
HAAg 
Fn10 
(P24) 
HAAg 
50 
(P24) 
HAAg 
Fn50 
(P24) 
HAAg 
100 
(P24) 
HAAg 
Fn100 
(P24) 
HAAg 
100 
(P48) 
HAAg 
Fn100 
(P48) 
Pol 
 
 
 
 
 
 
 
 
 
 
 
 
HA 
0.001 
 
0.000 
 
0.198 
 
0.045 
 
0.291 
 
0.977 
 
HAFn 
 
0.000 
 
0.000 
 
0.002 
 
0.068 
 
0.001 
 
0.000 
HAAg10 
 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn10 
 
 
 
 
 
 
 
 
 
 
 
 
HAAg50 
 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn50 
 
 
 
 
 
 
 
 
 
 
 
 
HAAg100 
 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn100  
 
 
 
 
 
 
 
 
 
 
 
 
HAAg10  (P4) 
0.000 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn10 (P4) 
 
0.033 
 
 
 
 
 
 
 
 
 
 
HAAg50 (P4) 
 
 
0.003 
 
 
 
 
 
 
 
 
 
HAAgFn50 (P4) 
 
 
 
0.001 
 
 
 
 
 
 
 
 
HAAg10 (P8) 
 
0.242 
0.887 
 
0.012 
 
 
 
 
 
 
 
HAAgFn10 (P8) 
 
 
 
0.266 
 
0.003 
 
 
 
 
 
 
HAAg50 (P8) 
 
 
 
 
 
 
0.143 
 
 
 
 
 
HAAgFn50 (P8) 
 
 
 
 
 
 
 
0.002 
 
 
 
 
HAAg10 (P24) 
 
 
 
 
 
0.178 
0.410 
 
 
 
 
 
HAAgFn10 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
HAAg50 (P24) 
 
 
 
 
 
 
 
 
0.291 
 
 
 
HAAgFn50 (P24) 
 
 
 
 
 
 
 
 
 
 
 
 
HAAg100 (P24) 
 
 
 
 
 
 
 
 
 
 
0.160 
 
HAAgFn100 (P24) 
 
 
 
 
 
 
 
 
 
 
 
0.069 
HAAg100 (P48) 
 
 
 
 
 
 
 
 
 
 
 
 
HAAgFn100 (P48) 
 
 
 
 
 
 
 
 
 
 
 
 
Kruskall W
allis Pol, HA (not HAFn) and HAAg+/-Fn groups after P24 and P48  p=0.548 
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3.4.3  Alamar Blue Absorbance - Benjamini Hochberg Procedure 
Rank p value Threshold 
(i/m)Q 
Reject Null 
Hypothesis (Y/N) 
1 0.000 0.000909091 Y 
2 0.000 0.001818182 Y 
3 0.000 0.002727273 Y 
4 0.000 0.003636364 Y 
5 0.000 0.004545455 Y 
6 0.000 0.005454545 Y 
7 0.000 0.006363636 Y 
8 0.000 0.007272727 Y 
9 0.000 0.008181818 Y 
10 0.000 0.009090909 Y 
11 0.000 0.01 Y 
12 0.000 0.010909091 Y 
13 0.000 0.011818182 Y 
14 0.000 0.012727273 Y 
15 0.000 0.013636364 Y 
16 0.000 0.014545455 Y 
17 0.000 0.015454545 Y 
18 0.000 0.016363636 Y 
19 0.000 0.017272727 Y 
20 0.000 0.018181818 Y 
21 0.001 0.019090909 Y 
22 0.001 0.02 Y 
23 0.001 0.020909091 Y 
24 0.002 0.021818182 Y 
25 0.002 0.022727273 Y 
26 0.003 0.023636364 Y 
27 0.003 0.024545455 Y 
28 0.003 0.025454545 Y 
29 0.008 0.026363636 Y 
30 0.012 0.027272727 Y 
31 0.012 0.028181818 Y 
32 0.033 0.029090909 N 
33 0.043 0.03 N 
34 0.045 0.030909091 N 
35 0.060 0.031818182 N 
36 0.068 0.032727273 N 
37 0.069 0.033636364 N 
38 0.143 0.034545455 N 
39 0.143 0.035454545 N 
40 0.16 0.036363636 N 
41 0.178 0.037272727 N 
42 0.198 0.038181818 N 
43 0.219 0.039090909 N 
44 0.219 0.04 N 
! 279 
45 0.242 0.040909091 N 
46 0.266 0.041818182 N 
47 0.291 0.042727273 N 
48 0.291 0.043636364 N 
49 0.410 0.044545455 N 
50 0.671 0.045454545 N 
51 0.799 0.046363636 N 
52 0.799 0.047272727 N 
53 0.887 0.048181818 N 
54 0.977 0.049090909 N 
55 0.977 0.05 N 
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4  Chapter Four Statistics 
4.1  S aureus Direct Colony Counts 
4.1.1  S aureus: Biofilm Direct Colony Counts  
Median Values and (95% Confidence Intervals) 
Surface Median values 
and (95% confidence intervals) 
Pol 1500000    (925200.4274 to 2074799.5726) 
HA 5000000    (1926808.1444 to 10406525.1889) 
HAFn 15000000  (12969166.7744 to 19030833.2256) 
HAAg10 410000      (353082.7610 to 496917.2390) 
HAAgFn10 170000      (63412.2180 to 341587.7820) 
HAAg50 215000      (149145.7784 to 323354.2216) 
HAAgFn50 38000        (-143149.3237 to 586482.6570) 
HAAg100 0                (constant) 
HAAgFn100 0                (constant) 
Pol (P24) 6500          (-2102.30 to 35435.63) 
HA (P24) 2000000    (884450 to 6493327.78) 
HAFn (P24) 2000000    (1453869.04 to 7257242.07) 
HAAg10 (P24) 1000000    (688676.84 to 1711323.16) 
HAAgFn10 (P24) 2000000    (910760.50 to 2533683.95) 
HAAg50 (P24) 1000000    (795782.48 to 1718762.98) 
HAAgFn50 (P24) 390000      (70593.01 to 1709406.99) 
HAAg100 (P24) 3000          (1580.54 to 4619.46) 
HAAgFn100 (P24) 17000        (11454.59 to 21878.75) 
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4.1.2  S aureus: Biofilm Direct Colony Counts - p values 
 Kruskall W
allis p= 0.000 
 
Pol 
HA 
HAFn 
HAAg 
10 
HAAg 
Fn10 
HAAg 
50 
HAAg 
Fn50 
HAAg  
100 
HAAg 
Fn100 
Pol  
P24 
HA 
P24 
HAFn  
P24 
HAAg 
10  
P24 
HAAg 
Fn10  
P24 
HAAg 
50 P24 
HAAg 
Fn50 P24 
HAAg 
100 P24 
HAAg 
Fn100  
P24 
Pol 
 
0.008 
 
(0.000) 
 
 
 
 
 
 
0.001 
 
 
 
 
 
 
 
 
HA 
 
 
0.001 
0.001 
 
 
 
 
 
 
0.088 
 
 
 
 
 
 
 
HAFn 
 
 
 
 
0.000 
 
 
 
 
 
 
0.000 
 
 
 
 
 
 
HAAg10 
 
 
 
 
0.010 
0.002 
 
 
 
 
 
 
0.002 
 
 
 
 
 
HAAgFn10 
 
 
 
 
 
 
0.228 
 
0.000 
 
 
 
 
0.000 
 
 
 
 
HAAg50 
 
 
 
 
 
 
0.272 
0.000 
 
 
 
 
 
 
0.001 
 
 
 
HAAgFn50 
 
 
 
 
 
 
 
 
0.000 
 
 
 
 
 
 
0.020 
 
 
HAAg100 
 
 
 
 
 
 
 
 
1.000 
 
 
 
 
 
 
 
0.000 
 
HAAgFn100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
Pol P24 
 
 
 
 
 
 
 
 
 
 
0.000 
 
0.000 
 
0.000 
 
0.005 
0.394 
HA P24 
 
 
 
 
 
 
 
 
 
 
 
0.796 
0.040 
 
0.020 
 
 
 
HAFn P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.481 
 
0.021 
 
 
HAAg10 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.059 
0.824 
 
 
 
HAAgFn10 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.065 
 
 
HAAg50 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.206 
0.000 
 
HAAgFn50 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.001 
HAAg100 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
HAAgFn100 P24 
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4.1.3  S aureus: Biofilm Direct Colony Counts - Benjamini Hochberg procedure 
Rank p value Threshold 
(i/m)Q 
Reject Null 
Hypothesis (Y/N) 
1 0.000 0.001282051 Y 
2 0.000 0.002564103 Y 
3 0.000 0.003846154 Y 
4 0.000 0.005128205 Y 
5 0.000 0.006410256 Y 
6 0.000 0.007692308 Y 
7 0.000 0.008974359 Y 
8 0.000 0.01025641 Y 
9 0.000 0.011538462 Y 
10 0.000 0.012820513 Y 
11 0.000 0.014102564 Y 
12 0.000 0.015384615 Y 
13 0.000 0.016666667 Y 
14 0.000 0.017948718 Y 
15 0.001 0.019230769 Y 
16 0.001 0.020512821 Y 
17 0.001 0.021794872 Y 
18 0.001 0.023076923 Y 
19 0.001 0.024358974 Y 
20 0.002 0.025641026 Y 
21 0.002 0.026923077 Y 
22 0.004 0.028205128 Y 
23 0.008 0.029487179 Y 
24 0.010 0.030769231 Y 
25 0.020 0.032051282 Y 
26 0.020 0.033333333 Y 
27 0.021 0.034615385 Y 
28 0.040 0.035897436 N 
29 0.059 0.037179487 N 
30 0.065 0.038461538 N 
31 0.088 0.03974359 N 
32 0.206 0.041025641 N 
33 0.228 0.042307692 N 
34 0.272 0.043589744 N 
35 0.394 0.044871795 N 
36 0.481 0.046153846 N 
37 0.796 0.047435897 N 
38 0.824 0.048717949 N 
39 1.000 0.05 N 
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4.1.4  S aureus: Planktonic Direct Colony Counts -  
Median Values and (95% Confidence Intervals) 
Surface Median values 
and (95% confidence intervals) 
Pol 260000     (123410.86 to 315255.81) 
HA 3600000   (1687072.81 to 5979593.85) 
HAFn 5000000   (3028182.06 to 7071817.94) 
HAAg10 2550000   (1937358.96 to 3012641.04) 
HAAgFn10 2200000   (1839358.97 to 3010641.03) 
HAAg50 800000     (351153.67 to 1373846.33) 
HAAgFn50 405000     (73492.98 to 1499840.36) 
HAAg100 5000         (1275.73 to 29168.72) 
HAAgFn100 25000       (14114.36 to 64330.08) 
Pol (P24) 535000     (150225.74 to 989774.26) 
HA (P24) 25000000 (17179959.51 to 32820040.49) 
HAFn (P24) 20000000 (16980179.84 to 27686486.83) 
HAAg10 (P24) 4800000   (3065903.63 to 7756318.59) 
HAAgFn10 (P24) 2000000   (1502844.68 to 2652710.87) 
HAAg50 (P24) 150000     (81829.76 to 193988.42) 
HAAgFn50 (P24) 1300000   (1123431.05 to 2009902.28) 
HAAg100 (P24) 70000       (24001.52 to 97331.81) 
HAAgFn100 (P24) 65000       (49711.32 to 96955.35) !
!
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4.1.5  S aureus: Planktonic Direct Colony Counts - p values 
!Kruskall W
allis p= 0.000 
 
Pol 
HA 
HAFn 
HAAg 
10 
HAAg 
Fn10 
HAAg 
50 
HAAg 
Fn50 
HAAg  
100 
HAAg 
Fn100 
Pol  
P24 
HA 
P24 
HAFn  
P24 
HAAg 
10  
P24 
HAAg 
Fn10 P24 
HAAg 
50 P24 
HAAg 
Fn50 P24 
HAAg 
100 P24 
HAAg 
Fn100  
P24 
Pol 
 
0.000 
 
*(0.000) 
 
*(0.008) 
 
(0.002) 
(0.002) 
0.029 
 
 
 
 
 
 
 
 
HA 
 
 
0.063 
0.730 
 
0.001 
 
 
 
 
0.000 
 
 
 
 
 
 
 
HAFn 
 
 
 
 
0.008 
 
 
 
 
 
 
0.000 
 
 
 
 
 
 
HAAg10 
 
 
 
 
0.863 
0.001 
 
 
 
 
 
 
0.000 
 
 
 
 
 
HAAgFn10 
 
 
 
 
 
 
0.000 
 
 
 
 
 
 
0.340 
 
 
 
 
HAAg50 
 
 
 
 
 
 
0.743 
0.001 
 
 
 
 
 
 
0.000 
 
 
 
HAAgFn50 
 
 
 
 
 
 
 
 
0.000 
 
 
 
 
 
 
0.031 
 
 
HAAg100 
 
 
 
 
 
 
 
 
0.529 
0.000 
 
 
 
 
 
 
0.181 
 
HAAgFn100 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.031 
Pol P24 
 
 
 
 
 
 
 
 
 
 
0.000 
 
*(0.000) 
 
(0.000) 
 
(0.000) 
(0.000) 
HA P24 
 
 
 
 
 
 
 
 
 
 
 
0.489 
0.000 
 
 
 
 
 
HAFn P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
 
 
 
 
HAAg10 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
0.000 
 
 
 
HAAgFn10 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.113 
 
0.000 
HAAg50 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
0.020 
 
HAAgFn50 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.000 
HAAg100 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0.931 
HAAgFn100 P24 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*HAAg10 and HAAg50 had greater bacterial numbers than Pol.  HAAg100 and HAAgFn100 were the only surfaces that were antibacterial compared to Pol. 
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4.1.6  S aureus: Planktonic Direct Colony Counts -  
Benjamini Hochberg procedure 
Rank p value Threshold 
(i/m)Q 
Reject Null 
Hypothesis (Y/N) 
1 0.000 0.001190476 Y 
2 0.000 0.002380952 Y 
3 0.000 0.003571429 Y 
4 0.000 0.004761905 Y 
5 0.000 0.005952381 Y 
6 0.000 0.007142857 Y 
7 0.000 0.008333333 Y 
8 0.000 0.00952381 Y 
9 0.000 0.010714286 Y 
10 0.000 0.011904762 Y 
11 0.000 0.013095238 Y 
12 0.000 0.014285714 Y 
13 0.000 0.01547619 Y 
14 0.000 0.016666667 Y 
15 0.000 0.017857143 Y 
16 0.000 0.019047619 Y 
17 0.000 0.020238095 Y 
18 0.000 0.021428571 Y 
19 0.000 0.022619048 Y 
20 0.000 0.023809524 Y 
21 0.000 0.025 Y 
22 0.001 0.026190476 Y 
23 0.001 0.027380952 Y 
24 0.001 0.028571429 Y 
25 0.002 0.029761905 Y 
26 0.002 0.030952381 Y 
27 0.008 0.032142857 Y 
28 0.008 0.033333333 Y 
29 0.020 0.03452381 Y 
30 0.029 0.035714286 Y 
31 0.031 0.036904762 Y 
32 0.031 0.038095238 Y 
33 0.063 0.039285714 N 
34 0.113 0.04047619 N 
35 0.181 0.041666667 N 
36 0.340 0.042857143 N 
37 0.489 0.044047619 N 
38 0.529 0.045238095 N 
39 0.730 0.046428571 N 
40 0.743 0.047619048 N 
41 0.863 0.048809524 N 
42 0.931 0.05 N 
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4.2  P aeruginosa Direct Colony Counts 
 
4.2.1  P aeruginosa Bacterial Challenge 106 cfu: Biofilm Direct Colony Counts - 
Median Values and 95% Confidence Intervals 
Surface Median values 
and (95% confidence intervals) 
Pol 800000     (339224.83 to 1871886.29) 
HA 30000000 (4158527.71 to 37241472.29) 
HAFn 8650000   (-5971233.19 to 45237899.85) 
HAAg100 235000     (-661844.75 to 2501844.75) 
HAAgFn100 325000     (246885.23 to 399781.44) 
Pol P24 280000     (221828.56 to 358171.44) 
HA P24 200000     (149018.59 to 250981.41) 
HAFn P24 350000     (166533.30 to 560133.37) 
HAAg100 P24 210000     (99165.22 to 523334.78) 
HAAgFn100 P24 230000     (180181.33 to 293152.00) 
 
 
 
4.2.2  P aeruginosa Bacterial Challenge 106 cfu : Biofilm Direct Colony Counts - p values 
Kruskall Wallis p= 0.001 
 Pol HA HAFn HAAg  
100 
HAAg 
Fn100 
Pol  
P24 
HA 
P24 
HAFn  
P24 
HAAg 
100 
P24 
HAAg 
Fn100  
P24 
Pol  0.005  (0.190) 0.040 0.142     
HA   0.628 0.001   0.000    
HAFn     0.113   0.181   
HAAg100     0.730    0.321  
HAAgFn100          0.730 
Pol P24       0.606  (0.397) (0.210) 
HA P24        0.931 0.673  
HAFn P24          0.605 
HAAg100 
P24 
         0.888 
HAAgFn100 
P24 
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4.2.3  P aeruginosa Bacterial Challenge 106 cfu : Planktonic Direct Colony Counts - 
Median Values and 95% Confidence Intervals 
Surface Median values 
and (95% confidence intervals) 
Pol 150000000 (95979413.48 to 1123312746.82) 
HA 110000000 (77892763.50 to 124964379.36) 
HAFn 190000000 (-128724657.15 to 1188724657.15) 
HAAg100 150000000 (77593778.73 to 209156221.27) 
HAAgFn100 105000000 (10434720.80 to 208565279.20) 
Pol P24 80000000   (26951240.76 to 160763044.96) 
HA P24 120000000 (42269367.90 to 221063965.44) 
HAFn P24 110000000 (45480546.03 to 321852787.30) 
HAAg100 P24 255000000 (108295104.27 to 305954895.73) 
HAAgFn100 P24 220000000 (90341191.44 to 257214364.11) 
 
 
4.2.4  P aeruginosa Bacterial challenge 106 cfu : Planktonic Direct Colony Counts - p values 
 
Kruskall Wallis p=0.114     
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4.2.5  P aeruginosa Bacterial Challenge 5 x 104  cfu: Biofilm Direct Colony Counts - 
Median Values and 95% confidence intervals 
Surface Median values 
and (95% confidence intervals) 
Pol 12000000 (5509240.65 to 44557426.02) 
HA 30000000 (16561597.06 to 50549514.05) 
HAFn 20000000 (16041514.22 to 28625152.45) 
HAAg100 1200000   (878937.04 to 1743285.18) 
HAAgFn100 300000     (215030.85 to 584969.15) 
Pol P24 3000000   (2282230.21 to 3584436.46) 
HA P24 4000000   (2173908.10 to 6714980.79) 
HAFn P24 6000000   (1294653.75 to 14530346.25) 
HAAg100 P24 1500000   (1033671.53 to 1788550.69) 
HAAgFn100 P24 1700000   (856241.51 to 2014869.60) 
 
 
 
4.2.6  P aeruginosa Bacterial Challenge 5 x 104  cfu: Biofilm Direct Colony Counts –  
p values 
Kruskall Wallis p= 0.000 
 Pol HA HAFn HAAg  
100 
HAAg 
Fn100 
Pol  
P24 
HA 
P24 
HAFn  
P24 
HAAg 
100 
P24 
HAAg 
Fn100  
P24 
Pol  0.387  (0.003)  0.024     
HA   0.340 0.000   0.000    
HAFn     0.000   0.002   
HAAg100     0.000    0.605  
HAAgFn100          0.071 
Pol P24       0.094  (0.000) (0.000) 
HA P24        0.605 0.000  
HAFn P24          0.008 
HAAg100 
P24 
         0.436 
HAAgFn100 
P24 
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4.2.7  P aeruginosa Bacterial Challenge 5 x 104  cfu: Planktonic Direct Colony Counts - 
Median Values and 95% Confidence Intervals 
Surface Median values 
and (95% confidence intervals) 
Pol 8000000000 (6283966941.43 to 8360477503.01) 
HA 3000000000 (1868167117.84 to 6442943993.27) 
HAFn 4900000000 (2709823260.98 to 7401287850.13) 
HAAg100 41000000     (20557925.99 to 111219851.79) 
HAAgFn100 8000000       (6004209.68 to 13995790.32) 
Pol P24 8000000000 (3999354029.46 to 8289534859.43) 
HA P24 4200000000 (3108182336.52 to 6980706552.37) 
HAFn P24 6850000000 (3316802337.87 to 7958197662.13) 
HAAg100 P24 330000000   (336051.97 to 1672997281.36) 
HAAgFn100 P24 200000000   (103335775.49 to 254442002.29) 
 
 
4.2.8  P aeruginosa Bacterial Challenge 5 x 104  cfu: Planktonic Direct Colony Counts -  
p values 
Kruskall Wallis p= 0.000 
 Pol HA HAFn HAAg  
100 
HAAg 
Fn100 
Pol  
P24 
HA 
P24 
HAFn  
P24 
HAAg 
100 
P24 
HAAg 
Fn100  
P24 
Pol   0.031  (0.000)  0.546     
HA   0.730 0.000   0.297    
HAFn     0.000   0.673   
HAAg100     0.000    0.000  
HAAgFn100          0.000 
Pol P24       0.546  (0.000)  
HA P24        0.815 0.000  
HAFn P24          0.000 
HAAg100 
P24 
         0.014 
HAAgFn100 
P24 
          
 
 
 !
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5  Chapter Five Statitstics 
 
Wettability 
Kruskall Wallis p=0.008 
 Pol HA HAFn HAAg HAAgFn HAAg  
(P24) 
HAAgFn 
(P24) 
Pol  0.002 0.002 0.002 0.002 0.002 0.010 
HA   1.000 0.699    
HAFn     0.937   
HAAg     0.937 0.310  
HAAgFn       0.171 
HAAg (P24)       0.476 
HAAgFn (P24)        
 
Kruskall Wallis HA +/- Ag +/- Fn groups=0.671 
 
N.B. The remainder of the statistics for Chapter Five are presented in the chapter. 
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6  Chapter Six Statistics 
6.1  Epithelial Downgrowth 
6.1.1  Median Values and 95% Confidence Intervals 
Surface Median value and (95% confidence interval) 
SP 6.0753 (5.2082 to 8.7915) 
DF 4.2043 (2.6040 to 4.3087) 
PT 1.2900 (0.9936 to 3.1139) 
PT-HA 1.7826 (1.2789 to 3.3195) 
PT-HAFn 1.7655 (1.2074 to 2.3601) 
PT-HAAg 1.7562 (0.9242 to 2.9181) 
PT-HAAgFn 1.7888 (1.3366 to 2.1510) 
 
6.1.2 Epithelial Downgrowth - p values 
Kruskall Wallis p= 0.000 
 SP DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
SP  0.000      
DF   0.027 0.052 0.003 0.017 0.001 
PT    0.786 0.898 0.880 0.786 
PT-HA     0.566 0.551  
PT-HAFn      0.976 0.695 
PT-HAAg       0.799 
PT-HAAgFn        
 
6.2 Epithelial Attachment - p values 
 
Kruskall Wallis (all groups) p = 0.044 
Kruskall Wallis (DF and PT +/- coatings) p=0.859 
 SP DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
SP  0.045      
DF   0.347 0.713 0.590 0.713 0.843 
PT    0.590 0.671 0.630 0.291 
PT-HA     0.932 0.977  
PT-HAFn      0.932 0.514 
PT-HAAg       0.590 
PT-HAAgFn        
 
(Median values and 95% confidence intervals are shown in Chapter Six) 
 
 
 
 
 
 
 
! 292 
6.3 Subepithelial Attachment 
6.3.1 Median Values and 95% Confidence Intervals 
Surface Median value and (95% confidence interval) 
SP 0 (-3.9951 to 47.4251) 
DF 56.4400 (43.8219 to 71.0281) 
PT 80.4700 (67.5846 to 89.7167) 
PT-HA 71.2850 (67.5673 to 83.2277) 
PT-HAFn 91.3500 (80.4524 to 97.8596) 
PT-HAAg 76.1200 (65.4293 to 81.5557) 
PT-HAAgFn 83.5000 (76.2449 to 90.5268) 
 
6.3.2 Subepithelial Attachment - p values 
Kruskall Wallis p=0.000 
 SP DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
SP  0.017      
DF   0.020 0.014 0.002 0.089 0.004 
PT    0.590 0.091 0.410 0.443 
PT-HA     0.023 0.977  
PT-HAFn      0.006 0.316 
PT-HAAg       0.039 
PT-HAAgFn        
 
6.4  Percentage Soft Tissue Fill within the Inner Pores 
6.4.1  Median Values and 95% Confidence Intervals 
Surface Median value and (95% confidence interval) 
SP 65 (35.3703 to 80.2963) 
DF 90 (82.8587 to 93.8079) 
PT 82.5 (77.2816 to 91.0517) 
PT-HA 90 (87.6562 to 95.0711) 
PT-HAFn 80 (71.5110 to 87.4890) 
PT-HAAg 90 (81.9386 to 94.4251) 
PT-HAAgFn 65 (35.3703 to 80.2963) 
 
6.4.2 Percentage Soft Tissue Fill within the Inner Pores - p values 
Kruskall Wallis p= 0.001 
 DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
DF  0.000 0.005 0.000 0.010 0.001 
PT   0.319 0.266 0.060 0.755 
PT-HA    0.068 0.443  
PT-HAFn     0.002 0.266 
PT-HAAg      0.143 
PT-HAAgFn       
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6.5  Number of Cell Nuclei/mm2 within the Inner Pores 
 
6.5.1 Median Values and 95% Confidence Intervals 
 
Surface Median value and (95% confidence interval) 
DF 1520.5050 (1028.8516 to 2332.6951) 
PT 3922.6250 (2590.6413 to 5182.6021) 
PT-HA 2883.8250 (2029.4570 to 3891.7696) 
PT-HAFn 2945.8300 (2473.5655 to 3708.2709) 
PT-HAAg 3086.2450 (2595.8449 to 4017.1911) 
PT-HAAgFn 2606.3700 (1990.1559 to 4334.6132) 
 
6.5.2  Number of Cell Nuclei/mm2 within the Inner Pores - p values 
Kruskall Wallis p = 0.084 
 DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
DF  0.018 0.041 0.002 0.003 0.024 
PT   0.410 0.478 0.539 0.713 
PT-HA    0.799 0.497  
PT-HAFn     0.674 0.799 
PT-HAAg      0.674 
PT-HAAgFn       
Kruskall Wallis PT +/- coatings p=0.889 
 
 
6.6  Number of Blood Vessels/ mm2 within the Inner Pores 
6.6.1 Median Values and 95% Confidence Intervals 
Surface Median value and (95% confidence interval) 
DF 0 (-23.2890 to 97.4090) 
PT 213.2150 (133.9067 to 293.7583) 
PT-HA 134.1550 (66.4745 to 224.9305) 
PT-HAFn 224.7700 (182.1744 to 277.3820) 
PT-HAAg 335.3450 (198.7168 to 431.9032) 
PT-HAAgFn 159.1100 (108.2056 to 237.7671) 
 
6.6.2 Number of Blood Vessels/ mm2 within the Inner Pores - p values 
Kruskall Wallis p = 0.005 
 DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
DF  0.002 0.102 0.001 0.005 0.005 
PT   0.143 0.651 0.219 0.413 
PT-HA    0.134 0.024  
PT-HAFn     0.316 0.101 
PT-HAAg      0.104 
PT-HAAgFn       
 
!
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6.7  Chapter Six Correlation  
Spearman’s rho      
Epithelial 
downgrowth 
(mm) 
Percentage 
Epithelial 
Attachment 
Percentage 
Subepithelial 
attachment 
Percentage 
Fill Inner 
Pores 
Pore - Cell 
Nuclei/mm
2 
Pore - Blood 
Vessel/mm
2 
Epithelial downgrowth 
(mm) 
Correlation Coefficient 
 
-0.214 
-0.496 
-0.149 
-0.141 
-0.145 
Sig (2-tailed) 
 
0.053 
0.000 
0.240 
0.732 
0.322 
Percentage Epithelial 
Attachment 
Correlation Coefficient 
 
 
0.412 
0.027 
-0.037 
-0.103 
Sig (2-tailed) 
 
 
0.000 
0.831 
0.774 
0.420 
Percentage Subepithelial 
attachment 
Correlation Coefficient 
 
 
 
0.246 
0.074 
0.094 
Sig (2-tailed) 
 
 
 
0.048 
0.566 
0.462 
Percentage Fill Inner 
Pores 
Correlation Coefficient 
 
 
 
 
0.360 
0.373 
Sig (2-tailed) 
 
 
 
 
0.004 
0.002 
Pore - Cell Nuclei/mm
2 
Correlation Coefficient 
 
 
 
 
 
0.439 
Sig (2-tailed) 
 
 
 
 
 
0.000 
Pore - Blood Vessel/mm
2 
Correlation Coefficient 
 
 
 
 
 
 
Sig (2-tailed) 
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7  Chapter Seven Statistics 
7.1  Skin Surface Swab Direct Colony Counts  
7.1.1  Medians Values and 95% Confidence Intervals 
Surface Median value and (95% confidence interval) 
SP 2050 (1060.29 to 13264.71) 
DF 2200 (-4504.73 to 106592.23) 
PT 2900 (-4136.42 to 36222.13) 
PT-HA 1650 (-4348.12 to 27859.23) 
PT-HAFn 5000 (-4120.76 to 104304.09) 
PT-HAAg 4000 (-18993.45 to 259829.81) 
PT-HAAgFn 90000 (-6853.25 to 807398.7) 
 
7.1.2  Skin Surface Swab Direct Colony Counts - p values 
Kruskall Wallis p=0.225 
 
 
7.2  Superficial Soft Tissue Biopsy Direct Colony Counts 
 
7.2.1  Medians Values and 95% Confidence Intervals 
Surface Median value and (95% confidence interval) 
SP 83.965 (123.4488 to 566.2424) 
DF 84.015 (61.9483 to 193.3567) 
PT 19.755 (17.6234 to 40.958) 
PT-HA 61.11 (49.866 to 121.084) 
PT-HAFn 142.5 (67.5629 to 277.0088) 
PT-HAAg 43.64 (19.0178 to 74.284) 
PT-HAAgFn 51.16 (36.4087 to 256.5949) 
 
 
7.2.2  Superficial Soft Tissue Biopsy Direct Colony Counts - p values  
 
Kruskall Wallis p=0.000 
 SP DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
SP  0.355      
DF   0.000 0.079 0.556 0.000 0.171 
PT    0.000 0.019 0.602 0.259 
PT-HA     0.656 0.011 0.673 
PT-HAFn      0.022 0.343 
PT-HAAg       0.503 
PT-HAAgFn        
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7.3  Deep soft tissue biopsy 
 
7.3.1  Medians values and 95% confidence intervals 
 
Surface Median value and (95% confidence interval) 
SP 6.2 (11.1668 to 88.1857) 
DF 25.625 (19.8165 to 154.9747) 
PT 1.485 (0.7332 to 4.4425) 
PT-HA 10.5 (13.6632 to 78.1946) 
PT-HAFn 0.8250 (0.1559 to 5.1608) 
PT-HAAg 4 (2.6592 to 6.0553) 
PT-HAAgFn 6.25 (2.0437 to 11.7599) 
 
 
 
7.3.2  Deep soft tissue biopsy - p values  
 
Kruskall Wallis p= 0.000 
 SP DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
SP  0.224      
DF   0.000 0.135 0.000 0.000 0.000 
PT    0.008 0.526 0.901 0.766 
PT-HA     0.007 0.009 0.020 
PT-HAFn      0.861 0.539 
PT-HAAg       0.830 
PT-HAAgFn        
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7.4  Deep Soft Tissue-Implant Interface Swab 
 
7.4.1  Medians Values and 95% Confidence Intervals 
 
Surface Median value and (95% confidence interval) 
SP 160000 (99137.85 to 439112.15) 
DF 60000 (-22380.62 to 1570380.62) 
PT 850 (1008.13 to 55420.44) 
PT-HA 3250 (3671.48 to 15517.41) 
PT-HAFn 1900 (1017.78 to 9698.89) 
PT-HAAg 300 (1.81 to 4998.19) 
PT-HAAgFn 400 (289.42 to 6583.31) 
 
 
 
7.4.2  Deep Soft Tissue-Implant Interface Swab - p values   
 
Kruskall Wallis p=0.000 
 SP DF PT PT 
-HA 
PT 
-HAFn 
PT 
-HAAg 
PT-
HAAgFn 
SP  0.938      
DF   0.000 0.000 0.000 0.000 0.000 
PT    0.815 0.839 0.075 0.357 
PT-HA     0.214 0.012 0.220 
PT-HAFn      0.106 0.808 
PT-HAAg       0.259 
PT-HAAgFn        
 
 
!
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 7.5  Correlation (Chapter Seven results combined Chapter Six) 
 
Spearman’s rho      
Skin surface 
swab cfu/mL 
Superficial 
soft tissue 
cfu/mL 
Deep soft 
tissue cfu/mL 
Deep swab 
cfu/mL 
Epithelial 
downgrowth 
(mm) 
Percentage 
epithelial 
attachment 
Percentage sub- 
epithelial 
attachment 
Percentage fill 
inner pores 
Pore - cell 
nuclei 
/mm2 
Pore - blood 
vessels 
/mm2 
Skin 
surface 
swab 
cfu/mL 
Correlation  
Coefficient 
 
-0.174 
-0.022 
-0.154 
-0.349 
-0.116 
0.000 
0.133 
0.170 
0.051 
Sig (2-
tailed) 
 
0.059 
0.816 
0.098 
0.001 
0.294 
1.000 
0.287 
0.178 
0.688 
Superficial 
soft tissue  
cfu/mL 
Correlation  
Coefficient 
 
 
0.470 
0.385 
0.165 
-0.115 
-0.221 
-0.103 
-0.327 
-0.412 
Sig (2-
tailed) 
 
 
0.000 
0.000 
0.155 
0.315 
0.052 
0.435 
0.012 
0.001 
Deep soft 
tissue 
cfu/mL 
Correlation  
Coefficient 
 
 
 
0.433 
-0.080 
-0.105 
-0.239 
-0.053 
0.066 
-0.258 
Sig (2-
tailed) 
 
 
 
0.000 
0.485 
0.355 
0.034 
0.683 
0.615 
0.048 
Deep swab  
cfu/mL 
Correlation  
Coefficient 
 
 
 
 
0.437 
-0.203 
-0.297 
-0.021 
-0.318 
-0.190 
Sig (2-
tailed) 
 
 
 
 
0.000 
0.073 
0.008 
0.872 
0.014 
0.150 
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7.6  Chapter Seven Correlation - Benjamini Hochberg procedure 
Rank p value Threshold 
(i/m)Q 
Reject Null 
Hypothesis (Y/N) 
1 0 0.001666667 Y 
2 0 0.003333333 Y 
3 0 0.005 Y 
4 0 0.006666667 Y 
5 0.001 0.008333333 Y 
6 0.001 0.01 Y 
7 0.008 0.011666667 Y 
8 0.012 0.013333333 Y 
9 0.014 0.015 N 
10 0.034 0.016666667 N 
11 0.048 0.018333333 N 
12 0.052 0.02 N 
13 0.059 0.021666667 N 
14 0.073 0.023333333 N 
15 0.098 0.025 N 
16 0.15 0.026666667 N 
17 0.155 0.028333333 N 
18 0.178 0.03 N 
19 0.287 0.031666667 N 
20 0.294 0.033333333 N 
21 0.315 0.035 N 
22 0.355 0.036666667 N 
23 0.435 0.038333333 N 
24 0.485 0.04 N 
25 0.615 0.041666667 N 
26 0.683 0.043333333 N 
27 0.688 0.045 N 
28 0.816 0.046666667 N 
29 0.872 0.048333333 N 
30 1 0.05 N !
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